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ABSTRACT
Acrylamide (AA) is a vinyl monomer that has many applications in chemical industries. 
The aim o f  this work was to assess the reproductive toxicity o f  AA and clarify its 
underlying mechanism o f  action in rat; in particular, whether AA or its reactive 
metabolite glycidamide is responsible for the majority o f  the noted adverse effects. 
Moreover, the protective effect o f 5-aminosalicylic acid (5-ASA) against AA testicular and 
genotoxicity was investigated.
Acrylamide gavaged at doses from 5-60m g/kg daily for 5 consecutive days caused dose- 
dependent toxicity. Light microscopy examination showed multinucleated giant cells and 
tubular atrophy in the testis. In addition, electron microscopy showed Ley dig cell atrophy 
and Sertoli cell toxicity. Epididymal sperm count showed a significant reduction in caudal 
sperm count in particular at higher concentrations. Despite these microscopic effects on 
the testis, this work also showed that AA has no toxic effects on absolute or relative testis 
or cauda weight, and no toxic effect on seminiferous tubule diameter. Outside o f  the 
testis, COMET assay undertaken on peripheral blood leukocytes showed genotoxicity in 
the form o f  COMET cells with increased Tail moment, while ELISA o f  serum 
testosterone showed severe reduction in testosterone level after AA treatment, which was 
reversed by concomitant ASA treatment. ELISA o f  CYP2E1 showed a 2-fbld higher 
concentration in control liver S9 when compared to control testis S9. Further, 5-ASA  
(50mg/kg) induced the level o f  liver CYP2E1, potentially increasing AA metabolism and 
clearance; this induction was accompanied by an improvement o f  testicular pathology and 
reduction in COMET Tail moments. Together, these data are consistent with AA being 
the main causative agent responsible for the toxicity noted in the testis and genotoxicity 
in blood. Moreover, 5-ASA could potentially offer a protective mechanism against AA- 
mediated toxicity, by increasing AA clearance.
In conclusion, at the used dose, AA caused toxic effects in male rat that can be reduced 
by concomitant treatment with 5-ASA, which might be considered as an antidote to AA  
toxicity in victims o f  AA poisoning.
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1 Introduction
1.1 The Testis
The testis is an oval organ possessing a thick covering o f fibrous tissue named tunica 
albuginea. In humans, its average dimensions are from 4 to 5 cm in length, 2.5 cm in 
breadth and 3 cm in the anteroposterior diameter. Its weight varies from 10.5 to 14g 
(Williams and Warwick, 1980); each testis is ellipsoidal in form, compressed laterally and 
has an oblique position in the scrotum. The epididymis is attached to the postero-lateral 
surface o f the testis. The testes, epididymis and tunica vaginalis lie in the scrotum 
surrounded by thin membranes, adherent to each other, which are downward 
prolongations o f  the coverings o f  the spermatic cord.
The upper pole o f the epididymis is attached high up on the postero-lateral surface o f  the 
testis. From this area, fibrous septa radiate into the testis and reach the tunica albuginea. 
The rete testis is present in this place, the fibrous mass containing the rete is known as 
the mediastinum testis. The septa radiating from the mediastinum divide the organ into 
some 400 spaces, each o f which contain two (sometimes three or four) highly convoluted 
seminiferous tubules, each 2ft (60 cm) long. The seminiferous tubules open into the rete 
testis which is a network o f  intercommunicating channels lying in the mediastinum testis. 
From the rete, the vasa efferentia (fifteen to twenty in number), enter the 
commencement o f  the canal o f  the epididymis, and each efferent tubule is coiled into a 
small lobule before connecting with the canal o f the epididymis (Fig. 1).
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Seminiferous tubule
Lobes of testis
Tunica albuginea
111 Tunica vaginalis
' b - -----------------
Head of epididymis
Straight seminiferous \ \  
tubules
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Vasa efferentia
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Vas deferens
Tail of epididymis
F i g .  1. Section through an adult testis
Demonstrates general structure o f the testes, taken from (Johnson and Everitt, 2000).
1.1.1 M icroscopic Anatom y
The testis is surrounded by a thick, dense regularly arranged connective tissue capsule 
called the tunica albuginea. Some o f this connective tissue extends into the interior o f the 
testis as fibrous septa, dividing the testis into lobules. Their num ber in the human testis is 
estimated to be between 200 and 300(Williams and Warwick, 1980). Each lobule consists 
o f one to four highly folded tubules named seminiferous tubules; the total num ber in 
each testis is estimated to be between 400 and 600 (Williams and Warwick, 1980). These 
seminiferous tubules actually represent the exocrine portion o f the testis, and it is the site 
o f spermatogenesis.
Seminiferous tubules: these are surrounded by an outer lamina propria o f compact 
connective tissue with flattened fibroblasts and an inner, thin basement membrane. 
Internal to the basement membrane is the germinal epitheHum, which consists o f two 
elements, one spermatogenic, and the other supportive.
1.1.1.1 Spermatogenic Cells
These are renewing cells that divide, differentiate, and mature. These cells are arranged 
within the wall, in sequence with the earliest cells at the periphery and the latest ones at 
the lumen. They include five types o f cells, representing the stages o f spermatogenesis, as 
follows;
i. Spermatogonia
These are in contact with the basement membrane o f the seminiferous epithelium. 
Several populations o f spermatogonia are usually recognized. In fact, they are the stem 
cells from which all spermatozoa are derived, which are descended from those primordial 
germ cells, which reach and multiply in the genital cords o f the developing testis.
3
Type- A Spermatogonia are highly proliferative and undergo mitosis to provide an 
extensive pool o f cells. For subsequent mitoses, two types are recognized, dark-type A- 
spermatogonia with a darker stained nuclei that divide to maintain the basic store o f 
spermatogonia and that also give rise to some pale type-A cells. These in turn divide and 
differentiate into type B spermatogonia, the immediate precursors o f the spermatocytes. 
Type B Spermatogonia : These are cells that differentiate into primary spermatocytes.
ii. Primary Spermatocytes
These have diploid chromosome content, and divide to form secondary spermatocytes 
with a haploid num ber o f chromosomes. This constitutes the nuclear division (meiosis-I) 
and passes through a preleptotene (resting) stage followed by leptotene, zygotene, 
pachytene, and diplotene stages and the completion o f cell division.
iii. Secondary Spermatocytes
These are small cells with granular chromatin and rounded nuclei. They contain the 
haploid num ber o f chromosomes but diploid in D N A  content and are smaller than the 
primary spermatocytes.
iv. Spermatids
Secondary spermatocytes undergo the second meiotic division (meiosis-II) to give
spermatids, which have haploid num ber o f chromosomes and also in D N A  content.
They arc located adjacent to the lumen o f the seminiferous tubule and gradually mature
into spermatozoa through a series o f nuclear and cytoplasmic modifications and several
stages have been identified on the basis o f nuclear shape; round and elongated
spermatids being generally recognized. Spermatids mature into spermatozoa by migration
4
o f the nucleus into one end (the head) and thinning out o f the cytoplasm into a tail that 
projects into the lumen while still attached by the head, the cell is called a spermatid. 
Only when free in the lumen, it is nam ed as spermatozoon,
v. Mature Sperm
These consist o f a head and a tail, with the head containing an elongated nucleus and 
acrosomal cap. The tail consists o f  the neck, which contains two centrioles, the middle 
section, which has an outer sheath o f mitochondria for energy production, the principal 
piece, which has an outer fibrous sheath for support, and lastly, an end piece.
1.1.1.2 Sertoli Cells
Sertoli cells are supporting (sustentacullar) cells in the seminiferous tubule that have a 
num ber o f im portant functions (Kessel, 1998). They arise from the epithelial cords in the 
developing gonads, and are columnar in shape; basally, they are in contact with the 
basement membrane and extend to the lumen o f the seminiferous tubule. The Sertoli 
cells are non- proliferating cells in the adult. The nucleus is large, irregular in shape, stains 
weakly and is located basally in the cell. It contains a large prom inent nucleolus. The 
cytoplasm contains prom inent Golgi complexes, mitochondria, smooth endoplasmic 
reticulum (sER), rough endoplasmic reticulum (rER), lipid droplets, lysosomes, residual 
bodies, and a lipochrome pigment. The Sertoli cells produce a secretion called testicular 
fluid, which is released into the lumen o f the seminiferous tubules. This fluid appears to 
be im portant for sperm survival and is especially rich in potassium, glutamate, and 
inositol. The Sertoli cells are responsive to follicle stimulating horm one (FSH), since they 
possess cell surface receptors for this hormone. In response to FSH, Sertoli cells 
synthesize and secrete an androgen binding protein (ABP) that binds testosterone, so
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that a microenvironment consisting o f a high concentration o f testosterone is maintained 
in the seminiferous tubules.
In order for spermatogenesis to occur, a high concentration o f testosterone m ust be 
maintained in the seminiferous tubules. Sertoli cells: (i) play an im portant role in 
providing the appropriate microenvironment for sperm differentiation; (ii) are im portant 
in the m ovem ent o f the interconnected germ cells; (iii) play a role in the release 
(spermiation) o f the spermatozoa into the seminiferous tubule lumen; (iv) phagocytose 
degenerating sperms or residual bodies that are sloughed from spermatids and digest 
them intracellularly; (v) protect against toxins and (vi) create & maintain blood-testis 
barrier. The histological structure o f a seminiferous tubule is shown in (Fig. 2).
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Fig. 2. Photomicrograph o f parts o f seminiferous tubules
Demonstrates spermatogonia (Sg) and spermatogonia in mitosis (arrows), note the Primary 
spermatocytes (Ps) and die Sertoli cells (SC), myoid cells (M), and fibroblast (F) cells (Cl), 
connective tissue and (L), interstitial cells of Leydig. x487. Taken from (Berman, 1998).
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The blood-testis barrier consists o f  extensive circumferential zonulae occludens (tight 
junctions) between adjacent Sertoli Cells near their base (Fig. 3). As a result o f these 
many sealing strands, the seminiferous tubule is divided into a basal compartment, which 
contains proliferating type-A spermatogonia and an adluminal com partment, which 
contains type B spermatogonia. The presence o f the blood-testis barrier means that it is 
possible for the Sertoli Cells to direct the flow o f fluid to the lumen o f the seminiferous 
tubule, so that it does not pass back into the interstitium. Therefore, a special 
microenvironment can be maintained for the spermatids in the adluminal com partment 
o f the seminiferous tubule (Fig. 4). This testicular fluid contains a high concentration o f 
ABP and K + ions, but a low concentration o f N a+ions (Kessel, 1998). Since the haploid 
primary spermatocytes that have completed meiosis are genetically different from the 
parent or host (Kessel, 1998), a barrier could prevent foreign proteins associated with the 
spermatocytes or spermatids from reaching the host's blood stream and perhaps inducing 
antibody formation.
MYCiC CELL
Fig. 3. Diagram o f the Sertoli cell
Demonstrates the relationship between the Sertoli cell and the spermatogonia, spermatocytes, 
and spermatids. Circumferential tight junctions from basal and adluminal compartments for the 
seminiferous epithelium. Taken from (Kessel, 1998).
Fig. 4. Inter-Sertoli cell junctions
Demonstrates how Sertoli cell will divide the seminiferous epithelium into a basal compartment 
and into an adluminal compartment, taken from (De Kretser and Kerr, 1994).
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1.1.1.3 The Testicular Interstitial (Peritubular) Tissue
The interstitial cells o f the testis (Leydig cells) also include various other cells; some o f 
the connective tissue type, together with the vessels and nerves in the tissue between the 
seminiferous tubules. The Leydig cell is a large, polyhedral cell with a poorly staining 
cytoplasm and an eccentric nucleus that contains one to three nucleoli. Leydig cells 
contain much granular endoplasmic reticulum vacuoles, rich in ascorbic acid, fats, 
phospholipids, and cholesterol (Williams and Warwick, 1980). These cells develop from 
the mesenchyme and they synthesize testosterone. In response to luteinizing horm one 
(LH), the interstitial cells o f Leydig produce androgens; the principal one is testosterone. 
Testosterone has several im portant effects including; (i) stimulation o f spermatogenesis; 
(ii) stimulation o f secretion o f accessory glands; and (iii) development o f secondary male 
sex characteristics such as growth o f facial, axillary and pubic hair, enlargement o f  the 
larynx and the additional musculo-skeletal growth (Kessel, 1998).
Functions o f Lamina Propria are; i) a source o f mechanical support and contractile 
function for the seminiferous tubule through myoid cells; ii) Passive paracrine influence 
on spermatogenesis via secretory products stimulated by testosterone; iii) Partial and 
species-specific restriction o f macromolecules entering seminiferous tubules through the 
intertubular tissues; iv) a source o f precursor cells which are able to differentiate into 
Leydig cells (De Kretser and Kerr, 1994).
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1.1.1.4 The Epididymis
This is a firm structure attached behind the testis, with the ductus deferens to its medial 
side. It consists o f  a single tube 6 m long, highly coiled and packed together by fibrous 
tissue. It has a large head and a small tail connected by the intervening body, which is 
applied in a crescentic manner to the back o f the testis. A narrow slit between the 
epididymis and the testis is known as the sinus o f  the epididymis. The head receives the 
vasa efferentia from the rete testis and is thus firmly attached to the testis. Elsewhere, the 
epididymis has no functional connection with the testis, to which it is, however fairly 
firmly bound by fibrous tissue. From the tail, the vas deferens is a direct continuation o f  
the canal o f the epididymis; it passes up medially and enters the spermatic cord, passing 
through the inguinal canal, across the side wall o f  the pelvis, and crosses the pelvic cavity. 
It pierces the prostrate and opens by the ejaculatory duct into the prostatic urethra. The 
spermatozoa that emerge from the testis are stored in the ductus epididymis; the 
spermatozoa that enter the epididymis are not motile and are not yet capable o f  
fertilization. These spermatozoa undergo a capacitation process in the epididymis before 
they are capable o f fertilization. It is thought that the secretory epithelial cells in the 
epididymis produce a protein that causes the spermatozoa to become motile and undergo 
forward motion (Kessel, 1998). The secretions o f  other accessory glands are also 
important to the forward motility o f  the spermatozoa.
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1.2 Spermatogenesis in Rats
1.2.1 General Overview and Cytology
The basic features o f spermatogenesis are com m on to all mammals (Chubb, 1993) 
Spermatogenesis is the sequence o f cytological events that ends up with formation o f 
mature spermatozoa from precursor cells. Three major elements together form 
spermatogenesis: a) stem cell (spermatogonia) renewal by the process o f mitosis; b) 
reduction o f chromosomal num ber by meiosis; and c) the transformation o f a 
conventional cell into a more complex structure, a spermatozoon, by a series o f changes 
with no further cell division, this metamorphic process is called spermiogenesis.
The testes are composed o f germ cell elements and non-germ cell elements, namely the 
Sertoli cells, which form the blood-testis barrier and give support to migratory 
population o f cells that proliferate at the base o f the tubule and migrate progressively 
toward the lumen as the cells differentiate (De Kretser and Kerr, 1994).
Spermatogonia are the cells that divide by mitosis and constitute the pool o f cells from 
which meiosis and spermatogenesis proceed. Two types o f  these cells were defined in 
rats: the 'dusty' cells characterized by peripherally placed nuclei with fine palely stained 
chromatin granules (type-A) and the 'crusty' cell characterized by centrally placed nuclei 
with coarse, dark granules (type-B). This classification was accorded due to differences in 
the chromatin patterns o f the nuclei. Studies on seminiferous tubules revealed that 
spermatogonia, because o f incomplete cytokinesis during mitosis, remain connected by 
intercellular bridges so that large numbers are effectively linked together.
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These bridges are 2-3 jam in width and do not usually contain organelles or microtubules 
(De Kretser and Kerr, 1994). By electron microscopy (Fig. 5), the basal position o f 
spermatogonia within the epithelium and their extensive contact with the basement 
membrane o f the tubule can be easily identified. However, the extent o f this contact 
decreases in type B spermatogonia, because these will eventually lose all contact with the 
basement membrane, to become preleptotene primary spermatocytes (De Kretser and 
Kerr, 1994).
Fig. 5. Ultra structure o f  rat seminiferous epithelium
Showing Sertoli cells(S) spermatogonia (SU), primary spermatocytes (P), and round (RS) and 
elongated spermatids (ES), taken from (De Kretser and Kerr, 1994).
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Spermatocytes are the cells that are involved in meiosis and are o f two types, primary and 
secondary. Each primary spermatocyte moves into the adluminal com partment o f  the 
seminiferous tubules and duplicates its D N A  and subsequently undergoes meiosis I  to 
produce two haploid secondary spermatocytes.
Type-B spermatogonia which lose contact with the basement membrane o f the 
seminiferous tubule, divide to give primary spermatocytes. Secondary spermatocytes are 
spherical cells, intermediate in size between primary spermatocytes and spermatids. They 
are located close to the lumen o f the seminiferous tubules (De Kretser and Kerr, 1994). 
Several stages o f spermatids have been identified on the basis o f their nuclear shape: 
round and elongated spermatids are generally recognized. The newly formed spermatids 
are spherical cells that are smaller in size than secondary spermatocytes and are found at 
the luminal part o f the seminiferous tubule (De Kretser and Kerr, 1994).
1.2.2 Spermiogenesis
This is the process o f transformation o f spermatids to spermatozoa, in which no cell 
division is required. However, it is a metamorphosis by which a conventional cell is 
changed to a highly organized and motile structure. Its major features are com m on to all 
species. However, the genetic factors for each species determine the morphological 
features between spermatozoa and hence, the details o f species spermiogenesis (De 
Kretser and Kerr, 1994). In mammals, spermiogenesis is a long cell biological process, 
lasting approximately 20 days in rats and 24 days in humans (Heller and Clermont, 1964). 
Spermatid differentiation is not independent o f the surroundings but their development 
is in intimate relationship with the surrounding Sertoli cells (Clermont et al., 1993). It is a 
continuous process that commences at the time o f spermatid formation and results in 
release o f the fully formed spermatozoon. There are 19 steps o f spermiogenesis defined
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in rats and 6 in humans (Clermont et al., 1993). The changes are grouped into: i) 
acrosome formation; ii) nuclear changes; iii) development o f the flagellum.
i) Formation o f the Acrosome
This arises from the Golgi complex. Many proacrosomic granules coalesce together to 
form a single granule, which comes into contact with the nuclear membrane. It is 
composed o f glycoprotein and spreads over 25% to 60% o f the nuclear surface (De 
Kretser and Kerr, 1994). The acrosome arises from the Golgi complex in the spermatid 
and it contains enzymes that are necessary for sperm penetration during egg fertilization; 
it looks like a cap over the nucleus. Its main structure is composed o f an inner acrosomal 
membrane overlying the anterior part o f  the nuclear membrane and the outer acrosomal 
membrane. It consists o f two segments: the acrosomal cap (Anterior acrosome) and the 
equatorial segment (posterior acrosome). It contains multiple enzymes, including several 
acid hydrolases usually present in lysosomes. For this reason, it has been described as a 
specialized lysosome. After release and activation o f acrosomal enzymes by calcium- 
mediated exocytosis in response to specific signals, the spermatozoa penetrate the zona 
pellucida surrounding the oocyte (Eddy and O'Brien, 1994).
ii) Nuclear Changes
During the acrosome phase (step 8-14 o f spermiogenesis), the nucleus elongates, 
condenses, and changes its position by shifting toward the cell surface, with progressive 
condensation o f chromatin to form larger, electron dense, granules. This shift in nuclear 
position with progressive reduction in nuclear size results in the flow o f the bulk o f the 
cytoplasm to the opposite pole o f the cell, where it extends along the developing tail 
(Clermont et al., 1993).
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iii) Formation o f the Tail
The newly formed spermatids have a pair o f centrioles (proximal and distal) in their 
cytoplasm. These centrioles migrate toward the nucleus, pulling the plasma membrane 
with them. Simultaneously, one o f the two centrioles starts the formation o f the axoneme 
and then it elongates, as in any other growing cilia, by the addition o f a and (3 tubulins at 
the distal ends o f the microtubular singlets and doublets. The full growth o f the 
axoneme (150pm) appears to be completed by the end o f the cap phase o f 
spermatogenesis.
The basic structure o f the axial filament is common to flagella and cilia and is composed 
o f nine peripheral axonemal doublet microtubules arranged equidistant from each other 
in a circular manner, in which two single microtubules are found in the center. These 
doublets consist o f two subfibers, A and B (Fig. 6).
The outer dense fibers are the major cy to skeletal element o f the spermatozoon's tail. One
O D F  per axonemal doublet presents along the middle piece. There are nine coarse
OD Fs, each with a characteristic size and shape. The O D F  decreases in diameter from
the proximal to the distal extremity o f the middle piece. However, in the principal piece,
O D Fs numbers 3 and 8 are replaced by longitudinal columns o f the fibrous sheath and
the remaining OD Fs decrease in diameter dis tally and disappear at the end piece o f the
tail. The fibrous sheath is a complex structure extends lengthwise opposite microtubular
doublets numbers 3 and 8. The functions o f O D Fs and the fibrous sheath are still not
clear, although they obviously modulate the type o f motion o f the axoneme. Condensed,
crescentic mitochondria are arranged side by side and transversely along the cytoskcletal
com ponent o f the tail (helical rearrangement) (Fig. 7). The annulus is a ring-like
stabilizing structure seen in fully formed spermatozoa at the junction o f the middle piece
and the tail, preventing caudal displacement o f mitochondria in actively motile sperm tail
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Out e r  f ibre ( d o u b l e t )
D y n e  in a r m s
C e n t r a l  s h e a t h
N e x i n  l ink
C e n t r a l
m i c r o t u b u l e s R a d i a l  s p o k e s
Fig. 6. Components o f the axial filament when cut in perfect cross section 
Taken from (De Kretser and Kerr, 1994).
M iddle P iece
 F  TTZC—
Principal P iece
Fig. 7. General features o f the mammalian spermatozoon
The middle piece contains the mitochondrial sheath, and the principal piece contains the fibrous 
sheath. Longitudinal and cross sectional views of the principal piece and a segment of fibrous 
sheath are indicated by arrows. Taken from (Eddy and O'Brien, 1994).
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1.2.3 Horm onal Regulation o f Spermatogenesis
One o f the primary events to occur in puberty is the proliferation o f spermatogonia, and 
this is under Sertoli cell control. The two horm ones FSH and testosterone are the most 
im portant horm ones for this control. For convenience, it is possible to divide the 
horm onal regulation for spermatogenesis into two stages: one before maturation, or 
prepubertal, in which Sertoli cells are FSH modulated and its primary role in 
spermatogenesis is stimulation o f Sertoli cell proliferation (Holdcraft and Braun, 2004). 
The other stage is after puberty, in which Sertoli cells are testosterone-modulated and its 
primary role is Sertoli cell maturation (Sharpe, 1994).
1.2.3.1 Gonadotrophic Regulation o f Spermatogenesis
The pituitary gland is located in the hypophyseal fossa o f the sphenoid bone. It has an 
extremely rich blood supply. There are three lobes o f the pituitary gland, but we are more 
concerned here with the anterior lobe, which secretes the gonadotrophins (FSH and LH), 
prolactin, growth horm one, adrenocorticotrophic horm one (ACTH), and thyroid 
stimulating hormone. All lobes are connected anatomically and functionally to the 
overlying hypothalamus (Johnson and Everitt, 2000).
I-Follicle Stimulating H orm one (follitropin) FSH
Follicle stimulating horm one is a glycoprotein hormone. In order for FSH actions to be 
initiated, there should be an interaction o f the horm one with the receptors that 
specifically interact with FSH. These receptors in the male are present on Sertoli cells 
(Griswold, 1993).
FSI I-stimulated Sertoli cells, produce specific proteins such as; androgen binding protein 
(ABP), plasminogen activator, transferrin, sulfated glycoproteins 1 & 2, and a num ber o f 
growth factors. Successful spermatogenesis needs structural maturation o f the Sertoli
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cells and the increased secretion o f proteins into the lumen o f the tubules. FSH also 
appears to play a role in regulating development o f the appropriate num ber o f Leydig 
cells to balance the high level o f testosterone when needed later on (Griswold, 1993).
II-Luteinizing Horm one (LH)
Is another glycoprotein horm one secreted by the anterior pituitary gland. Its main 
function is to stimulate Leydig cell to synthesis and secrete testosterone. LH receptors 
(LH- R) are present primarily on the surface o f Leydig cells (Johnson and Everitt, 2000). 
Two other horm ones affect the activity o f LH. These are prolactin and inhibin, which 
bind to LH receptors and facilitate the stimulatory action o f LH. However, they do not 
stimulate testosterone production (Johnson and Everitt, 2000).
Gonadotropin Releasing H orm one (GnRH) provides a link between the neural and 
endocrine systems. It is synthesized and stored in the hypothalamus; G nRH  is released in 
pulses and then is conducted to the anterior pituitary, where it stimulates release o f the 
gonadotropins (LH and FSH) (Conn, 1994). Any abnormality in G nRH  synthesise, 
storage, or release results in partial or complete failure o f gonadal functions (Johnson and 
Everitt, 2000) (Fig. 8).
Testosterone is the main horm one regulating LH secretion. It also can inhibit FSH 
secretion, but with the lesser effect than on LH. In fact, a complete suppression o f FSH 
comes from combined action o f androgen and inhibin (Johnson and Everitt, 2000).
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Pituitary
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Leydig Inhibin
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Fig. 8. Horm onal regulation o f spermatogenesis
Most hormones shown can have both positive and negative effects, either at the level of receptor 
activation/desensitization or through activation and repression of downstream targets GnRH, 
gonadotrophin releasing hormone; LH, luteinizing hormone; FSH, follicle stimulating hormone; 
T, testosterone. Taken from (Holdcraft and Braun, 2004).
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1.2.3.2 Testosterone
Androgens are the m ost im portant horm ones produced by the testis. These hormones 
play a major role during development and reproductive function in the mature male. The 
main testicular androgen is testosterone (Johnson and Everitt, 2000), which belongs to a 
group o f steroids with unique structural and functional features. It is synthesized from 
acetate and cholesterol by the Leydig cells o f the interstitial tissue. This synthesis is 
stimulated by LH that is secreted from the anterior pituitary gland. This involves a series 
o f enzymes and cofactors that together form the biosynthesis pathway and a source o f 
energy. It appears that the mitochondria are the primary organelles that are responsible 
for the conversion o f cholesterol, which is either supplied to them from the plasma or is 
stored as lipid droplets in the cytoplasm in the form o f pregnenolone. In addition, it 
transports cholesterol to the inner membrane.
After its formation by the Leydig cell, testosterone, which is relatively lipid soluble, 
passes through the cellular barriers between testicular compartments to enter the 
seminiferous tubules (Sharpe, 1994). A large am ount is then converted to the m ore active 
form, dihydrotestosterone, by the influence o f 5-oc reductase activity in the Sertoli cells 
(Johnson and Everitt, 2000). After its formation, it is bound to androgen receptors, 
mainly on the Sertoli cells. These androgen receptors are also present in peritubular cells, 
Leydig cells and it has been shown that they are present in the muscular layer o f all 
arteries within the rat testis (Sharpe, 1994).
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Studies have shown that these receptors are not present in germ cells; accordingly, it is 
suggested that testosterone action in supporting the development o f germ cells is indirect 
and occurs through the Sertoli cell or peritubular myoid cells o f the seminiferous tubules. 
In addition, within the adluminal compartment, testosterone binds to the androgen- 
binding protein (ABP) that was secreted by the Sertoli cell and it carries the horm one in 
the testicular fluid (Johnson and Everitt, 2000). Testosterone and its metabolites are 
called sex hormones, and this reflects their primary role in the gonadal and germ cell 
developmental regulation in males and females, in addition to sexual differentiation in 
males (Holdcraft and Bruan, 2004). In general, it is an essential horm one for normal 
spermatogenesis and fertility in all male mammals that have been investigated (Sharpe, 
1994).
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1.3 Testicular T oxicity of Xenobioitics
Toxicological disturbance o f male reproductive function can occur at several sites and 
can produce a range o f effects. Some o f these are primary and some are secondary to the 
triggering insult (Creasy, 2001). Toxic agents can possibly interfere with the male 
reproductive system at many targets. Careful examination o f the earliest morphological 
abnormality produced may allow the detection o f the target cell o f the toxicity.
The male reproductive system can be affected by several toxicants that act either 
indirectly through alteration o f the complex horm onal control o f  the testes, or directly by 
affecting their chemical reactivity. Both types o f insult may require metabolic 
biotransformation to gain activity, and the site o f activation might play a role in 
modulation o f testicular toxicity (Working, 1989). A summary o f toxicants to the male 
reproductive tract is given in Table 1. Creasy, (2001) has summarized the pattern and 
mechanisms o f testicular toxicity, as follows:
1.3.1 Patterns o f Damage Associated with Sertoli Cell Toxicants
The Sertoli cell is considered to be one o f the m ost common target cells for toxicity. 
Vacuolation is the m ost common pathological response o f Sertoli cells to injury; some 
vacuolations are large and scattered while others are small and present at the basal area o f 
the Sertoli cell. These vacuoles usually represent the dilated cisternae o f the smooth 
endoplasmic reticulum when examined ultrastructurally, but the convoluted nature o f the 
cytoplasmic processes o f this cell interferes with the subcellular localization o f the 
vacuoles. Several toxic compounds present with Sertoli cell vacuolations, including 
cyclohexylamine, phthalate esters, and 2, 5-hexanedione. Functional compromise o f the 
Sertoli cell would be reflected on the survival o f the dependent germ cells.
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Thereby, germ cell degeneration, disorganization, or exfoliation could be seen. In 
addition, the responses o f germ cells vary with different toxicants and this might be 
related to the functional disturbance within the Sert oh cells, which are highly resistant to 
death. Thus, even though there may be partial or complete depletion o f germ cells, 
Sertoli cell will remain intact and continue to line the depleted tubules (Creasy, 2001).
1.3.2 Patterns o f Damage Associated with Germ  Cell Toxicity
Germ  cell toxicity often shows cell and stage specificity (affecting target cells only in 
specific stages o f the spermatogenic cycle). The early response o f germ cell specific 
toxicity is rapid apoptosis and phagocytosis by Sertoli cells. This leaves the tubules 
depleted o f a single generation o f germ cells and is followed by progressive depletion o f 
spermatogenesis (depletion o f cell generation maturation). For example, in the case o f 
glycol ether toxicity, 12 h following a single oral dose, necrosis can be seen in pachytene 
spermatocytes, with mid-pachytene spermatocytes showing least sensitive stage and 
prepachytene cells being unaffected. At 48 h following dosing, Sertoli cells have 
phagocytosed the apoptotic spermatocytes, leaving no signs o f cell death (Creasy et al., 
1985).
In general, spermatogenesis is characterized by organized specific cell stages that proceed 
from spermatogonia to spermatocytes, followed by spermatids, and finally sperm. 
Thereby, any loss o f a specific cell population will result in progressive loss o f all o f  the 
following cell types by (maturation depletion).
This leaves the seminiferous tubules lined only with Sertoli cells and with germ cells that 
preceded the killed specific cell stage affected by the toxicant, and gives a picture o f 
"maturation arrest". Most probably, in the case o f functionally com petent Sertoli cells 
and unaffected spermatogonia, these cells will continue to replenish the germ cell 
population.
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In the case o f cell-specific germ cell toxicants, the delay time between spermatogonial 
death and the appearance o f reduction in fertility depends on the affected germ cell 
population. Furthermore, this time delay is species specific, since the duration o f 
spermatogenesis is different from one species to another. In the case o f the rat, fertility 
will not be changed for approximately 8-10 weeks following exposure, which is the time 
needed for the unaffected developing spermatids and spermatocytes in the testes to 
complete their maturation to sperm and pass through the epididymis. In contrast, in the 
mouse, the time delay is shorter, approximately o f 6-8 weeks following exposure and this 
is obviously because o f the shorter spermatogenic cycle in the mouse.
As with the Sertoli cell, the underlying mechanism o f germ cell toxicity is not well 
known. A well-understood mechanism o f action is that o f the cytotoxic effects o f 
antimitotic agents such as Busulfan or cyclophosphamide on the spermatogonial 
population. These compounds target D N A  replication in specific subpopulations o f 
spermatogonia (differential spermatogonia). Because spermatogonia are located within 
the basal com partment o f the testes, they are exposed to interstitial fluid toxicants. In 
contrast, spermatocytes and spermatids are located within the adluminal com partm ent o f 
the tubule, so they are protected from the toxicants entering the interstitial compartment. 
This is the reason behind the relative resistance o f spermatocytes to the cytotoxicants 
and it answers the question o f why not all o f the somatic cell mutagens are germ cell 
mutagens. Ethane methane sulfonate is one o f the genotoxicants that has the ability to 
enter the luminal compartment, causing irreversible D N A  damage to the germ cells, in 
contrast to spermatogonia, which have extensive D N A  repair mechanisms (Meistrich 
1984,1986).
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Target Cell T oxicant Effect Reference
Leydig Cell E thancdim ethancsulfonate
Lansoprazole
Leydig cell necrosis w ith secondary 
germ  cell death and depletion and 
atrophy o f  secondary sex organs
Inhib ition  o f  testosterone synthesis 
w ith secondary Leydig cell tum or 
induction
(C oulson et al., 2003)
Sertoli Cell Phthalate esters, 2,5-hexanedione Sertoli Cell vacuoles w ith secondary 
germ  cell death and exfoliation
(Creasy et al., 1987);(Chapin et 
al., 1983)
Sperm atogonia Busulfan,bleom ycin Sperm atogonial death w ith secondary 
depletion o f  postsperm atogonial germ  
cells
(M eistrich, 1984,); (Meistrich, 
1986)
Sperm atocytes 2-m ethoxyethanol, dinitropyrroles Sperm atocyte death with secondary 
depletion o f  postsperm atid germ  cells
R ound sperm atids Ethylm ethane sulfonate, m ethyl 
chloride
Sperm atid death w ith secondary 
depletion o f  postsperm atid  germ  cells
(Creasy, 2001); 
(Chellm an et al., 1987)
E longated sperm atids Boric acid, dibrom oacetic acid R etention  and phagocytosis o f  step 19 
sperm atids, abnorm alities in release 
sperm
(Chapin and ku, 1994) ; 
(L inder et al., 1990)
Testicular blood vessels C adm ium  chloride Endothelial necrosis w ith secondary 
ischem ic necrosis o f  all cell types
(A oki and I lo ffer, 1978)
5-hydroxytryptam ine, histam ine Reduced blood flow, w ith secondary 
anoxic dam age ranging from  oncotic 
necrosis o f  the sem iniferous 
epithelium  to germ  cell apoptosis and 
depletion
(Bocabella et al., 1962, 
O 'steen , 1963)
Epididym al epithelium a-chlorohydrin (high dose) Inhibits fluid resorp tion  and causes 
edem a o f  the caput resulting in sperm  
granulom as
(W ong and Y eung, 1977)
M ethyl chloride carbendazim Epithelial necrosis resulting in sperm  
granulom as
E fferen t duct necrosis resulting in 
sperm  granulom as
(Chellm an et al., 1986)
Epididym al sperm a-chlorohydrin (low doses), 
deoxychloroglucose
Inhib ition  o f  glycolysis resulting in  
sperm  im m otility
(Jones, 1978)
Vas deferens G uanetliidine Inhib ition  o f  ejaculation due to 
adrenergic ganglion blockade resulting 
in rapture o f  vas-epiidiym al junction 
and sperm  granulom as
(Bhatal et al., 1974)
P rostate gland and 
seminal vesicles
Flutam ide A ndrogen recep to r blockade resulting 
in secretory inhibition and atrophy
(M archetti and Labrie, 1988)
F inasteride Inhib ition  o f  dihydrotestosterone 
production  from  testosterone 
resulting in secretory inhibition and 
atrophy
(Lewis et al., 1997)
T ab le 1. Ccll-specific toxicants o f the male reproductive tract (Creasy, 2001).
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1.3.3 Pattern o f Damage Associated with Disturbance o f Fluid Balance within the Testis 
Fluid secretion in the testis has essential functions in transporting oxygen and nutrients 
from the blood to the tubule through the interstitial fluid as well as transport o f sperm 
and proteins from the tubule to the rete testis through the seminiferous tubule fluid. 
These fluids are im portant media for the paracrine factor transport between neighboring 
cells in the testis.
1.3.3.1 Effects on the Interstitial Fluid
In the rat, the interstitial fluid is located within large lymphatic sinusoids and this 
essentially makes up the interstitial extracellular space. The composition o f interstitial 
fluid is very similar to testicular blood plasma, with higher levels o f testosterone and 
androstenedione that are secreted by Leydig cells. Several factors can increase or decrease 
the interstitial fluid volume. For instance, its volume is decreased following 
hypophysectomy or estradiol administration. Furthermore, hCG  or LHRF1 agonist 
administration, obstruction o f the lymphatic drainage, or the damage following cadmium 
administration can increase its volume. Detection o f increased interstitial fluid volume is 
difficult in Bonn's fixed tissue because it causes artificial shrinkage o f tubules, but it can 
be observed by increase in testicular weight.
1.3.3.2 Effects on Seminiferous Tubule Fluid
Seminiferous tubule fluid is formed by the Sertoli cells and is mainly reabsorbed by the 
rete testis, efferent ducts, and the epithelium o f the caput epididymis. It contains 
secretory products o f the Sertoli cells, such as androgen binding protein and inhibin; and 
it also acts as a transport medium for sperm once they are released into the tubular 
lumen. Contraction o f the peritubular myoid cells surrounding the tubules partly controls 
the fluid movement from the tubule into the rete testis. Further, oxytocin, cndothclin-1 
and prostaglandins also can affect the contraction o f these cells. The volume o f the
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seminiferous tubule fluid is controlled by the rate o f secretion or the rate o f transport 
from the tubules and the rate o f reabsorption in the rete and epididymis. Any change in 
these targets can cause tubular lumen dilatation or contraction. Several testicular 
toxicants can cause reduced fluid secretion and tubular contraction. In many cases, it is 
secondary to germ cell loss, while in others it appears early and might reflect disturbed 
Sertoli cell functions. Any com pound that interferes with testicular testosterone secretion 
and reduces its level will reduce fluid secretion and will be followed by reduction in 
tubular diameter, because tubule fluid secretion is an androgen-dependent function.
1.3.3.3 Effects on Blood Flow
The seminiferous epithelium has no blood vessels and depends on transport o f oxygen 
and nutrients from the interstitial vasculature. Since many toxic compounds, such as 
cadmium salts, exert their effects on testicular capillaries and thereby reduce blood flow, 
these have been shown to be highly toxic for the endothelial cells o f the testicular 
capillaries in the post pubertal rat. This results in severe reduction in blood flow, which is 
followed by ischemic necrosis o f the testes that involves all cell types. Less severe effects 
can be seen with histamine, which causes focal tubular necrosis.
1.3.4 Patterns o f Damage Associated with Effects on Leydig Cells
Interference with several potential sites can produce functional disturbances in horm one
balance, including substances that interfere with the Leydig cell functions (since its major
function is steroidogenesis), substances that interfere with androgen or gonadotropin
receptor binding, with circulating sex horm one levels, and with metabolism or clearance
o f androgens. Fligh levels o f intracellular testosterone arc required to maintain maximal
efficiency o f spermatogenesis. Reduction in testosterone level will cause quantitative but
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not qualitative reduction in the efficiency o f spermatogenesis. The most sensitive marker 
o f reduced testosterone production is the num ber o f degenerating spermatids in stages 
VII and VIII, which are small and need careful examination to be detected. The size o f 
the seminal vesicles and prostate are another indicator o f reduced plasma testosterone 
level. The androgen receptor antagonist and 5-oc reductase, which metabolizes 
testosterone, can also affect secretory functions.
1.3.5 Patterns o f Damage Associated with Epididymal and Sperm Toxicity 
N ot all o f the epididymis functions are completely understood. D evelopm ent o f 
epithelial inflammation followed by sperm granulomas is one o f the m ost com m on 
epididymal responses to injury. This is often seen in the caput epididymis with 
com pounds that may act through ischemic mechanisms, such as a-chlorohydrin and 
cadmium. High doses o f a-chlorohydrin specifically damage the caput epididymal 
epithelium, resulting in edema and inhibition o f the tubular fluid reabsorption. This leads 
to duct dilatation and rupture o f  the ducts, with the exposure o f the antigenically foreign 
sperm to the immunocompetent cells o f  the interstitial tissue leading to formation o f 
sperm granulomas that may obstruct the passage o f sperms through the epididymis. 
Oxidative D N A  damage represents another potential mechanism o f toxicity for the 
epididymal sperm. Damage to epididymal sperm results in an immediate influence on 
fertility parameters, in contrast to testicular toxicants that result in a delayed effect on 
fertility.
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1.4 Acrylamide General Properties and ADME
1.4.1 Background
Acrylamide (propenamide or acrylic amide; AA, (Fig. 9), a vinyl m onom er that is readily 
soluble in water, has many applications in chemical industries (Zenick et a l, 1986). A 
large num ber o f studies have been reported on AA neurotoxicity, because it was first 
identified as a neurotoxin in laboratory animals and industrial workers a long time ago 
(Dearfield et ak, 1988). However, many recent investigations o f AA have been conducted 
to evaluate its other toxic effects, including reproductive toxicity (Yang et ak, 2005a,b; 
Hashim oto et ak, 1981), genotoxicity (Yang et ak, 2005b; Sega et ak, 1989) and 
carcinogenicity (Rice, 2005; Friedman et ak, 1995; Johnson et ak, 1986).
O
Fig. 9. Structural formula of Acrylamide 
From (Paulsson et ak, 2005).
1.4.2 Chemical and Physical Properties o f Acrylamide
Acrylamide has the molecular formula o f (C3H5 NO) and a molecular weight o f 71.08. It 
is white in color and a crystalline solid at room  temperature. It has a boiling point o f 
125°C, melting point o f 84.5°C and a density o f 1.27g/ml. It is quite soluble in water and 
many polar solvents, including acetone and methanol; however, it is insoluble in 
nonpolar solvents such as carbon tetrachloride. Acrylamide possesses an clcctrophilic 
vinyl group that might react with nucleophiles to produce polymers, which accounts for 
its major use. Alternatively, it also allows AA to react with biological macromolecules,
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causing toxicity (Dearfield et al., 1988).
1.4.3 Uses o f Acrylamide
The major use o f AA that accounts for 90% o f all uses is the production o f 
polyacrylamide polymers. Some polymers are used in sewage treatment and potable 
water treatment and purification, paper industry, petroleum industry to enhance oil 
recovery and greatly used for chromatography & electrophoresis in experimental 
research. Acrylamide m onom er used also in the production o f grouts and soil stabilizers 
(Dearfield et al., 1988).
1.4.4 Pharmacokinetics o f Acrylamide
Hum an exposure to AA can be through ingestion, inhalation, and skin contact (Dearfield 
et al., 1995). Acrylamide has been administered by oral gavage or intraperitoneal (IP) 
injection in most o f  the short-term studies o f AA, while in studies conducted for sub­
chronic and chronic AA toxicity in rodents, oral administration o f AA either in drinking 
water or diet was the major route o f administration. Unfortunately, the pharmacokinetics 
o f AA following dermal or inhalation exposure has received little research attention 
worldwide. The route o f AA administration is an im portant influencing factor in 
determining the extent o f AA metabolism (Sumner et ak, 2003).
1.4.4.1 Absorption
In a previous study conducted by (Miller et al., 1982), for investigating AA toxokinetics
in rats after administration o f 10 m g/kg  o f 14 [C] labeled AA by oral or IV route, the total
radioactivity was used for determination o f AA toxokinetics. Miller's study showed that
AA is rapidly and extensively absorbed after oral or IV administration and is widely
distributed to tissues. Therefore, this study indicated that A A is rapidly absorbed through
the gastrointestinal tract. In the study conducted by (Ramsy et al., 1984), for evaluating
AA absorption after dermal application, only 25% o f the applied dose o f AA was
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absorbed through the rat skin, indicating incomplete absorption o f the applied dose. In a 
study conducted by (Sumner et ak, 2003), 24hr dermal application o f 162m g/kg o f 14[C]- 
labeled AA to four male F344 rats, followed by determination o f the radioactivity in the 
urine, feces, expired air, tissues and cage wash revealed that the am ount o f  absorbed dose 
was 14, 15, 29 and 30% for the four rats. This result was highly consistent with the 
previous study conducted by (Ramsy et ak, 1984).
In a study conducted by (Fennell et ak, 2006) in humans reported that, after dermal 
exposure there is a lag period o f several hours before AA appears in the urine and this is 
the same time required for the AA to cross the stratum corneum and penetrate the 
dermis o f the skin. In the study by (Sumner et ak, 2003) , rats were exposed to a single 
2.9 ppm  (19 pmol) inhalation o f AA vapor for 6hr (6h L D 50 for exposure to AA vapor is 
more than 5.6 ppm). The total recovered A A, 24hr following the exposure, was 
approximately 6 times lower than the radioactivity recovered after dermal application o f 
AA. To assess AA toxokinetics after sub-acute IP injection in the (Barber et ak, 2001) 
study, 50 m g/kg /day  o f 14 [C] AA was administered to rats for 11 days. The IP route had 
relatively more rapid uptake, in comparison to oral administration o f a single dose o f 
20m g/kg o f 14[C]-AA by oral gavage.
1.4.4.2 Distribution
Following the IV or oral administration o f different doses o f AA, radio-labeled AA was
equally and rapidly distributed to all tissues except for fat, liver, kidney, testes, and plasma
because these seemed to have an initial absorption phase (Miller et ak, 1982). The highest
amounts o f radioactivity distributed to tissues were muscle (48%), skin (15%), blood
(12%), liver (7%), and neural tissues (1%); however, when the data were expressed as
pmol of AA per g o f tissue, the distribution o f radioactivity between different organs was
equal (Miller et ak, 1982). The ability o f  AA to bind to erythrocytes is due to its ability to
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bind to hemoglobin, forming an adduct (Barber et a l, 2001; Calleman et a l, 1990; 
Sumner et al., 2003). Furthermore, rapid AA distribution has been reported in other 
species; for instance, in dogs and pigs, it was found in the blood, brain, heart, liver, 
kidney, and lungs, with more rapid and extensive absorption in dogs than in pigs (Ikeda 
et ak, 1985). Following a 24h dermal application o f 14[C] AA, the highest radioactivity (~1 
p m o l/g tissue) was found in blood cells compared with all other tissues. Skin (non dose 
site 0.4 p m o l/g tissue) and liver, spleen, testes, and kidney had approximately the same 
level (~ 0.3 p m o l/g tissue). Radioactivity was also recovered from other organs such as 
lungs, thymus, brain, and epididymis (~0.2 pm ol/g  tissue), with the lowest radioactivity 
(>0.05pm ol/g tissue) recovered in fat (Sumner et ak, 2003). After 24h following the 6h 
inhalation exposure to 2.9 ppm  AA, the highest relative level o f radioactivity was found 
in blood cells o f rats ( ~ 0.1 pm ol/g  tissue) in comparison with all other tissues, followed 
by the testes, skin, liver, kidney brain, spleen, lung, epididymis, and fat (rank order). 
Plasma radioactivity levels were higher following exposure termination (0.03pmol /g  
tissue) but this was reduced after 24h (0.004 pm ol/g  tissue). For mice, the relative 
radioactivity 24h after exposure was greatest for testes, skin, liver, kidney, epididymis, 
brain, lung, blood, and fat (rank order). Following IP injection o f (50mg/kg/day) for 11 
days, AA was evenly distributed to tissues, with the same result obtained for radioactivity 
distribution following oral administration o f 10m g/kg o f 14[C] AA (Barber et ak, 2001).
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1.4.4.3 Metabolism
(Fig. 10) illustrates metabolic pathways for AA and glycidamide.
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Fig. 10. Metabolic pathways o f acrylamide and glycidamide. GSM (glutathtionc), FI I (epoxide 
hydrolase). Taken from (Kirman et al., 2003).
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The two main metabolic pathways that have been elucidated for AA metabolism are
glutathione conjugation (Miller et al., 1982; Sumner et al., 1992) and epoxidation to
glycidamide (GA) (Sumner et al., 1992; Calleman et al., 1990). Furthermore, in vivo
metabolism o f AA with the formation o f many metabolites has been investigated
(Sumner et ah, 1992, 1999, 2003) by administration o f 13C NM R (Nuclear Magnetic
Resonance) spectroscopy. Based on previous studies, direct glutathione (GSH)
conjugation catalyzed by glutathione-S-transferase (GST) and excretion o f mercapturic
acid (N-acetyl-S (2-Carbamoylethyl) cysteine, as a major urinary metabolite, seems to be
the main metabolic pathway for AA (Müller et al., 1982; Sumner et al., 1992). Mercapturic
acid accounts for 70% o f the total metabolites excreted in the rat and 40% o f the total
metabolites excreted in the mouse (Sumner et al., 1992, 1997). The remaining metabolites
for the rat (30%) and mouse (60%) are derived from glycidamide (Sumner et al., 1992).
This quantitation o f metabolites in rodent urine would indicate a species difference in the
metabolism o f AA, with AA being converted to glycidamide to greater extent in the
mouse (59%) than in the rat (33%) (Sumner et al., 1992). Glutathione (GSH) is present in
many tissues such as liver, brain, and kidney, but (Dixit et ah, 1981) showed that hepatic
GSH-S-transferase catalyzes the reaction o f AA and GSH. Direct conjugation o f AA
with glutathione represents the major metabolic pathway in rat, accounting for 69% (IP),
71 % (PO), 52 % (Dermal), and 64% (inhalation) o f  the metabolism. In mice, the AA—
GSH represents only 27% (inhalation) o f the total urinary metabolites (Sumner et al.,
2003). Many studies have been reported on the role o f cytochrome P450 in the
metabolism o f AA (Calleman et al., 1990), in particular cytochrome P450 2F1
(Ghanayem et al., 2005a; Sumner et al., 1999). Recently, human CYP2F1 was reported to
mediate the formation o f glycidamide from acrylamide (Settels et al., 2008). In turn
glycidamide either reacts with glutathione, giving rise to other GSH metabolites, or is
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hydrolyzed possibly by epoxide hydrolase into glyceramide (Paulsson et a l, 2005). In 
humans, the hydrolysis o f  glycidamide by epoxide hydrolase enzyme appears to account 
for the majority o f glycidamide metabolites in the urine (Fennell et al., 2006). 
Epoxidation o f AA to glycidamide has been shown to occur in animals (Calleman et ah, 
1990) and in humans (Bergmark et al., 1993; Fennell et al., 2005). Recent studies 
conducted by (Fennell et al., 2005; K opp and Dekant, 2009) showed that glutathione 
conjugation was the major pathway for AA metabolism in humans, forming N-acetyl-S- 
(3-amino-3-oxopropyl) cysteine, as observed in rodents, as well as its S-oxide (not 
reported before). Although glycidamide was detected in low amounts; epoxidation o f AA 
to glycidamide represents as other im portant pathway in humans, with glyceramide as a 
major metabolite formed. Glutathione conjugation o f glycidamide appears to occur at 
very low levels in humans, in contrast to the rodents. It also has been dem onstrated that 
metabolism via glycidamide (derived from GA and glyceramide) was approximately 12% 
o f the total urinary metabolites (Fennell et ah, 2005). Hum an liver contains a high 
concentration o f GSH, ranging from 3 to 5 pm ol/g  o f liver wet weight (Friedman, 2003). 
Certain conditions can increase AA toxicity, even with lower exposure, due to GSH 
deficiency: (1) Malnutrition with a diet low in the sulfur amino acids, cysteine and 
methionine, which are im portant for GSH synthesis; (2) Oxidation stress which might 
result in GSH oxidation to GSSG; and (3) Liver damage associated with liver cirrhosis, 
alcoholic hepatitis, and malignancy (Friedman, 2003).
1.4.4.4 Excretion
Following oral or IV administration o f AA, 71% o f the total AA-derived radioactivity 
was excreted in rat urine and the excretion o f AA as a parent com pound in the urine and 
bile o f the rat was very low, accounting for < 2% o f the given dose (Miller et al., 1982).
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Following dermal application o f radioactive AA in rat, 36% o f the total absorbed dose 
was recovered in feces and 1% eliminated as organic volatiles (Sumner et al., 2003). After 
24h following an inhaled AA dose in the rat, the majority o f  excreted radioactive AA was 
found in the urine (31% o f the total absorbed dose), while a minor portion was excreted 
in feces (3%) and (2%) was eliminated as organic volatiles (Sumner et al., 2003). AA has 
short plasma half life after oral (20mg/kg) or (IP) administration (50mg/kg) in male SD 
rats, estimated at < 2 h (Barber et al., 2001).
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1.5 Acrylamide General Toxicity
A crylam ide has been  considered  as "p robab ly  carcinogenic to h u m an s” by the 
International Agency for Research on Cancer (IRAC, 1994). Furthermore, AA, which is 
used in manufacturing o f polyacrylamide and grouting agents, has now been reported to 
form during cooking o f carbohydrate rich foods. Workplace exposure to AA by dermal 
and inhalation routes can also occur in humans. For all o f these reasons, concerns about 
a newly discovered food toxicant with possible genotoxic, carcinogenic, neurotoxic and 
reproductive toxicity, has energized research efforts worldwide to define the underlying 
m ech an ism s o f  AA to x ic ity  an d  its p o ss ib le  h az a rd o u s  e ffec ts  on  h u m an s .
1.5.1 Acute Toxicity o f Acrylamide
Acrylamide is a known skin and respiratory irritant. Previous acute toxicity studies have 
been conducted to determine the L D 50 for AA. In a study conducted by (McCollister et 
ak, 1964), the oral L D 50 reported for rats, rabbits, and guinea pigs following a single oral 
dose was 150-180 m g/kg body weight, which indicated that AA was moderate in acute 
oral toxicity for these species. A 10% (w/v) aqueous solution o f AA applied to intact 
skin o f a rabbit was reported not to cause any irritation, but when applied to an abraded 
area, it caused very slight redness and edema (McCollister et a l, 1964). In humans, 
dermal application o f a 50% solution o f AA produced mild contact dermatitis due to a 
delayed hypersensitivity reaction (Fennell et ak, 2005). Placing a 10% aqueous solution 
into a rabbit eye produced a trace pain and slight conjunctival irritation that completely 
healed within 24h, while a 40% aqueous solution (without washing) produced moderate 
pain and slight conjunctival irritation which was slow in healing and caused significant 
corneal injury that completely healed within 24h (McCollister et ak, 1964).
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1.5.2 Acrylamide Genotoxicity
Over many years, several in vivo and in vitro studies have been conducted to evaluate the 
mutagenic activity o f AA. Several investigators have used many strains o f Salmonella 
(Tsuda et ah, 1993), Escherichia coli (Tsuda et ah, 1993) and Klebsiella pneumoniae (Knaap et 
ah, 1988) to test the mutagenicity o f AA at high concentration (up to lOOmg/culture 
plate). The results o f these studies showed that AA consistently exhibited negative results 
on growth, with and without metabolic activation, in contrast to glycidamide, which 
produced a positive growth result in Salmonella strain TA100 (Hashimoto and Tanii, 
1985).
Both AA and GA can form adducts with sulfhydryl groups on hemoglobin and other 
proteins (Hashimoto and Aldridge, 1970). For AA, it accounts for its weak clastogenicity 
rather than effects on D N A  (Dearfield et ah, 1995). In many studies, hemoglobin 
adducts have been used as measure o f AA or glycidamide exposure in rodents (Paulsson 
et ah, 2003). In humans, Bergmark et ah, (1993) demonstrated a hemoglobin adduct in 
Chinese workers exposed to A A. Analysis revealed that both AA and glycidamide 
adducts were present, so this study implies that adducts can also be detected in humans. 
Acrylamide also has the ability to bind to sperm protamines (proteins unique to sperm 
cells o f m ost mammals; Sega et ah, 1989) by alkylation, forming adducts. Its interaction 
with sperm protamines has an im portant role in establishing its great toxic effect in 
spermiogenic cells. In one study (Sega et ah, 1989), mice received 125m g/kg o f R e­
labeled AA by IP injection. Sperm head D N A  alkylation accounted for a very small 
fraction (< 0.5%) o f the total sperm head alkylation and protamine alkylation accounted 
for the majority o f AA binding. A strong level o f binding was observed in the late 
spermatid to early spermatozoon stages, which are also the most sensitive stages to the
genotoxic effects o f AA. In a recent study conducted by (Mei et ah, 2010) in Big Blue
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rats, it was reported that AA acts as a gene mutagen in the rat via its metabolism to the 
epoxide metabolite, glycidamide.
1.5.3 Acrylamide Neurotoxicity
Because human epidemiological studies have reported a significant increase in the 
incidence o f neurotoxicity in populations occupationally exposed to AA (LoPachin, 
2004a), AA neurotoxicity has been extensively studied in various animal models including 
rats, mice, monkeys, guinea pigs, dogs and cats (LoPachin, 2004a). Occupationally 
exposed workers subjected to low sub chronic doses o f AA exhibited symptoms o f 
peripheral neuropathy characterized by ataxia, skeletal muscle weakness and numbness o f 
the hands and feet (Deng et ak, 1993). H e et al., (1989) demonstrated neurotoxic 
symptoms and signs such as weak legs, loss o f toe reflexes and sensations, and numbness 
in hands and feet with hand skin peeling. This study was conducted on 71 workers in 
China who were occupationally exposed to AA over a short term. Severe symptoms 
resulting from longer exposure included cerebellar dysfunction followed by neuropathy. 
A t this point in time, the underlying mechanism o f neurotoxicity produced by AA is not 
fully understood. Research efforts conducted by Miller and Spencer, (1985) have shown 
that AA produced neuropathological changes (peripheral distal axonopathy) in 
experimental animals. LoPachin, (2002a) showed that nerve terminal degeneration is the 
primary lesion behind AA neurotoxicity with the result o f direct inhibition o f 
neurotransmission. Sickles et ak, (2002) also have dem onstrated an inhibition o f kinesin- 
based fast axonal transport by AA. (Srivastava et ak, 1986) demonstrated that A A can 
inhibit the action o f brain GSH and can decrease brain dopamine receptors in a dose- 
dependent manner. (Lehning et ak, 2002), demonstrated that AA could induce 
degeneration o f the brain stem, cerebellum, and spinal cord after a short-term  oral 
feeding o f high amounts o f AA in rats.
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A study conducted by (LoPachin, 2004a) showed that AA induced synaptic dysfunction, 
which was due to adduction o f presynaptic protein thiol groups and which resulted in a 
reduction in neurotransm itter release. Currently, there is a new hypothesis regarding the 
mechanism o f AA neurotoxicity that AA acts primarily on nerve terminal and it inhibits 
neuro transmission by disrupting presynaptic nitric oxide (NO) signaling which mediates 
the development o f neurological deficits (Lopachin and Gavin, 2008). In a recent study 
conducted by (LoPachin et al., 2008) reported a potential relationship between 
environmental type-2 alkene exposure and neurodegenerative disease such as Alzheimer's 
disease. The authors reported that acrylamide is an a,P-unsaturated carbonyl derivative 
which is characterized by a conjugated structure that is formed when an electron- 
withdrawing g ro u p (^  amide group) is linked to an alkene (type-2 alkenes). Acrylamide 
considered as type-2 alkenes, which are widely recognized as environmental pollutants 
and dietary contaminants. It is possible that exogenous exposure to AA can accelerate 
the development o f AD, because common nerve terminal proteins are targeted by type-2 
alkene and neurodegenerative conditions such as AD (LoPachin et al., 2008).
In rat and mice studies, the N O E L  (No Observable Effect Level) for neuro toxic effect 
has been reported to be between 0.2-10 m g/kg body w t/day, and this is far above dietary 
exposure (W HO, 2005).
1.5.4 Carcinogenicity
Acrylamide has been classified as a probable hum an carcinogen by IARC (group-2A)
(IARC, 1994). This classification was based on experimental rodent models that indicated
AA causing tumors at many organs in both male and female mice and rats. It must be
highlighted that evidence for the induction o f cancer by AA in humans is inadequate,
mainly because o f the difficulty to associate dietary consum ption o f AA with a specific
cancer outcome, even in occupational workers; studies have failed to indicate that A A is
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carcinogenic (Rice, 2005; Pelucchi et al., 2011). A  recent study reported that AA  
producing cancer in multiple organs o f  male and female F344 rats through a genotoxic 
mechanism, with the glycidamide metabolite binding covalently to D N A  and induce 
mutations and cell transformation (Mei et al., 2010). A  non-genotoxic mechanism for 
AA carcinogenicity was suggested by (Lamy et al., 2008) that depletion o f  GSH store due 
to glutathione conjugation, would lead to increasing oxidative stress and thereby affecting 
gene expression. Also in another recent study conducted by (Chatzizacharias et al., 2008) 
that AA and glycidamide caused inhibition o f  mitotic/meiotic motor protein and this 
might be an alternative mechanism to D N A  adduction in the production o f  defects in 
cell division and potential carcinogenicity. Further, (WHO, 2005) postulated a hormonal 
effect in rat endocrine (thyroid) and mammary glands carcinogenicity.
Acrylamide administration via different routes (orally, topically, and systemically) 
induces organ specific carcinogenicity in both mice and rat. Acrylamide also affects 
mostly endocrine sensitive tissues (Klaunig and Kamendulis, 2005). Few chronic 
bioassays have been performed on AA to assess the oncogenic potential o f  AA in 
experimental animals. In an early study conducted (Johnson et al., 1986), AA was 
administered in drinking water to male and female Fischer 344 rats at dosages o f  0.01,
0.1, 0.5 or 2 mg A A /kg body weight/day for two years with 60 rats/sex/dose. Decreased 
survival, decreased body weight gain, and several toxic effects were recorded, especially 
at high doses. The mean body weight for female and male rats receiving 2 m g/kg/day  
was decreased significantly in comparison to the control.
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The study showed that the peripheral nerve degeneration and the incidence o f  many 
tumors were also increased in the rats receiving 2 m g/kg/day in comparison to the 
control. In females, tumors were observed in the mammary gland, central nervous 
system, thyroid gland, oral tissues, uterus, and clitoral gland. In males, tumors were 
observed in the thyroid gland, scrotal mésothélium, and central nervous system. Recent 
study conducted by Hogervorst et al., (2008a) showed that AA intake was not associated 
with colorectal, gastric, pancreatic, and esophageal cancer risk. Recent prospective 
studies conducted (Wilson et al., 2010; Hogervorst et al., 2007) have demonstrated no 
association between acrylamide and breast cancer, however they observed increased risks 
o f postmenopausal endometrial and ovarian cancer with increasing dietary AA intake. A  
recent study conducted by (Hogervorst et al., 2009a) showed that AA intake was not 
associated with lung cancer risk in men, but was associated in women in particular to 
adenocarcinoma. Another recent study reported a positive association between dietary 
acrylamide and renal cell cancer risk and no positive associations with bladder and 
prostate cancer risk (Hogervorst et ak, 2008b). In a recent prospective cohort study AA  
intake was shown not to be associated with brain cancer (Hogervorst et ak, 2009b).
1.5.5 Developmental Effects
In the (Zenick et ak, 1986) study, male rats received AA in drinking water (50, 100, or 
200 ppm) for up to 10 weeks. Females received AA (25, 50, or 100 ppm) for 2 weeks 
before breeding and then throughout gestation and lactation. This resulted in disruption 
o f mating performance in males, which preceded the appearance o f  ataxia or significant 
post-implantation loss in females mated to 100 ppm males.
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Depression in body weight and fluid intake in females receiving AA at 100 ppm  
decreased pup body weight at birth (100 ppm  group) and decreased pup body weight 
gain during lactation through post weaning day 42 (50 and 100 ppm  group). Recently 
(Takahashi et al., 2008) showed that maternal AA exposure causes maternal toxicity 
which results in poor lactation.
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1.6 Acrylamide in food
Intensive investigations have been conducted to evaluate AA food toxicity, following the 
recent announcem ent by National Food Administration o f the formation o f AA in 
carbohydrate-rich food, including potatoes and cereals, when cooked at high 
temperatures (SNAFA, 2002c).
Many common food products contain AA; in total, these foods represent approximately 
40% o f calorie intake, it is present mostly in plant-based foods, in particular potato and 
wheat products that are cooked at high temperatures (Petersen, 2003). The concentration 
o f AA in different food products is shown in (Fig. 11).
The top acrylamide sources vary according to the country, depending on local food 
choices (Dybing et al., 2005). Food items with relatively low acrylamide concentration 
that consumed in great quantities-such as bread- could be im portant sources o f 
acrylamide exposure, because exposure considers both acrylamide concentration and 
food consumption. Acrylamide concentration in food is directly related to cooking 
temperature. In general, the higher the cooking temperature, the higher the concentration 
o f acrylamide formed in food (Matthys et al., 2005).
1.6.1 Formation o f Acrylamide
Although the underlying mechanism o f AA formation in cooked foods has no t been fully 
established, one possible mechanism is that AA is formed due to a heat-catalyzed 
chemical reaction between the amino acid asparagine and certain sugars (e.g. glucose), 
both o f which occur naturally in foods (Blank, 2005; Tareke et al., 2002). (Mottram et al., 
2002; Stadler et ak, 2002) were the first to report that acrylamide is the result o f a thermal
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1.6.2 Factors affecting Acrylamide formation
In plant foods, including potatoes, glucose and fructose are the major reducing sugars, 
and therefore have the largest influence on acrylamide formation. A study conducted by 
(Amrein et al., 2003) on a 74 samples o f potatoes from 17 different cultivars 
demonstrated that acrylamide content correlated m ost closely with fructose; however in 
potatoes the glucose content typically is twice that o f  fructose, so overall, glucose and 
fructose seem to influence the formation o f acrylamide similarly. Potato tubers that 
stored at 2°C contain higher concentrations o f  glucose and fructose than tubers stored at 
20°C. W hen these low-temperature-stored potatoes were fried into chips, the produced 
product was darker and had higher acrylamide concentrations than chips from potato 
tubers stored at 20°C (Noti et al., 2003). In addition, amino acid and asparagines content 
were unaffected by storage temperature (Chuda et al., 2003). In general, acrylamide 
formation increases with increasing temperature from 120°C to 170°C (Stadler et al., 
2002).
1.6.3 Assessing exposure to Acrylamide in foods
The average human intake is estimated to be 0 .4pg/kg bw /day from two years o f age 
onwards. However this intake may vary from 0.3 to 2 |ig /k g  bw /day or even may reach 
5 |ig /kg  bw /day at the 99th percentile (W HO, 2005).
Typically Children an d /o r adolescents have higher dietary acrylamide intakes than adults 
on a bw basis, both because o f the higher consum ption o f certain acrylamide-containing 
foods (such as potato chips and french fries) and also because children have a lower 
mean bw than adults (Dybing et al., 2005).
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Fig. 11. Concentration o f Acrylamide in food products 
From(Viator and Muth, 2004).
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1.7 Acrylamide Testicular Toxicity
1.7.1 Germ  Cell Genotoxicity
1.7.1.1 UDS, Chromosomal Aberrations, Micronuclei, SCE, Dom inant Lethal M utation 
Assay, and Heritable Translocation Assay
In the early study conducted by Shirashi, (1978), AA was considered to be a specific 
germ cell mutagen. Unscheduled D N A  synthesis (UDS) was found positive in an in vivo 
assay in rat spermatocytes (Butterworth et al., 1992); moreover, it was found positive in 
an in vivo study conducted on mouse germ cells by (Sega and Generoso, 1990). In the 
latter study, AA was shown to induce a delayed and maximum (5 times greater than the 
response measured immediately after treatment) UDS in germ cells o f male mice, 
observed 6 hr after IP exposure to AA. This was the longest delay observed ever 
between the chemical treatment and the maximum UDS in mouse germ cells. Acrylamide 
exposure from 7.8 to 125 m g/kg also resulted in a linear relationship between UDS 
response and AA exposure. Temporal patterns o f adduct formation in testis D N A  
paralleled that o f  the UDS response, as determined with 14C-labeled AA, with maximum 
binding recorded 4-6 hours after exposure. However, the temporal pattern o f adduct 
formation in the liver D N A  showed maximum binding within 1-2 hr after exposure, and 
was substantially greater than that found for the testis DNA. Even though AA was not 
active in an in vitro Ames test, it demonstrated mutagenic effects in stem cell 
spermatogonia (Dearfield et al., 1995). A study conducted Adler et al., (1988) revealed 
that chromosomal aberrations were not found in spermatogonia. In contrast, aberrations 
were found in spermatocytes (Adler, 1990). Further, micronuclei were observed in 
spermatids (Collins et al., 1992; Xiao and Tates, 1994; Russo et al., 1994). Acrylamide 
also has been shown to induce a similar response in mice spermatids (Russo et al., 1994) 
as well as peripheral reticulocytes. In a (Collins et al., 1992) study, when mice were
48
treated with AA, spermatid micronucleus assays demonstrated a doubling o f spermatid 
MN level over baseline levels, in which approximately one third showed kinetochore- 
positive staining, suggesting a possible aneuploidy effect. The spermatid micronucleus 
assays with rats and mice showed that AA exhibited its major effect in primary 
spermatocytes and premeiotic G r S phases. Furthermore, some effects were also noted 
in late spermatogonial stages and in primary spermatocytes at the leptotene and zygotene 
stages (Dearfield et ak, 1995). In addition, sister chromatid exchange (SCE) analysis 
conducted in differentiating spermatogonia in mice treated with 50 and 100 m g/kg  IP 
injection confirmed the weak genotoxicity o f AA in the premeiotic stages o f 
spermatogenesis. In the (Russell et ak, 1991) study, mice were exposed to 50 mg A A /kg 
for 5 days. Increased mutations in the post-meiotic stages o f spermatogenesis 
(spermatozoa and late spermatids) were seen.
1.7.1.2 Specific Locus Tests and Heritable Translocation Assay
These two tests can provide quantitative data in a heritable risk assessment in humans 
(Dearfield et ak, 1995). In the study conducted by Ehling and Neuhauser-Klaus, (1992) 
mice were administered a single dose o f 100 mg or 125 mg A A/kg. Acrylamide induced 
positive specific locus mutations in spermatogonia at 100 m g/kg  as well as in the post 
spermatogonial stages, indicating multilocus lesions. Because dominant lethal studies 
have been shown to be positive after AA exposure, many investigators have studied the 
ability o f AA to induce heritable translocations in male germ cells (Shelby et ak, 1987; 
Adler et ak, 1994; Marchetti et ak, 1997). In the early study conducted by Shelby et ak, 
(1987), exposure o f male mice for 5 consecutive days to 40 or 50 m g/kg  o f A A by IP 
injection, followed by mating on day 7-10, resulted in a high frequency o f translocation 
carriers in the Fj male population compared to a historical control frequency. This
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demonstrated the effective induction o f translocations in post-meiotic germ cells by AA. 
In the Adler et al., (1994) study, male mice were treated with a single IP injection o f 50 or 
100 m g/kg, which resulted in a high frequency o f translocation carriers in the F 1 males 
and females, m ated 7-16 days post treatment, compared to a historical control frequency.
1.7.1.3 Dom inant Lethal M utation Assays
Many dominant lethal m utation assays have been conducted in both mice and rats. All
studies reported the induction o f dominant lethal mutations by AA (Dearfield et al,
1995). In a study conducted by Smith et al., (1986) male Long-Evans rats were subjected
to a sub chronic oral dosing o f 0, 15, 30 or 60 ppm  o f AA in their drinking water for 80
days. A t the end o f 72 day, males were mated to untreated females. There was a
significant elevation in pre-implantation loss in females m ated to males exposed to 30
and 60 ppm  AA. N o  neurotoxicity was observed, nor was any chromosomal aberration
detected. Reciprocal translocations were observed in spermatocytes o f treated animals. In
the (Sega et ak, 1989) study, mice received 125 m g/kg  l4C-labeled AA by IP injection,
followed by daily analysis o f spermatozoa for 3 weeks. The am ount o f bound AA was
also assayed. Late spermatids and early spermatozoa had a significant increase in the level
o f binding, < 0.5% o f the radio-labeled sperm head alkylation was due to sperm D N A
alkylation. In contrast >99% o f the total sperm head alkylation was due to protamine
alkylation. The highest level o f alkylation was observed by the second week after
treatment, which is consistent with late spermatid and early spermatozoon exposure.
Analysis o f hydrolyzed radio-labeled protamine samples showed that the primary adducts
found was S-(2-carboxyethyl) cysteine. In conclusion, the authors proposed that
protamine alkylation played an im portant role in the genotoxicity o f A A. The Sega and
Generoso, (1990) study evaluated D N A  breakage in spermiogenic stages o f the mouse,
using an Alkaline-Elution technique, daily for three weeks after a single IP injection o f
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lOOmg AA/kg. In this study, mature spermatozoa were recovered from both treated and 
control animals. Elution o f the germ cell D N A  from AA treated animals with a high pH 
(12) buffer revealed a high level o f D N A  strand breaks in late spermatids to early 
spermatozoa (i.e. stages sensitive to dominant lethal changes) following AA treatment. 
The DNA-breakage due to AA was also studied in pachytene spermatocytes and in early 
spermatids 4 days after exposure. AA induced D N A  breakage in these cell stages at 
maximum levels occurred after one day o f exposure. However, the breakage was later 
gradually decreased, perhaps due to D N A  repair. Ultimately, no genetic effects could be 
observed by the time these cells reached the functional spermatozoon stage. A recent 
study conducted by Yang et ak, (2005b) used male Sprague Dawley rats exposed to AA at 
different doses (0, 5, 15, 30, 45, or 60 m g/kg) by oral gavage for 5 consecutive days. 
D N A  breakage in the AA treated rat testis was m onitored using a TU N E L assay, which 
allows the exposed 3' ends o f broken D N A  strands to be detected. Apoptotic 
seminiferous tubules were detected at the spermatogenetic stage, with significant 
increases in apoptotic signs observed in the AA treated group. Furtherm ore, AA 
regulated the expression o f genes related to apoptosis, which explained the apoptotic 
signs observed in seminiferous tubules by the T U N E L assay. Many histopathological 
lesions, such as many multinucleated giant cells and vacuolations in the seminiferous 
tubules, were also evident. These multinucleated giant cells are attributed to the inability 
o f primary 4C spermatocytes to develop meiotic divisions to generate sperm cells, which 
in turn, undergo additional D N A  replication, resulting in multinucleated giant cells 
(Rotter et ak, 1993). Further vacuolations seen are due to nonsynchronous evolution o f 
spermatogenesis (anachronistic spermiation, giving rise to groups o f germ cells at 
different steps o f development) as reported by (Cho and Park, 1994).
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1.7.1.4 Acrylamide Perturbs Gene Expression Level in the Rat Testis 
In the study by Yang et ah, (2005b), cDNA microarray analysis was used to study the 
effects o f AA treatment o f  60 m g/kg/day. Genes related to testicular functions, 
apoptosis, cellular redox, cell growth, cell cycle and nucleic acid binding were up/down  
regulated in isolated testes (Table 2). Genes related to testicular functions, such as the 
testis-specific transporter (TST), 1 -sulfotransferase family, steroid receptor RNA  
activator-1 and dynein-associated protein PKM23, were up regulated. Acrylamide also 
apparently regulated the expression o f  genes related to apoptosis, which explains 
apoptotic signs observed by the TUNEL assay. Furthermore, thioredoxin and GST 
genes were up-regulated; these two genes are involved in cellular redox. Interestingly, 
dynein-associated protein (PKM23) was up-regulated in isolated testes exposed to AA. 
This protein may directly regulate motor functions because it is closely associated with 
dynein heavy chains and may reflect the AA effect on spermatid transport in Sertoli cells 
(Yang et ah, 2005b). Thioredoxin and GST genes were also noted to be up-regulated by 
AA. The thioredoxin system regulates reduction/oxidation status directly by antioxidant 
effects and indirectly regulates protein-protein interactions o f  signaling molecules (e.g. 
apoptosis). Therefore, up-regulation o f  this gene in the testes following AA exposure 
might affect the cellular redox status and apoptosis signaling pathway (Yang et al, 2005b). 
G-S-transferase genes have been shown to be up-regulated in the rat testes, which causes 
a reduction in cellular thiol status (GSH), resulting in morphological transformation o f  
the cell.
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Recently, a study conducted in rats after oral administration for two weeks, reported that 
AA induced genomic imprinting aberrations mainly in spermatogonia and primary 
spermatocytes, which interferes with the remodeling process in spermatogenesis (Wang 
et ah, 2010).
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F unction
A ccess io n
num ber
G ene nam e F old  ch a n g e
Testicular AA926193 Sulfotransferase family, 1C2 3.21
Function AI144778 Testis-specific transporter (TST)1 2.23
AA900464 Steroid receptor RNA activator 1 1.71
AA933176 Dynein-associated protein RKM23 1.62
Apoptosis AA925597 Calpain 2 4.10
AA866442 CD36 antigen 3.19
AA900276 Cytochrome C, somatic 2.27
AI072219 Program m ed cell death 2 1.62
AI06030f Granzyme K 0.24
Cellular redox AA955668 Glutathione S-transferasc, pi 2 3.22
AA925862 Thioredoxin 2.42
AA818339 Glutathione S-transfcrase, alpha 1 2.00
Cell growth AA963258 Insulin-like growth factor (IGF)1 2.66
AA874918 PAK-interacting exchange factor beta 0.65
AA924727 Collagen, type 1, alpha 1 0.63
AA859599 Tissue-type transglutaminase 0.62
AI043649 G row th associated protein 43 0.48
Cell cycle AI059028 Cyclin L 1.67
CYP family AH 36404 Cytochrome P450, 3A9 1.85
AI029671 Cytochrome P450, 7A1 1.79
AA818329 Cytochrome P450,11A 0.55
Nucleic acid- AA925755 Glutaminase 2.36
binding AI059334 Translation initiation factor (TIF)2, 1 alpha 1.88
AI044042 Zinc finger protein 191 1.68
AI030825 ATP-depcndent, RNA helicase 1.50
Table 2. Up/down-regulated genes of rat testis as determined by cDNA microarray analysis 
(Y ang et al., 2005b).
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1.7.2 Acrylamide an d /o r Glycidamide Binding to Spermatid Protamines (establishing 
genotoxic effect) Results in Dom inant Lethality and Affects Sperm Morphology 
Acrylamide has an electrophilic vinyl group that is vulnerable to attack by nucleophiles. 
This reactive vinyl group is the cornerstone for the major use o f AA in various polymer 
syntheses. In addition, this vinyl group has the ability to react with biological 
macromolecules. The double bond between the C 2 and C3 atoms is responsible for AA 
reactivity. This double bond can open to allow alkylation o f the nucleophiles (Sega et ak, 
1989). Several lines o f evidence suggest that AA biological activity is mainly due to 
adduction with protein, while its primary activity with D N A  is alkylation, mainly due to 
its active metabolite glycidamide (Dearfield et ak, 1995) (Table 3).
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Hypothesis
The primary activity by AA is binding to proteins. AA has weak binding to DNA. AA can be 
converted in vivo to GLY. GLY is much more reactive than is AA in binding to DNA. GLY 
also binds to proteins; therefore, the primary consequences of AA exposure would be due to 
protein binding, while those from GLY would be due to both DNA and protein binding.
AA protein adduct Gly. DNA adduct
-AA is negative in a Salmonella assay.
-Long period needed to detect DNA binding 
after exposure.
-Delay in maximum UDS after exposure, 
suggests conversion needed.
-Primary urinary metabolites are glutathione 
adducts.
-Detectable hemoglobin adducts.
-Protein alkylation parallels germ cell stage 
sensitivity in dominant lethal and heritable 
translocation tests.
-Synaptonemal complex effects 
(proteinaceous structures).
-Spindle disturbances; kinetochore (+ve) 
staining.
-GLY is positive in a Salmonella assay 
-No delay in UDS after exposure. 
-Predominant adduct in DNA of in vivo 
rodents was a GLY DNA adduct.
-Major adduct as expected for epoxide is at 
N7 of guanine.
-DNA adduct level in vivo is similar in several 
tissues.
-GLY evenly distributed.
-Epoxide known to induce germ mutations 
-may contribute to spermatogenic specific- 
locus mutations.
Table 3. Acrylamide versus glycidamide adducts (Dearfield et al., 1995).
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Late spermatids and early spermatozoa have been recognized in several studies to be the 
primary sensitive cellular stages o f spermatogenesis, as in dominant lethal mutation 
studies and in heritable translocation assays. To investigate the pattern o f  binding o f AA  
to D N A  at these sensitive stages and to compare it to the magnitude o f induced damage, 
Sega et al., (1989) conducted an important and valuable study evaluating this binding. In 
this study, mice received an intraperitoneal injection o f  14C-labeled AA with an exposure 
o f 125mg/kg, followed by daily analysis o f  spermatozoa for 3 weeks. The major sperm 
head alkylation was found to be due to protamine alkylation and not due to D N A  
alkylation. In hydrolyzed protamine samples, the major adduct found was S-carboxyethyl 
cysteine. The dominant lethal frequency increased at the end o f  the first week after 
treatment and then it decreased substantially by the end o f the second week. The most 
sensitive stages were the late spermatid and the early spermatozoa. Acrylamide might also 
produce alkylation o f protein sulfhydryl groups present in the sperm tail, which may 
interfere with sperm motility and therefore fertilization (i.e., preimplantation loss) (Tyl 
and Friedman, 2003). The mechanism o f  AA alkylation o f  sperm-head protamine is 
proposed to involve direct in vivo binding o f  AA to free cysteine sulfhydryls o f  
protamines, in early spermatozoa and late spermatids. (This results in the formation o f  S- 
formamidoethyl cysteine, which on acid hydrolysis o f  this protamine is converted to S- 
carboxyethyl cysteine by loss o f  an amino group) (Sega et ak, 1989). This disrupts normal 
chromatin condensation, causing stress in the chromatin structure and inducing D N A  
breaks and the dominant lethal effect (Dearfield et ak, 1995; Sega et ak, 1989) (Fig. 12).
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In a recent study conducted by (Kermani-Alghoraishi et al., 2010) AA has been reported 
to affect the membrane integrity o f epididymal spermatozoa in mice, it also decreased 
sperm vitality and caused abnormal motility. In a sub-chronic study conducted by (Song 
et al., 2008) in rat, AA was shown to affect the normal development o f the sperm, 
significantly affect hindlimb m otor coordination and directly damage Leydig cells.
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(AX Normal
(B). Acrylamide-treated
Fig. 12. Model for the alkylation o f mouse chromatin by AA in sensitive germ cell stages, 
which leads to breakage and dominant lethality. The paired solid lines represent double­
stranded D N A  and the dashed lines represent the associated germ cell protamine. The 
sulfhydryl (-SH) groups are part o f the cysteine residues in the protamine. Alkylation by 
AA is represented by (-Aik). In normal nuclear condensation (A), the sulfhydryl groups 
o f cysteine crosslink to form disulfide bridges in the chromatin. However, if  alkylation o f 
a nucleophilic sulfhydryl group occurs before a disulfide bond forms (B), cross-linking o f 
the sulfhydryl groups may not take place. This could lead to stresses in the chromatin 
structure that eventually produce either single-or double-strand breaks. Taken from (Sega 
et al., 1989).
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When AA alkylates the free sulfhydryl groups o f cysteine, it thereby blocks the normal 
disulfide bond formation that contributes to the keratinous nature o f mammalian sperm 
(alkylation gradually decreases in later stages as the num ber o f free sulfhydryl groups 
decreases). This will interfere with chromatin condensation in the sperm nucleus. A 
smaller, unidentified peak o f radioactivity was also present in the protamine hydrolysates, 
indicating the possibility that this adduct peak might be S-(2-carboxy-2-hydroxyethyl) 
cysteine, which is the hydrolysis product o f S-(2-formamido-2-hydroxyethyl) cysteine, 
and which is likely formed due to reaction o f glycidamide with protamine (Sega et ah, 
1989).
1.7.3 Acrylamide Binding to M otor Proteins Kinesin and Dynein
Several studies have reported the presence o f dynein- and kinesin-like m otor proteins in
the testis (Neely and Boekelheide, 1988; Criswell and Asai, 1998). Furthermore, Sickles et
al., (1996) dem onstrated that AA has effects on kinesin-related m otor proteins involved
in mitosis or meiosis. These nuclear proteins are involved in separating chromosomes in
anaphase o f mitosis or meiosis; apparently the antagonistic action o f AA on spindle fiber
proteins may be the cause o f the dominant lethal effect observed (Tyl and Friedman,
2003). This mechanism o f AA toxicity is a common mechanism that is shared by
neurotoxicity and reproductive toxicity induced by AA exposure (Tyl and Friedman,
2003). These proteins are found both in peripheral axons (Spencer and Shaumburg,
1974) and also in sperm flagella (Miller et ah, 1999). Thus interference with these proteins
by AA might produce both hind limb weakness and also the characteristic peripheral
anterograde axonopathy seen after AA exposure (because these proteins have a role in
anterograde axonal transport). Moreover, it will produce impairment o f the swimming
ability o f sperms and thereby their ability to reach and fertilize the ova, and these effects
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are consistent with the observed increased sperm beat frequency and reduced pregnancy 
rates at higher doses o f  AA (Tyl and Friedman, 2003). M ounting behavior and breeding 
competence certainly are affected by the observed reduction in hind limb grip strength 
and the increase in hind limb foot splay, and further anesthesia o f the penis from 
neurotoxicity may also have some effect, all o f which will negatively affect mating success 
(Tyl and Friedman, 2003). Dynein is a m otor protein that is present in Sertoli cell regions 
involved in spermatid transport (dynein based spermatid translocation in Sertoli cells) so 
it is most likely responsible for the apical m ovement o f elongating spermatids that occurs 
just before sperm release (Miller et al., 1999).
1.7.4 Effect o f  AA on Testosterone Concentration and Leydig Cell Viability
Some investigators have reported an effect o f AA on serum testosterone concentration.
One study (Ali et al., 1983) confirmed the reduction in serum testosterone levels in rats
following AA treatment, but the authors infer that this horm one drop after AA exposure
is due to the neurotoxicity induced by AA. In a recent study conducted by (Yang et ah,
2005b), AA was administered to male Sprague Dawley rats by oral gavage for 5
consecutive days, and then 72 h after the last administration, the rats were sacrificed.
Leydig cells were isolated from AA treated testes and the serum testosterone level in the
culture media o f Leydig cells was measured by radioimmunoassay. Testosterone levels in
the culture media were also measured after 24 h incubation. Many histopathological
changes were seen in the rat testis, including reduction in epididymal sperm
concentration and abnormal sperm morphology. The viability o f Leydig cells that were
isolated from AA treated rat testes was examined using a nitrotetrazolium (NBT) assay.
The NBT assay showed that the degree o f Leydig cell death was increased following AA
treatment. There was a significant increase in N BT absorbance (P < 0.001) in rats treated
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with 45 and 60 mg AA /kg/day . Furthermore, testosterone concentrations in sera from 
rats treated with 30, 45 or 60 m g/kg /day  AA were decreased significantly to 19, 21 and 
9% o f the control values, respectively. Moreover, there was a significant reduction in 
testosterone concentration in the culture media o f Leydig cells from all AA treated 
groups. The authors refer to this drop in testosterone level as reflecting increased death 
o f Leydig cells after AA treatment, which resulted in reduced levels o f testosterone in the 
serum. This decrease in testosterone would in turn decrease spermatogenesis in the testis, 
thereby causing the decreased concentration o f caudal epididymis sperm that were 
observed in this study (Yang et ah, 2005b).
1.7.5 Acrylamide Causes Biochemical Perturbations in Plasma and Testes o f Rat
In a study conducted by Yousef and El-demerdash (2006) on female rats, the effects o f
different AA doses were examined on a num ber o f enzyme activities. Doses were 0.5, 5,
25, 50, 250 or 500 pg /k g  body weight o f AA in drinking water for 10 weeks.
Deterioration effects on some enzyme activities and lipid peroxidation occurred in a
dose-dependent manner. The study examined many tissues, including liver, brain, kidney,
lung, and testis. Concerning the testis, there was a significant increase in the levels o f
thiobarbituric acid reactive substances (TEARS) in the testis at AA doses o f 25, 50, 250
and 500pg /k g  body weight. Furthermore, there was a significant increase in the activities
o f Glutathione-S-transferase (GST) and superoxide dismutase (SOD) in the testis (as well
as in the liver, kidney, and lung) that occurred in a dose-dependent manner. A significant
dose-dependent inhibition o f the activities o f aspartate aminotransferase (AS'l), alanine
aminotransferase (ALT), alkaline phosphatase (ALP), and acid phosphatase (ACP) was
also observed in both liver and testes. However, A A treatment did not induce any
significant changes in lactate dehydrogenase (LDH) activity either in testis or liver,
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compared to their respective controls. Acetyl cholinesterase was significandy inhibited in 
the plasma at AA concentrations o f 50, 250, or SOOpg/kg, and this demonstrates the 
synaptic dysfunction reported for AA toxicity. In the plasma, the activity o f  ALP was 
increased at AA concentrations o f 25, 50, 250 or 500 pg. Plasma ACP increased at doses 
o f 250 or 500 pg AA, while the activity o f Creatinine kinase (CK) was decreased at all 
tested doses except for the lowest dose. Acrylamide significantly decreased total plasma 
protein levels, and albumin, globulin and tissue proteins in a dose-dependent manner. 
Superoxide dismutase is an antioxidant enzyme that plays an active role during stress. 
The various phosphatase enzymes are important in a number o f biological processes 
including detoxification, metabolism and biosynthesis o f energetic macromolecules that 
are important for different essential functions (Yousef and El-demerdash, 2006). Any 
interference with these enzymes will lead to impairment in cellular energy metabolism in 
vertebrates. Acrylamide exposure has been reported to decrease the activity o f CK in 
plasma, which might be due to thiol alkylation leading to protein thiol depletion, thereby, 
inactivation o f CK by AA. Regarding the decrease in body weight observed in rats, this 
could be due to excessive breakdown o f  tissue protein (as suggested by the authors).
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1.8 Five-Aminosalicylic Acid
5-Aminosalicylic acid is one o f  the derivatives o f salicylic acid.
1.8.1 Physical Properties (Dash et al., 1998)
A- Chemical Name 
5-Aminosalicylic acid 
B- Synonyms 
Mesalamine 
C- Proprietary Names
Asacol; Pentasa; Rowasa; Salofalk; Mesalazine; Mesasal; lixacol 
D - Availability
It is commercially available as tablets, capsules as well as rectal suppositories, rectal 
solution and rectal suspension
E- Formula
Empirical C7H 7N 0 3 
Structural (Fig. 13)
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Fig. 13. Structural formula o f 5-aminosalicylic acid, taken from(Dash et al., 1998).
F- Solubility
5-Aminosalicylic acid is slightly soluble in water (lm g/m l at 20°C). However, it is soluble 
in dilute hydrochloric acid and in dilute alkali hydroxides. It is very slightly soluble in 
dehydrated alcohol, acetone and methyl alcohol. It is practically insoluble in chloroform, 
ether, butyl alcohol, ethyl acetate, and propyl alcohol. 5-Aminosalicylic acid is a tan to 
pink crystalline powder in which crystals exhibit a needle-like morphology. It is odorless 
in the solid state.
1.8.2 Metabolism and Pharmacokinetics
1.8.2.1 Absorption & Elimination
Following oral administration o f Mesalamine, it is rapidly and completely absorbed from 
the upper intestine. However it is poorly absorbed from the colon. Then it is 
metabolized by N-acetyl transferase 1 (NAT 1), an enzyme present in the intestinal 
epithelial cells and the liver, converts it to N-acetyl-5-ASA, which is inactive as an anti­
inflammatory agent.
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Ultimately, it is excreted in the urine as a mixture o f  free 5-ASA and N-acetyl-5-ASA 
(Qureshi and Cohen, 2005).
1.8.2.2 Toxicity
5-Aminosalicylic acid did not show any mutagenic activity in an Ames mutagen test and 
also has no reported evidence o f reverse mutations or chromosomal effects in mice. 
Furthermore, no carcinogenic effects have been associated with its long-term use 
(Mcevoy, 1996).
1.8.3 Uses and Applications
1. For many years (since 1942), 5-amino salicylic acid has been used in the treatment 
o f inflammatory bowel disease. It is administered orally as sulfasalazine, which is 
composed o f sulfapyridine linked to 5-aminosalicylic acid by a diazo bond. 
Sulfasalazine is hydrolyzed by colonic bacteria into its active form (Svartz, 1942).
2. Restoration o f fertility in patients with ulcerative colitis occurs with chronic 
treatment with sulfasalazine (Cann and Holdsworth, 1984).
3. It interferes with colon carcinogenesis (Fina et al., 2006).
4. It is useful in treatment o f ulcerative colitis (Lakatos and Lakatos, 2009).
1.8.4 Mechanism o f Action
1.8.4.1 Anti-Inflammatory Properties
The exact mechanism o f action o f mesalamine is not known, but it is m ost likely due to
an assortment o f anti-inflammatory properties. It has been demonstrated to block the
production o f interleukin-1 (IL-1) and tumor necrosis factor-a (TNF-a) (Rachmilcwitz et
al., 1992) and to affect leukotriene metabolism (Klotz et al., 1980). In addition, it is a
strong inhibitor o f the cyclo oxygéna se pathway; therefore, it inhibits the production o f
prostaglandin E2 in the inflamed intestine (Sharon et al., 1978). Blockage o f the
lipoxygenase pathway also results in inhibition o f both 5-lipoxygenase and 5-
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lipoxygenase-activating protein. Thus, it blocks the production o f leukotrienes, such as 
Leukotriene B4 (LTB4) and hydroxyeicosatetraenoic acid (5-HETE). It is also involved 
in inhibition o f activation o f  nuclear factor kB (NF-kB), which is a central transcription 
regulatory factor involved in initiating and maintaining the inflammatory process 
(Qureshi and Cohen, 2005). It is also reported to inhibit antibody secretion (Macdermott 
et al., 1989). 5-Aminosalicylic acid has been proposed to act via activation o f a class o f  
nuclear receptors, in which PPAR-y, involved in the control o f  inflammatory processes, 
is the most important (Rousseaux et al., 2005). Activation o f  PPAR-y has also been 
shown to have anti-tumorigenic effects, which appeared as anti-proliferative activities.
1.8.4.2 Antioxidant Properties
An important cause o f tissue injury in inflammatory bowel disease is the oxidative 
damage to biological membranes. This is largely because o f  the leukocytic infiltration that 
accompanies colon inflammation. These leukocytes would therefore be a good source o f  
oxidants in the gut that would lead to oxidative stress. Thus the curative role o f  5-ASA in 
ulcerative colitis is believed to be due to its antioxidant effects in addition to its anti­
inflammatory effects (Miles and Grisham, 1994).
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1.9 Aims and Objectives
Acrylamide (AA) that is formed in carbohydrate rich foods is neurotoxic to humans and 
has also been shown to have toxic reproductive effects in laboratory rats. However, the 
AA induced testicular toxicity is not fully investigated and the mechanism is not fully 
elucidated. The hypothesis o f this study is that 5-aminosalicylic acid treatment would 
potentially provide a protective role against (AA) induced testicular and genotoxicity. The 
aims o f this work were therefore to prove this hypothesis and to provide a better 
understanding o f the molecular basis o f AA testicular toxicity. This will be achieved 
through three main objectives:
•  First, AA mediated potential testicular toxicity will be more characterized.
•  Second, the potential protective effects o f 5-aminosalicylic acid against AA- 
induced testicular and genotoxicity will be investigated.
•  Finally, spontaneous recovery o f testicular functions and leukocytes D N A  
damage, following a sub-acute exposure to AA will be monitored.
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2 Materials and Methods
2.1 Materials
2.1.1 General Materials
Unless otherwise mentioned in (Table 4) all chemicals and materials were purchased from 
BHD laboratory supplies (Analar®, England) and were o f molecular biology grade.
ITEM SUPPLIER
Plus One ™ Acrylamide (PAGE) 
grade, purity >  99.95 %, < 0.05 % 
impurities o f  acrylic acid.
Pharmacia Biotech (Upsala, Sweden)
Wright Stain Merck (Darmstadt, Germany)
Rose Bengal, Sodium Salt Sigma-Aldrich (Steinheim, Germany )
Triton X  —100 ICN — Biomedical inc.(Aurora, Ohio, USA )
Hematoxylin solution gill N o. 2 Sigma-Aldrich (Steinheim, Germany )
Low melting point agarose TREVIGEN (Helgerman, USA )
5-Am ino Salicylic Acid 95% Sigma-Aldrich (Steinheim, Germany )
Gum Acacia Fluka, Sigma-Aldrich (Steinheim, Germany )
DMSO Sigma-Aldrich (St.louis, USA )
Table 4. Suppliers o f specialist materials used in this work.
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2.1.2 Used Kits
Kits used in this study are shown in (Table 5).
Kits N am e Supplier
Testosterone kit ALPCO Diagnostics ™ (Windham, N H , USA)
Rat cytochrome P450 2E1, CYP2E1 
kit
USCNLIFE™ (Wuhan, CHINA)
TACS*XL® DAB in situ Apoptosis 
Detection Kit
TREVIGEN, Inc (Helgerman, USA)
Flex ® Reagent cartridge
SIEMENS Healthcare Diagnostics (Camberley, 
UK)
Table 5. Suppliers o f  the kits used in this work.
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2.2 M ethods
2.2.1 Animals and Husbandry
Sprague-Dawley rats were purchased from King Fahad Medical Research Center 
(KFMRC) in Jeddah, KSA, and were housed 4-5 per polycarbonate cage with wood  
shaving as bedding. Animals were maintained under controlled environment at 22 +  2°C 
and relative humidity at 40 - 65 % and 12 hrs/12 hrs light dark cycles throughout the 
experimental period. The rats were fed laboratory chow, which was supplied by Grain 
Silos and Flour Mills Organization (Jeddah, KSA), with its constituents are shown in 
(Table 6), Tap water in plastic bottles with steel sipper tubes were used for an adlibitum 
supply o f  water.
Crude Protein 20.2% Phosphorous 0.6%
Crude Fat 3.0% Vitamin A 20.0% lU/g
Crude Fiber 5.5% Vitamin E 2.2 lU /g
Ash 6.5% Vitamin D 70.0 lU/kg
Calcium 0.8% Energy 2850.0
Kcal/kg
Salt 0.5%
Trace element added includes: Cobalt, Copper, Iodine, manganese and zinc 
Table 6. Constituents of laboratory animal chow
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2.2.2 Study D esigns
Three major animal studies were undertaken during the work described herein, examining 
different aspects o f  acrylamide toxicity in the rat. Full details o f  each study protocol are 
provided below.
2.2.2.1 Characterization o f Acrylam ide M ediated Testicular T oxicity
2.2.2.1.1 Animals and D osage Formulation
A total o f 48 virgin male Sprague-Dawley rats were used and allowed to acclimatize at the 
experimental environment for 3 days before dosing initiation. The rats were 60 days old 
and weighed 250-300 gm. The doses o f acrylamide used were 0, 5, 15, 30, 45, 60 
m g/kg /day  for 5 consecutive days, because this is the dose range which has previously 
been reported in the literature to produce adverse effects on the testis (Yang et al., 
2005b). Dosing solutions were freshly prepared daily using distilled water, based on the 
initial body weight o f the rats at day zero. Control group gavaged with 1 ml o f distilled 
water.
2.2.2.1.2 Experim ental Schem e
The major aim o f the study was to determine the dose—response characteristics o f 
acrylamide testicular toxicity, by using different acrylamide doses to induce testicular 
damage. The study was conducted with 5 different acrylamide treatment groups and one 
vehicle control group with 8 randomly chosen animals in each group(n=8). Animals were 
dosed with acrylamide, once per day for 5 consecutive days by oral gavage using a metallic 
needle curved-ball ended (Size PS-20). All animals were weighed and observed for 
mortality or any behavioral changes once per day during the dosing and recovery period. 
Also, daily water intake was measured during the experiment. Seventy two hours after the
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last AA dose, 3 ml o f blood was collected from retro-orbital sinus in plain tubes, and then 
the rats were killed by cervical dislocation under ether anesthesia. Blood samples were 
centrifuged at 2000 g for 10 minutes and clear serum was separated from the clot and 
stored at - 80°C for further work. The right testis and right epididymis o f  all animals were 
isolated and weighed for further experimental evaluation.
2 .2 .2.2 Ability o f 5-ASA to Protect A gainst Acrylam ide M ediated  
T oxicity
2.2.2.2.1 Animals and D osage Formulation
A total o f 30 virgin male Sprague-Dawley rats were used. Animals were 6 weeks old and 
weighed 203 - 231 gm. In contrast to the previous study, rats were less than 60 days old; 
this allowed a more robust assessment o f seminiferous tubules, with a good germ cells 
population, in particular to the control group. The dose o f acrylamide used to produce 
testicular damage was 45 m g/kg/day; dosing solutions were freshly prepared daily using 
distilled water, based on the initial body weight o f the rats at day zero. 5-ASA was injected 
at two different doses, 25 and 50 m g/kg  based on (Jaiswal et al., 2005), as a freshly 
prepared suspension in 10% gum acacia, which is higher than the percentage used by 
Jaiswal et al., (2%), because o f poor solubility o f 5-ASA in 2% gum acacia. Control group 
received water and normal chow.
1 .2 .2 .2.2 Experim ental Schem e
The major aim of the study was the evaluation o f preventive effect o f 5-ASA on 
acrylamide induced testicular toxicity. The study was conducted with 5 treatment groups 
and one vehicle control group, with 5 randomly chosen animals in each group(n=5). 
Animals were oral gavaged with 1ml o f 45m g/kg acrylamide, using a metallic needle 
curved-ball ended (Size PS-20) to induce testicular damage. Concomitantly rats were
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treated with 1ml o f 5-ASA via intraperitoneal injection. The rats were exposed to AA and 
5- ASA for 5 consecutive days. All groups were observed for mortality or any behavioral 
changes once daily during the dosing period. Animal body weights, water and food 
consumptions were measured twice during the experiment. After 5 days o f exposure, 7 ml 
o f blood was collected from retro orbital sinus in plain tubes, and then the rats were killed 
by cervical dislocation under ether anesthesia. Seven milliliters o f blood was centrifuged at 
2000 g for 10 minutes using a high speed centrifuge (sigma, 3K18) and clear serum was 
separated from the clot and stored at -80°C for further biochemical work. O ne milliliter 
o f blood was collected in ED TA  tube for comet assay. The right testis and right cauda o f 
all animals were isolated and weighed for further experimental evaluation.
2.2.2.3 Reversibility o f Acrylam ide M ediated Testicular T oxicity
2.2.2.3.1 Animals and D osage Formulation
A total o f 36 virgin male Sprague-Dawley rats were used and allowed to acclimatize at the 
experimental environment for 3 days before dosing initiation. The rats were 60 days old 
and weighed 250 - 280 gm. The dose o f acrylamide used was 45m g/kg/day for 5 
consecutive days, dosing solutions were freshly prepared daily using distilled water, based 
on the initial body weight o f the rats at day zero. Control group received water only.
2.2.2.3.2 Experim ental Scheme
The major aim o f the study was to evaluate the natural recovery o f testicular toxicity 
caused by acrylamide, by using a dose that can produce testicular damage without 
producing major neurotoxicity. The study was conducted with 6 A A treatment group and 
one vehicle control group. Animals were dosed once per day for 5 consecutive days by 
oral gavage using a metallic needle curved-ball ended (Size PS-20). All groups were
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observed for mortality or any behavioral changes once daily during the dosing and 
observational periods. Animals body weights, water and food consumptions were 
measured three times a week and then twice weekly during the last two weeks o f the 
experiment. After completing 5 days o f acrylamide treatment, the acrylamide 
administration was stopped, and the animals were held for different recovery periods (3, 
5, 10, 15, 25 and 55 days), receiving normal chow and water. After this period, 7 ml o f 
blood was collected from retro-orbital sinus in plain tubes and then rats were killed by 
cervical dislocation under ether anesthesia. Six milliliters o f blood was centrifuged by 
using a high speed centrifuge (sigma, 3K18), at 2000 g for 10 minutes and clear serum was 
separated from the clot and stored at -80°C for further biochemical work. One milliliter 
o f blood was collected in ED TA  tubes for comet assay. The right testis and right cauda o f 
all animals were isolated and weighed for further experimental evaluation.
2.2.3 Experimental Methods
2.2.3.1 Mechanical Techniques
2.2.3.1.1 Preparation o f  Tissue Suspension from  Cauda Epididymis
Tissue suspension from right cauda was prepared according to the m ethod o f Sakamoto 
and Hashimoto (1986). The right Cauda epididymis from each rat was minced with 
scissors in 1 ml o f 10% neutral buffered formalin (4% formaldehyde, 33mM N aH 7P 0 4). 
The resulting suspension was filtered through a 340 |Llm, stainless steel mesh to remove 
large tissue fragments.
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2.2.3.1.2 Preparation o f  Hepatic and Testicular (S9) fractions
The preparation o f liver and testes microsomal supernatant (S9), was achieved according 
to the m ethod o f (loannides and Parke, 1975). Animals were sacrificed by cervical 
dislocation under ether anesthesia. The liver and testes immediately excised and placed in 
tubes immersed in ice until sacrificing all animals, provided that all steps were carried out 
at 4°C and using cold solutions. Organs were rinsed immediately in ice-cold 1.15% (w/v) 
freshly prepared KC1 to remove excess blood and were blotted dry before weighing. 
Organs were scissor minced in a small volume o f KC1 (less than the total required to 
produce 25% and 35% suspension) to produce coarse homogenate. After that the coarse 
homogenats was transferred to a mo tor driven potter Elvehjem homogenizer using a 
teflon pestle (B. Braun Melsungen AG, Germany). The tissues were homogenized on ice 
with keeping homogenization to the minimum required to produce a smooth 
homogenate where small bursts were applied to prevent heat build-up. Extra KC1 was 
added as required to allow full homogenization without exceeding the target suspension 
percentage. Then the homogenates were adjusted to a 25% suspension for the liver and 
35% suspension for the testes by using ice-cold 1.15% (w/v) KC1. Then the homogenates 
were centrifuged at 9000 g for 20 min at 4°C using a high speed centrifuge (Sigma, 3K18- 
Germany) to remove debris, nuclei, mitochondria and lysosomes. The supernatant (S9, 
microsomal supernatant) was decanted and aliquots into 1.5 ml tubes and stored at -80°C 
until required.
Protein concentration in (S9) was determined by Total Protein m ethod (TP method) 
which is a modification o f the biuret reaction (Henry et al., 1975). The whole procedure 
was automatically perform ed using Dade Behring Dimension clinical chemistry system 
(USA).
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The Principles o f Procedure:
Cupric ion (Cu++) reacts with the peptide linkage o f protein in a basic solution. The 
formed blue copper protein complex is proportional to the total protein concentration in 
the sample and is measured using a bichromatic endpoint technique at (540, 700nm). The 
m ethod incorporates tertrate as a complexing agent to prevent Cu (OH) 2 precipitation. 
Steps:
Sampling, reagents delivery, mixing, processing and printing o f results are automatically 
performed, according to manufacturer's instructions using purified human or bovine 
albumin as a standard. Briefly, sample volume used was 10 pi that was mixed with 85 pi 
o f reagent-1 and then with 85pl o f reagent-2 at a temperature o f 37°C and then the 
absorbance o f the developing color was red on 540 nm. The instrum ent automatically 
calculates and prints the concentration o f total protein in g /L  using the calculation 
scheme specific for the instrument. Then the concentration o f CYP2E1 in the sample 
was expressed as, n g /mg protein.
2.2.3.2 Visual Examination o f  Testis and Sperms
Light M icroscopy
2.2.3.2.1 Caudal Sperm Count
Two pi from each caudal tissue suspension (diluted 1:20) was taken, and sperm num ber 
was manually counted using a Makler Counting Chamber, Sefi-medical instruments 
(Haifa) in a strip o f ten squares. And in case o f oligospermia 3-4 strips were counted and 
their mean was used. The resultant num ber was multiplied by the dilution factor (20) and 
represented their concentration in millions/ ml o f suspension. Counting was undertaken 
using a LEICA, DM  1000 light microscopy at x 20 magnification.
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2.23 .2 .2  Smears Preparation for Visual Evaluation o f Sperms Shape Abnormality
Smear samples were prepared on slides after staining the slides with 10% rose Bengal 
(C20 H 2Cl4I4N a20 5) sodium salt solution for 15 minutes. In addition, Wright stain 
(Eosin methylene blue; composed o f Azure- II 0 .8g/L  and Eosin Y 0.7g/L) was also used 
for staining o f smear suspensions, in the first study o f this work. A total o f  100 Sperm for 
one animal from each group were examined for morphological abnormalities at x40 
magnification using LEICA-DM  1000 light microscopy: representative sperms, both 
normal and abnormal were photographed with Leica DC, 180 cameras.
2.2 .3 .23 H istopathological Evaluation
Organs were fixed by one o f two methodologies, dependent upon the end use for these 
tissues. Boun’s solution is recommended for the fixation o f tissues containing soft, 
delicate structures, such as testis, as it well preserves glycogen, and produces clear nuclear 
detail. However, its high acidity makes it inappropriate for TU N E L staining, and in this 
case straight formaldehyde fixation was used. The two methodologies described below; 
Tissue Fixation by Boun’s Solution
The organs were initially fixed in Bonn's solution (75 ml saturated aqueous picric acid, 25 
ml o f 40% formaldehyde and 5 ml glacial acetic acid), for 1 hour and then removed for 
preliminary cutting. Tissues were further fixed for another 24h in 10% neutral buffered 
formalin (Sakamoto et al., 1988).
Tissue Fixation by Formaldehyde
And hence, formaldehyde fixative was used. In this case, organs were initially fixed for 24 
hrs in formalin (12%): acetic acid (4%) and then removed for preliminary cutting, and 
tissues were further fixed for another 24h in 10% neutral buffered formalin. This m ethod 
o f fixation was according to (Kuriyama et ak, 2005).
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Processing o f Fixed Sections
Following fixation o f tissues by appropriate methodology, tissues were then processed 
using standard laboratory procedures for histology. Briefly tissues were embedded in 
paraffin blocks, sectioned perpendicular to the longest axis o f the testis at approximately 
3-5pm thickness and stained with hematoxylin & eosin. Stained sections were m ounted 
with dextran-plasticizer xylene (DPX) and were examined using light microscopy 
(LEICA, DM1000) at the indicated magnifications and representative images 
photographed with a Leica DC -180 camera.
2 .2 .3 .2.4 M orphometric Studies on Seminiferous Tubules Diam eter
To evaluate the effect o f ACR on seminiferous tubule diameters, and whether 5-ASA had 
an opposing action on them or not, 5 different fields o f the testes o f each rat in each 
experimental group (n=5), were evaluated under low power (x4), using light microscopy 
(LEICA, DM1000). Measurement o f tubule diameter was perform ed using Image-Pro 
express, version 5.0.1.26 for windows 2000/X P Professional (media cypernetics, INC), 
then mean o f 100 seminiferous tubules diameter for each rat in each group was 
calculated.
2.2.3.2.5 Electron M icroscopy
To evaluate the general toxicological effects o f acrylamide on the ultra structural histology 
o f the rat testis, a pilot study on a total o f four SD rats; two for test and two for control 
was applied. Rats were gavaged with 45m g/kg o f acrylamide for 5 consecutive days, and 
then they were killed by cervical dislocation under ether anesthesia. Testicular tissue 
processing, embedding, sectioning and staining for electron microscopy done in the 
electron microscopy unit at KFMRC, briefly, tissue fragments from right testis for each 
rat was fixed in Karnovsky's fixative (4% paraformaldehyde, 0.5% glutaraldehydc in 0.1M
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phosphate buffer at pH  7.2) (Yano and Bolder, 2002), and post-fixed in 1% osmium 
tetraoxide ( 0 S 0 4) for 30-60min after twice washing in distilled water. After dehydration 
in graded ethanol 5 minutes each, then tissues were immersed in propylene oxide for two 
changes, 5 minutes each. Finally tissue blocks were embedded in pure resin. Sectioning o f 
the block was done by using ultramicrotome diamond knife into thin sections (500- 
1000A) (ultrotome LKB-Sweden). Thin sections were stained with urinyl acetate followed 
by lead citrate. Sections were examined by electron microscopy (CM100 Philips, Holland).
2.2.3.3 Single Cell Gel Electrophoresis (CO M ET Assay)
Alkaline comet assay was perform ed according to the protocol o f  Hartm ann and Speit 
(1995), and was analyzed using Loafs Comet Assay Software with extended dynamic 
range imaging (EDRI). A total o f 2 pL o f whole blood taken from the rats, initially 
collected in ED TA  tubes, was mixed with 100 pL o f 1% low melting point agarose, after 
it was cooled to 37°C. Plating o f 75jlL o f agarose mixture was perform ed in a dimmed 
light using Trevigen comet slides, which are specially treated to prom ote adherence o f low 
melting point agarose, then slides were placed on ice for 8 minutes to allow agarose to 
solidify. After that, a gentle cell lysis was perform ed by immersing the slides in cold lysis 
buffer (2.5M NaCl, 100 mM EDTA, 10 mM Tris base, 1% sodium lauryl sarcosinate, pH  
10 and 1% Triton X-100 and 10% DM SO added just before use) for 30-60 minutes at 
4°C. The excess buffer was tapped off the slides and they were immersed in freshly 
prepared alkaline solution, (300 mM N aO H  pellets and Im M  EDTA , pH  14 and allowed 
to cool before use) for 20-60 minutes at room  temperature in the dark, to unwind the 
DN A and hydrolyze sites o f damage, and then slides were removed from the alkaline 
solution with gentle removal o f excess buffer as before. Slides were then transferred to a 
horizontal electrophoresis apparatus (Cl 1420, UK) and alkaline solution added.
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Electrophoresis was conducted for 20 minutes at 1 V olt/cm , 300 mA, in an ice bath and 
under dim light to minimize light induced D N A  breaks. Finally after gentle removal o f 
excess electrophoresis solution, the slides were placed in Tris buffer (pH?) for 10 minutes 
to neutralize alkali, and then immersed in absolute ethanol for 5 minutes to complete 
precipitation o f D N A  and accelerate dehydration. Slides were then drained, air dried, and 
then stained with 1 pg /m l o f ethidium bromide for 5 minutes, followed by washing for 5 
minutes with distilled water. Analysis o f comet tail was done by Loat's single gel comet 
assay software with ED R I and observed with fluorescent microscope, Olympus, BX- 
51 (Japan). Positive control used in this assay was glycidamide (from LKT laboratories, 
USA). It was reconstituted with distilled water. For preparation o f negative control, 
control rat whole blood was used, alkaline comet assay was performed, and the average 
tail m om ent was calculated. For the preparation o f different glycidamide dilutions (0.025- 
lOmM) , glycidamide was incubated with the whole rat blood for 4 hours at 37°C, then 
alkaline comet assay was performed, and analysis o f comet tail was done. The percentage 
o f cell viability and comet cells were calculated.
2.2.3 4 In-situ Apoptosis D etection  - A ntigen Retrieval (Tunel Assay)
D N A  fragmentation in testis was examined by performing Tunel m ethod using the
TACS-XL° DAB in-situ apoptosis detection kit, according to the manufacturer's
instructions. Briefly sections o f paraffin embedded 3 pm section from the right testis were 
m ounted on glass slides, which had been pretreated with 3-amino propyltriethoysilane 
and warmed at 37°C overnight; slides were deparaffinized with xylene and hydrated by 
sequential immersion in 100%, 95%, then 70% ethanol. The deparaffinized sections were 
heated in a microwave oven for 5 min in 2X SSC (0.3 M NaCl, 0.03 M trisodium citrate, 
pH 7.0)(Kon and Endoh, 2000), then slides were washed twice in IX  PBS, for 5 minutes 
each. Slides were then incubated with proteinase-K (lm g/m l) solution for 30 minutes at
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room temperature, followed by washing twice with IX  PBS. Slides were then treated with 
quenching solution (30% hydrogen peroxide in methanol) for 5 minutes at room  
temperature to remove endogenous peroxidase activity, followed by washing in IX  PBS 
for 1 minute at room temperature, finally, sections were immersed in IX  TdT labeling 
Buffer for 5 minutes, and incubated in a labeling mixture o f terminal deoxynucleotidyl 
transferase (TdT) and B-dNTP (optimized nucleotide mix o f brominated dNTPs) in IX  
TdT labeling buffer, for one hour in an humidified chamber at 37°C. Following labeling, 
IX  TdT stop buffer was added for 5 minutes at room temperature, and then samples 
washed two times in IX  PBS for two minutes at room temperature. Next, samples were 
incubated with antibody solution (containing anti-BrdU) at 37°C in a humidified chamber 
and after washing two times with IXPBS-Tween 20; samples were covered with SOpl o f  
strep-HRP solution and incubated for 10 minutes at room temperature. After washing the 
samples, end labeled D N A  was visualized by incubation with DAB solution (DAB, 30% 
hydrogen peroxide, IX  PBS, and DAB enhancer) for 2 - 7  minutes. Then samples were 
washed in several changes o f  deionized water. The sections were then counterstained with 
methyl green for 30 seconds and then dehydrated (70%, 95%, 100% ethanol and xylene). 
Stained sections were mounted with Dextran Plasticized Xylene (DPX) and were 
examined using LEICA, DM  1000 light microscopy at the indicated magnification and 
representative imaged photographed with a LEICA, DC -180 cameras.
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2.2.3.5 ELISA assay
2.2 3.5.1 Testosterone Assay
Direct quantitative determination o f free testosterone in rat serum was perform ed by 
using an ELISA kit for competitive enzyme immunoassay. All reagents were prepared 
an d /o r reconstituted according to the product protocol. A total o f 25|il o f each ready to 
use calibrators or standards with the following approximate concentrations (0, 0.35, 1.45, 
7.2, 30, and 150 pg/m l, they contain free testosterone in a serum based buffer with a non­
mercury preservative); the kit control (7.1pg/ml); and the serum samples were dispensed 
onto a 96-well anti-free testosterone antibody coated microwell plate. Then 100 pi o f  the 
conjugate working solution (free testosterone horseradish peroxidase conjugate) was 
added into each well and gently mixed for 10 seconds followed by incubation at 37°C for 
1 hour. Wells were then washed three times with wash buffer (buffer with a non-ionic 
detergent and a non-mercury preservative) using an automatic micro plate washer 
(ELX50, Biotek-USA) that dispensed 300 pi o f  wash solution per well per cycle. Excess 
wash solution was removed and the total o f 150 pi o f TMB substrate (tetramethyl 
benzidine and hydrogen peroxide in a DM SO-containing buffer) was then added to each 
well. After 10-15 minutes incubation at 37 °C the reaction was stopped with the addition 
o f 50 pl/w ell o f stopping solution (1 M sulfuric acid) the optical density (450 nm) o f each 
well was subsequently measured with multiwell microplate reader (ELX-800, Biotek- 
USA). The mean absorbance for each standard was calculated and calibration curve 
plotted on semi-log paper with the mean optical density on the Y-axis and the calibrator 
concentrations on the X-axis and the values o f the unknown samples were read directly 
from the curve.
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2.2.3.5.2 Estim ation o f CYP2E1 Concentration in T estis and Liver (S9) fractions
All reagents and standards were prepared and reconstituted according to the product 
protocol. After producing a serial dilutions (10, 5, 2.5, 1.25, 0.625, and 0.312) from the 
undiluted standard (20 ng/m l), where the sample diluent serves as the zero standard and 
the undiluted standard serves as the highest concentration (20 ng/m l) o f the CYP2E1, 
The undiluted standard is recom binant rat CYP2E1, produced by USCNLIFE CO. 
(CHINA) from which the kit was purchased. 100 pi o f all standards, and samples were 
loaded to the assay plate and covered with the plate sealer. After 2 h o f incubation at 
37°C, the liquid was removed from each well without washing. One hundred microliters 
o f  detection reagent-A working solution were added to each well and the plate was 
incubated for 1 h at 37 °C. Then each well was aspirated and washed 3 times by the kit 
washing solution using an automatic microplate washer (ELX50, Biotek-USA). After this 
washing step, the plate was inverted and blotted against clean paper towels. Then 100 pi 
o f detection reagent-B working solution were added to each well, covered with the plate 
sealer and incubated for another 1 h at 37 °C. After a further 5 times aspiration/ wash step 
for all wells, 90 pi o f substrate solution was added to each well, the plate was covered and 
incubated for 30 minutes at 37 °C under light protection. Finally 50 pi o f  stop solution 
were added to each well and the absorbances (Optical Density) o f  the stopped reaction 
mixture o f all wells were measured at 450 nm  using a multiwell microplate reader (ELX- 
800, Biotek-USA). For the results calculation the duplicate readings for each standard 
were averaged and the average zero standard optical density was subtracted from all 
results (standards and samples). A calibration curve was obtained by plotting the mean 
absorbance for each calibrator (X-axis) against the known concentrations (Y-axis) o f rat 
C Y P2Fland the best fit line through the points on the graph was determined by 
regression analysis using Microsoft Office, Excel-2007. Samples CYP2E1 concentrations
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were determined from the calibration curve in ng/m l. Measured data were analyzed by 
One-way Analysis o f Variance (ANOVA), a value o f p<0.05 was used as the criterion for 
statistical significance.
2 .23.6  HPLC
Reversed phase high performance liquid chromatography was used for determination and 
quantization of AA in rat plasma. This was achieved according to the m ethod reported by 
Barber et al., (2001b) with some modifications, provided that all liquids used were o f 
HPLC grade. The HPLC system used consists o f  a pum p, online degasser, auto sampler, 
all belong to Waters HPLC system (Alliance Waters separations module 2695, Waters 
2996) and Photodiode array detector Waters 2996 (Milford, MA, USA). HPLC system 
control and data processing was perform ed by the Em power software (Build 1154, 
Waters). Twenty five microliters aliquot o f samples were injected and separation was 
perform ed on a 4.6 x 250 mm, 5pm particle size, Zorbax Eclipsed -CIS analytical 
column (Agilent Technologies, Palo Alto, Ca, USA), employing Zorbax Eclipsed CIS 
security guard1M Guard cartridge, 4.6 x 12.5 mm, 5pm particle size (Agilent Technologies, 
Palo Alto, Ca, USA). Samples were eluted with a mobile phase consisting o f 950ml o f 
hexane sulphonic acid sodium (C6H 13N a 0 3S): double-distilled water: formic acid, 
(HCOOH) [300mg o f C6H 13N a 0 3S + 1L o f  distilled water + 0.5ml o f H C O O H  ] and 
50 ml methanol at a flow-rate o f 0.5 m l/m in. Detection was perform ed by monitoring 
absorbance at 205 nm. Peak area was integrated with the Em power 1154 software, and 
used to calculate sample concentrations by interpolation from a standard curve extracted 
from control rats’ serum. Standards for AA were prepared by adding 0.1-100 pg /m l o f  
AA to control rat serum, with the final preparation of AA stock solution o f 0.1pg/pL  
from which serial dilutions were made using 100 pL o f control rat serum for each
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standard (5, 10, 20, 40, 60, 100 (ig /ml). Recovery was determined by comparing the 
amount o f  AA recovered from fortified serum samples with the quantities o f  AA added. 
Sample Preparation
Three hundred microliters o f acetonitrile were added to 100 pL o f serum samples and 
mixed for 30 s with a vortex mixer to precipitate the proteins in the samples. After 
precipitation, samples were centrifuged for 5 min at 12000 g using a high speed centrifuge 
(Sigma, 3K18-Germany) and the supernatant removed. The resulting pellets were 
dissociated and washed by adding 300 pL o f acetonitrile, mixing for 30 s, centrifuging for 
2 min at 12000 g, and supernatant was collected. Pellets were washed twice in this 
manner. The pooled supernatants were mixed with 100 pi o f  acidified acetonitrile (HC1) 
and then dried under stream o f nitrogen gas at 40 °C. The residue was reconstituted with 
300 pL o f  mobile phase. Reconstituted samples were transferred to 300-pL auto sampler 
vials and analyzed by HPLC with injection volume o f 25pL.
2.2.3.7 Statistical Analysis
Differences between obtained values (mean ±  SD) were compared by one-way analysis o f  
variance (AN OVA), using Graph Pad Prism & Graph Pad Instat, followed by Tukey- 
Kramer multiple comparison test. A  P-value less than 0.05 were used as the criterion for a 
statistically significant difference.
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3 Characterization of Acrylamide Mediated Testicular 
Toxicity
3.1 Introduction
Acrylamide (AA) is an im portant com pound in the production o f polyacrylamide which is 
used in a variety o f industries. It is well known as a neurotoxin after human and animal 
exposure and it also has been shown to elicit genotoxic, reproductive and carcinogenic 
effects in laboratory animals. Following the announcem ent o f Swedish National Food 
Administration (SNAFA, 2002c) that acrylamide could be formed in carbohydrate rich 
foods when cooked at a high temperature, researchers worldwide have been energized to 
study acrylamide and its imptication to human health. Previous studies on acrylamide in 
relation to the reproductive system in rats and mice have provided information to assess 
several areas o f potential concern, with the conclusion that it can elicit reproductive 
effects, primarily through testicular toxicity (Hashimoto et ah, 1981; Yang et al., 2005a,b). 
This current work aimed to duplicate previous findings o f other workers, and to 
undertake a preliminary evaluation for the reproductive testicular toxicity o f AA in rat as 
well as some potential new areas in acrylamide mediated testicular toxicity. The study 
presented in this chapter was based upon the design conducted by Yang et al., using a 
wide dose range o f acrylamide over a sub acute period o f exposure (Yang et al., 2005a). 
Accordingly, five different dosing groups (5, 15, 30, 45, and 60 m g/kg/day) with one 
control group were used, each group consisting of eight Sprague Dawley male rats, with 
acrylamide administered by oral gavage for five consecutive days, followed by three days 
o f recovery prior to animals sacrifice. The following parameters were used to examine the 
testicular effects o f AA; change in rat body weight, absolute testis and epididymis weights, 
relative testis/body weight and relative epididymis/body weight ratios, sperm count per
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cauda, and histopathological examination o f AA induced changes in testis and epididymis 
morphology.
3.2 General Observations
Rats treated with a dose o f 45 m g/kg  o f AA showed signs o f aggression and rough coat, 
while animals treated with 60 m g/kg  showed severe hind limb weakness and unsteady 
m ovem ent which varied in severity along with lethargy in comparison with control groups 
(Fig. 14).
Fig. 14. Effect o f Acrylamide (60 m g/kg  for 5 days) on rat's hind limbs mobility
(A) Controlled (untreated) rat with normal hind limb dexterity, (B) Treated rat showes abnormal
hind limbs dexterity (arrow).
3.3 Effect of Acrylamide on Rats Body Weights
Administration o f acrylamide to rats at doses o f 5 and 15 m g/kg /day  for 5 consecutive 
days did not show any significant change in body weight during the treatment period, 
while doses o f 30, 45 and 60 m g/kg /day  o f acrylamide significantly decreased (p < 0.001) 
the body weight in comparison to respective controls (Fig. 15A). D uring the recovery 
period, after cessation o f acrylamide administration (day 5 to 8), body weight showed 
significant reduction at a dose o f 60 m g/kg /day  in comparison to control group (Fig. 
15B). Therefore, removing the AA challenge appeared to alleviate the body weight loss 
observed during the treatment period.
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Fig. 15. Effect o f AA on body weight changes at the end o f (A) treatment period and
(B) recovery period
Acrylamide was administered by oral gavage at doses of 5, 15, 30, 45 or 60 mg/kg/day for 5 
consecutive days, and the rats were observed for a further 3 days after cessation of AA treatment 
and then killed. Body weight changes at the end of treatment and observation periods were 
calculated and compared to respective controls (Data were expressed as mean ± SD, n = 8). The 
symbol represents statistical significance (ANOVA) from control: ***, p < 0.001. With Tukey- 
Kramer multiple comparisons test.
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3.4 Effect of Acrylamide on Cauda Sperm Count
Animals were sacrificed at the end o f the observation period. Acrylamide at doses o f 30, 
45 and 60 m g/kg significantly decreased sperm count in cauda epididymis, in comparison 
to control group (Fig. 16).
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Fig. 16. Effect o f AA on cauda sperm count
Acrylamide was administered by oral gavage at doses of 5, 15, 30, 45 or 60 mg/kg/day for 5 
consecutive days, and die rats were observed for further 3 days after cessation of AA treatment 
and then killed. (Data were expressed as mean ± SD, n = 8). The symbol represents statistical 
significance (ANOVA) from control: ***, p < 0.001. With Tukey-Kramer multiple comparisons 
test.
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3.5 Effect of Acrylamide on Absolute and Relative Testis Weights
Animals were sacrificed at the end o f the recovery period. Acrylamide administration at 
doses o f 5, 15, 30, 45 or 60 m g/kg /day  did not show any significant change in either 
absolute (A) or relative (B) testis weights in comparison to control group (Fig. 17).
A.
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Fig. 17. Effect o f  AA on (A) absolute and (B) relative testes 
weights. Acrylamide was administered by oral gavage at doses of 5, 15, 
30, 45 or 60 mg/kg/day for 5 consecutive days, and the rats were 
observed for other 3 days after cessation of AA treatment and then 
killed. (Data were expressed as mean + SD, n = 8). The statistical 
analysis was performed by One-Way ANOVA.
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3.6 Effect of Acrylamide on Absolute and Relative Epididymis Weights
Animals were sacrificed at the end o f  the recovery period. Acrylamide administration at 
doses o f 5, 15, 30, 45 or 60 m g/kg /day  did not show any significant change in either 
absolute (A) or relative (B) epididymis weights in comparison to control group (Fig. 18).
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Fig. 18. Effect o f AA on absolute (A) and relative (B) epididymis weights
Acrylamide was administered by oral gavage at doses of 5, 15, 30, 45 or 60 mg/kg/day for 5 
consecutive days, and the rats were observed for other 3 days after cessation of AA treatment and 
then killed. (Data were expressed as mean ± SD, n = 8). The statistical analysis was performed by 
One-Way ANOVA.
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3.7 Effects of Acrylamide on Histological Appearance of Rat Testes
Some evidences o f histological changes in the testis and epididymis were observed in rats 
treated with AA when compared with the control rats. In control rats; seminiferous 
tubules, spermatogenesis and epididymis appeared normal with normal defined basement 
membrane, normal general cellular arrangement o f the seminiferous tubule with apparent 
luminal sperm reserve, and normal appearance o f Ley dig cells in the rat testis (Fig. 19A).
In addition, the epididymis showed normal architecture (Fig. 21 A).
At a dose o f 5 m g/kg  acrylamide, the testes showed some germ cells degeneration with 
mild disruptions in the normal looking appearance o f the testis with many basal 
vacuolations and between the inner cells o f the seminiferous tubules (Fig. 19B).
At a dose o f 15 m g/kg  AA, the testes showed increased debris and reduction o f the 
mature spermatozoa in the lumen o f the tubule (Fig. 19C).
At a dose o f 30m g/kg AA, the testes showed vacuolations between the inner cells with 
disruptions in the normal looking appearance o f the tubules and reduction o f the mature 
spermatozoa in the lumen o f the tubules. In addition, the appearance o f many apoptotic 
like nuclei with condensed chromatin was observed in germ cells (Fig. 19D).
A t a dose o f 45m g/kg acrylamide, the testes showed sloughed seminiferous epithelium in 
tubular lumen. Further, at this dose, multinucleated giant cells were observed in the 
lumen o f the tubule (Fig. 19E).
At the higher dose o f acrylamide (60 mg/kg), the pathology seen before with the lower 
doses was again observed, although it was generally more pronounced. The multi 
nucleated giant cells started to increase in num ber and size and some o f them have 
cytoplasmic vacuolations. Those M N G  cells were not only increased in the tubule (Fig. 19 
F), but they also started to be noticed in the epididymis too (Fig. 2113). Sertoli cell 
vacuolations were numerously observed. Nuclear vacuolations o f round spermatids were
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also noted and the tubules in general appeared atrophied. The mature spermatozoa were 
significantly reduced in the lumen o f the tubules.
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Fig. 19. Light microscopy o f transverse sections o f  testes isolated from control and AA-treated 
rats (A) Normal control rat showed normal testis histology, (B) Rat treated with 5 m g/kg o f  AA, 
shows multiple vacuoles (v) o f  different sizes with sloughing o f  normal germinal epithelium into 
the lumen o f  the tubules, (C) Rat treated with 15 m g/kg o f  AA shows increased debris and 
reduction in mature sperm reserve in the lumen o f  the tubule. Sections were stained with H&E 
stain, (D) Rat treated with 30 m g/kg o f  AA, shows disruptions in the normal looking appearance 
o f the tubules with clear reduction in the mature spermatozoa in the lumen o f  the tubules (E) Rat 
treated with 45 m g/kg o f  AA, shows seminiferous tubules with many small multinucleated giant 
cells scattered in the lumen o f  the tubule, scanty mature spermatozoa (F) Rat treated with 60 
m g/kg o f  AA, shows multiple vacuoles o f  variable sizes in between the inner cells. Sections were 
stained with H&E stain and viewed with light microscopy.
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Fig. 20. Light microscopy o f transverse sections o f testis isolated from rat treated with 60 
m g/kg  o f AA (A) Normal control rat shows normal testis histology, (B) The testis shows 
seminiferous tubule with multiple scattered multinucleated giant cells of different sizes and scanty 
mature spermatozoa in the lumen of the tubule. Section was stained with H&E stain and viewed 
by using light microscopy.
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Fig. 21. Light microscopy o f transverse sections o f  epididymis isolated from control and 
AA treated rat (60m g/kg/ day) (A) Normal control rat shows normal histology with apparent 
sperm reserve in the lumen (star), (B) Rat treated with 60 mg/kg of AA, shows normal lining 
epithelium with multiple scattered multinucleated giant cells of different sizes in the lumen, also 
note clear reduction in sperm reserve. Section was stained with H& E stain, and viewed by using 
light microscopy.
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3.8 Electron Microscopy (EM) on Rat Testes
Electron microscopy studies on treated rat testes showed many pathological changes 
which could not be detected on light microscopy study. While EM  study on normal 
control testes showed normal seminiferous tubules with normal Sertoli cells and normal 
intercellular junctions (Fig. 22A), the testes o f AA treated rats showed degeneration o f 
spermatogonia with large basal vacuolations, widening o f intercellular junctions and 
degeneration o f peritubular myoid cell (Fig. 22B). The striking feature o f this study was 
the effect o f AA on Sertoli cells. While Sertoli cells from control (untreated) rats testis 
showed normal histological features (Fig. 23 A), Sert oh cells from AA treated rat testis 
showed numerous histological abnormalities. They showed clear change in color intensity 
(darkening), with pyknotic nucleus and intranuclear vacuolations. Also detachment o f 
Sertoli cells from the basement membrane, increase in the num ber and size o f lipid 
droplets in its cytoplasm, with swelling in Sertoli cell mitochondria were noted. Further, 
failure o f spermiation with phagocytosis o f mature testicular sperms by Sertoli cell was 
also detected (Fig. 23 B, C, and D). Leydig cehs showed clear atrophy after AA treatment 
(Fig. 2TB). EM  study o f the axoneme o f developing spermatids from AA treated rat 
showed normal shape, num ber and arrangements o f outer dense fibers (ODE) through 
the middle and principal piece o f the developing spermatid tail.
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F ig . 22. Electron micrographs o f sections from rat testes o f  control and AA treated rats
(A) Shows seminiferous tubule with normal cellular arrangement and intact intercellular junctions 
with normal Sertoli cells (S) Xl 100, (B) Shows widening of the intercellular junctions with 
disruption of the general appearance of the tubule, note also the damaged, flattened Sertoli cells(S). 
(V) Large vacuole due to sloughed spermatogonia, X3400. Thin sections were stained with urinyle 
acetate followed by lead citrate and were examined by electron microscopy (CM100 Philips, 
Holland).
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Fig. 23. Electron micrographs o f damaged Sertoli cells from AA treated rat (45m g/kg AA 
for 5 days) (A) Shows normal large pyramidal shape, pale stained Sertoli cell nucleus with apical 
cleft. Note its location near die basal lamina of the tubule. The content of the interior of die nucleus 
displays fine granular texture. It has dark, large and prominent nucleolus (long arrow). Note two 
characteristic bodies present near the nucleolus; the mykaryon and the coiled body (small arrow), 
X4600, (B) Shows disappearance o f the nucleus with failure o f spermiation, X1450, (C) 
Shows abnormal separation (star) o f  damaged Sertoli cell from the basal lamina and change 
in color intensity, with degenerated peritubular myoid cell X  5800, (D) Shows pyknosis o f 
the nucleus with intranuclear vacuolation (v) X13500. Thin sections were stained with urinyl 
acetate followed by lead citrate and were examined by electron microscopy (CM100 Philips, 
Holland).
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F ig . 24. Electron micrographs o f Leydig cell from the control (untreated) and AA 
(45m g/kg for 5 days) treated rat testes
(A) Shows normal Leydig cell from control rat testis, notice their aggregation around the blood 
vessel and their color intensityX620 (B) Shows Leydig cell atrophy, notice the change in color 
intensity and decrease number of cells X620. Thin sections were stained with urinyl acetate 
followed by lead citrate and were examined by electron microscopy (CM100 Philips, Holland).
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3.9 Discussion
In this study, the testicular toxicity o f acrylamide was investigated by examining the 
influence o f this com pound on rat bodyweight changes, testis & epididymal weight, 
sperm count & and histopathological changes in rat testis and epididymis. Rats gavaged 
with AA at doses o f 30, 45 or 60 m g/kg /day  for 5 days showed a significant reduction in 
body weight. A reduction in epididymal sperm count was observed in the group treated 
with 30, 45 or 60m g/kg AA. Abnormal histopathological findings were noted in the testis 
o f all treated rats. These dose response changes provided the initial characterization o f 
AA induced testicular toxicity in male rats.
3.9.1 Behavioral Changes and Neurotoxicity
Rats treated with AA at doses o f 45 and 60 m g/kg  showed signs o f aggression and 
alertness that started primarily at days 3-5 o f the AA treatment period. This was followed 
by lethargy, ataxia, and hind limb weakness noted on day 3 and day 2 o f the recovery 
period for the doses o f 45 and 60 m g/kg, respectively. Rough coat was also observed, 
mainly in rats treated with the higher dose o f 60m g/kg AA, as a non specific sign of 
stress. This result was entirely consistent with the previous study conducted by 
Hashim oto et al., (1981) who treated mice with 0.2 to 0.5 o f  the L D 50 o f AA 
(1.5m mol/kg equivalent to 106.6mg/kg) twice weekly by oral gavage for 8-10 weeks. The 
mice gradually developed signs o f weakness and ataxia o f the hind limbs as well as 
associated behavioral changes including aggressiveness and alertness in some cases 
(Hashimoto et ak, 1981). O ther groups have also reported this phenom enon in rats (Tyl 
et ak, 2000a; Lopachin, 2004a). For example, Tyl et ak reported that when male rats were 
gavaged with 0, 5, 15, 30, 45 or 60 m g/kg AA for 5 days, rough coat (a nonspecific 
indicator o f stress), lethargy, and unsteady m ovement were observed, mainly at the two
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highest doses, and were also accompanied by significant hind limb weakness (Tyl et al., 
2000a). These neurotoxic signs detected in the recovery period might have been ascribed 
to the cumulative nature o f AA in producing neurological defects (Lopachin, 2004a).
It must be highlighted that no clear mechanism underlying AA neurotoxicity has yet been 
uncovered, although several possible mechanisms have been suggested. These include 
inhibition o f kinesin-based fast axonal transport by AA (Srivastava et ak, 1986), induction 
o f synaptic dysfunction by AA (LoPachin et al., 2004b), or a central mechanism operating 
through inhibition o f brain GST and a decrease in brain dopamine receptors (Lehning et 
ak, 2003). Additionally, it should be noted that hind limb dysfunction is one o f the factors 
that negatively influences or disrupts the copulatory behavior o f male rats (Zenick et ak, 
1986).
3.9.2 E ffect o f  A A  on Rats Body W eight
In the current study, AA significantly decreased body weight at doses o f 30, 45 and 60 
m g/kg  during the 5 day o f AA treatment period, with no statistically significant effect at 
the other dose levels. This reduction in body weight at the higher dose levels was 
continued even after stopping AA administration for 3 days, with significant reduction in 
gained body weight at dose o f 60 m g/kg. Similarly, AA has been reported by many 
investigators to decrease the body weight o f treated animals. For example, in a study 
conducted by Yang et ak, (2005a), there was a significant reduction in rat body weights at 
doses o f 45 and 60 m g/kg /day  compared to the control group, following the oral gavage 
o f AA for five consecutive days. Furthermore, the body weight gained after the 5 days o f 
AA treatment period and at the end o f the 72 hr recovery period was decreased 
significantly at these doses. In a study reported by Sakamoto et ak, in which prepubertal 
and adult male mice received a single oral dose o f 150 or 100 m g/kg o f A A, the mice 
showed a significant reduction in body weight for 5 and 3 days, respectively, following the
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treatment (Sakamoto et a l, 1988). W hen male rats were gavaged with AA at 0, 5, 15, 30, 
45 or 60 m g/kg /day  for 5 days, there was a significant reduction in rat body weights at 
the 15, 30, 45 and 60 m g/kg  dosages during the treatm ent period (days 1-5) . Although 
there was some weight gain in days 5-8, in general, there was a significant reduction in 
body weight on day 1-8 o f the experiment at doses o f 15, 30, 45, and 60 mg /k g  (Tyl et 
ak, 2000a). In contrast to the above studies, many other investigators have reported that 
AA has no influence on the body weight o f treated animals (Smith et ak, 1986; 
Hashim oto et ak, 1981; Lafferty et ak, 2004). It is unclear at present why these differences 
should exist in the influence o f AA on body weight. However, it might be a function o f 
the dose or the rat strain used.
The interpretation for this body weight loss following AA treatment may be due to loss 
o f appetite by the treated animals, leading to decreased food intake and consequent 
decline in weight. This loss o f appetite could be due to the central damaging effects o f 
AA on the brain feeding center (lateral nuclei o f the hypothalamus) or to an 
overstimulation o f the brain satiety center (ventromedial nuclei o f the hypothalamus) 
leading to a decreased desire for food or inhibition o f the feeding center, respectively. 
O ther causes may be related to the reduction in the brain dopamine receptors in response 
to AA (Lehning et ak, 2003), which would lead to a decrease in dopamine reuptake by the 
brain feeding center, and hence, decreased appetite. An alternative explanation could that 
damage to the olfactory nervous system causes the animal to lose the sense o f smell and 
its inability to smell food suppresses the desire to feed.
3.9.3 E ffec t o f  A A  on  T estis and  E pididym is W eight
In the current study, no significant decrease in absolute weight o f either testicular or 
epididymal tissues was observed, in contrast to several previous studies that reported a 
significant decrease in testis weight following AA treatment. These decreases were m ost
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likely due to severe atrophy o f the testes (Sakamoto and Hashim oto 1986; Yang et ak, 
2005a; Hashim oto et ak, 1981). Yang et ak, (2005a) also observed a significant reduction 
in epididymis weight in all groups o f rats treated with AA (Yang et ak, 2005a). The 
explanation for these apparent differences is not clear at present, but again, might be 
related to dose/strain differences. In addition, in the current study, no significant 
difference in relative testis or epididymis weights were detected compared to the control, 
this result is opposite to the finding o f (Sakamoto et ak, 1988) in adult mice following a 
single oral dose o f AA (150 mg /  kg). In that case, the absolute testicular weight was not 
affected, but the relative testes weigh increased significantly, 1-5 days post AA treatment.
3.9.4 E ffects o f  A A  on Epididymal Sperm Count
Many studies have investigated the effect o f AA on the numbers o f sperm reserves o f the 
cauda epididymis in experimental animals. In the current study, AA induced a significant 
reduction in total sperm count per cauda in the rats treated with 30, 45 or 60m g/kg o f 
AA. This finding tends to support results reported in a previous study (Yang et ak, 2005a, 
b), which demonstrated that male rats receiving AA at doses o f 5, 15, 30, 45 or 60 
m g/kg /day  for 5 consecutive days by oral gavage showed a significant reduction in sperm 
reserves in a dose dependent manner, even at the lowest dose o f AA (5m g/kg/day). The 
results o f the current study were also consistent with the observations made by Sakamoto 
and Hashim oto (1986) conducted on male mice, which showed a significant reduction in 
sperm count and an increase in abnormal sperm morphology following the administration 
o f the highest dose o f AA (1.2 mM) in the drinking water. In contrast to the latter two 
studies, Tyl et ak reported that AA had no significant effect on either epididymal sperm 
motility or concentration in rat testis after oral administration o f 5, 15, 30, 45, or 60 mg 
A A daily for 5 days (Tyl et ak, 2000a). The possible interpretation for reduction in sperm
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count in the cauda epididymis observed with AA treatment might be due to a dominant 
lethal effect o f AA on germ cells, mainly at the stages o f late spermatid and early 
spermatozoa formation (Tyl et al., 2000a).
AA exerts its effect on these germ cell stages primarily by protam ine alkylation o f the 
sperm (Sega et ak, 1989). Subsequently, the normal cycle for spermatogenesis cannot be 
completed, which results in a decreased sperm production by the testis and a consequent 
reduction in sperm reserves in the cauda epididymis. Another explanation could be that 
AA perturbs gene expression related to spermatogenesis, which might cause reduction o f 
the sperm reserves in the cauda epididymis (Yang et ak, 2005a).
A nother explanation for this abnormal spermatogenesis, in the form o f quantity and 
quality o f produced spermatozoa, might involve the known intimate relationship between 
Sertoli cell injury and abnormal spermatogenesis. Sertoli cells have a num ber o f  different 
biological functions, such as delivery o f nutrients to germ cells, secretion o f fluids 
containing proteins, phagocytosis, and supply o f FSH and testosterone to germ cells (Li 
and Heindel, 1998). As will be discussed later in this section, some forms o f Sertoli cell 
injury due to AA treatment, manifested as Sertoli cell vacuolations and detachment and 
sloughing o f germ cells, were detected. These effects led subsequently to abnormal 
spermatogenesis and the resulting reduction in numbers o f normal mature spermatozoa.
3.9.5 Effects o f Acrylamide on Testicular Morphology
Acrylamide has been reported by many investigators to produce characteristic 
histopathological changes in the rat. In the current study, AA induced morphological 
changes in all treated groups, but these were more pronounced at the higher doses o f 45 
and 60 m g/kg AA. Changes included germ cell degeneration, tubular atrophy, sloughed 
spcrmatogenic cells in the lumen o f seminiferous tubules, and vacuolations between the 
inner cells o f the tubules, in addition to Sertoli cells vacuolations. For the group o f rats 
receiving doses o f 45and 60 m g/kg AA, unique and characteristic histopathological
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changes in the seminiferous tubules were seen. Multinucleated giant cells, with or without 
cytoplasmic vacuolations, were detected in the lumen o f the seminiferous tubule, in 
addition to nuclear vacuolations o f round spermatids. Additionally, AA exposure resulted 
in many multi-nucleated giant cells in the lumen o f the epididymis, with an apparent 
reduction in the sperm reserve observed at the higher doses. These findings were similar 
to the reports o f other investigators. In rat studies with AA administered by oral gavage 
in doses o f  5, 15, 30, 45 or 60 m g/kg  for 5 days, degeneration o f germ cells were 
observed, in addition to vacuolations between the inner cells o f the seminiferous tubules. 
Num erous multinucleated giant cells with sloughed spermatogenic cells in the lumen o f 
the seminiferous tubules have been reported with a dose o f 60 mg A A /kg for 5 days 
(Yang et al., 2005a,b). In a mouse study, AA produced morphological changes in 
spermatid nuclei, in the form o f nuclear vacuolations and swelling, and multinucleated 
giant cells appeared in the lumen o f the seminiferous tubules. Some tubules also 
contained degenerated spermatogonia and early spermatocytes (Sakamoto et al., 1988). 
The observations o f the current study are consistent with those reported by Sakamoto et 
al., (1988) in mice, in which the AA treated group showed the presence o f many 
vacuolated nuclei o f round spermatids in the lumen o f the epididymis (Sakamoto et al., 
1988). In contrast, (Hashimoto et ah, 1981) reported a normal histological appearance o f 
the epididymis (although there was slight reduction in relative weights o f the epididymis) 
following AA treatment o f male mice at 1.5 m m ol/kg (106.6mg/kg, twice weekly by oral 
gavage for 8-10 weeks). An attem pt has been made by (Rotter et ah, 1993) to explain the 
mechanism underlying the appearance o f multinucleated giant cells in the lumen o f the 
seminiferous tubules o f treated mice. They postulated that primary 4(1 spermatocytes 
were unable to undergo meiotic division to generate haploid sperm cells and instead 
underwent D N A  replication only, giving rise to multinucleated giant cells. In a recent
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study conducted by Yang et al., (2005a), AA was shown to perturb the gene levels that 
relate to cell proliferation and the cell cycle. This observation may be mechanistically 
related to the abnormal histopathological features observed. In addition, vacuolations are 
caused by anachronistic spermiation, which gives rise to groups o f  germ cells at different 
stages o f  development (non-synchronous evolution o f  spermatogenesis) (Cho and Park, 
1994). Gassner and Adler reported a cell cycle delay in spermatocytes following AA  
treatment (Gassner and Adler, 1996).
The consequence o f  Sertoli cell injury, which had been detected as Sertoli cell 
vacuolations in this study, is evident in the form o f  sloughing and shedding o f  germinal 
epithelium, leading to the appearance o f  aggregates o f  cellular material in the lumen 
(Boekelheide, 1993). Most Sertoli cell toxicants alter germ cell attachment to the Sertoli 
cell, resulting in loss o f  germ cell attachment to the seminiferous epithelium and hence, 
the presence o f  germ cells in the lumen. Nuclear margination in round spermatids and the 
formation o f  multinucleated giant cells are common morphologic features o f  germ cells 
necrosis detected with many testicular toxicants (Boekelheide, 1993). One important 
factor to consider as an explanation for detachment or sloughing o f  germ cells and 
resulting tubal atrophy after AA treatment is that AA might affect the adhesive contact 
between Sertoli and germ cells, as reported by (Johnson et al., 2000). They reported that a 
novel gene (flamingol) encoding a cell adhesion (cadherin) protein, was expressed in rat 
testis, and was likely a Sertoli cell product. Therefore, flamingol could be a target o f  AA  
testicular injury, and warrants further investigation and evaluation.
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3.9.6 Electron M icroscopy
The results o f the pilot EM  study were highly consistent with the detected 
histopathological changes observed by light microscopy. All changes, including some that 
had not been detected previously, were consistent with acute cell injury. AA exposure 
caused degeneration o f spermatogonia and atrophy o f Leydig cells. Sertoli cells showed 
intranuclear vacuoles with pyknotic nuclei, nucleolar shrinkage, swollen mitochondria, 
darkened cell colour, and increased size and num ber o f cytoplasmic lipids droplets. 
Excessive lipid droplets in the Sertoli cell cytoplasm are indicative o f germ cell 
degeneration (Schulze and Holstein, 1993). AA treatment also caused widening o f 
intercellular spaces in the tubule.
Abnormal spermatogenesis due to a reduction in testosterone horm one resulting from 
Leydig cell atrophy might be an im portant factor for this abnormality. The AA insult to 
the Sertoli cell that was detected by EM  study provides a fundamental link between AA 
treatment and the histopathology features detected in the testis o f AA treated rats. The 
consequence o f testosterone reduction would be abnormal Sertoli cells, because 
testosterone influences the Sertoli cell to undergo normal spermatogenesis (Johnson and 
Everitt, 2000). The darkening o f the Sertoli cell that was detected during the EM  study is 
consistent with the report o f (Schulze and Holstein, 1993), in which increased colour 
intensity o f human Sertoli cells was detected in cases o f hypospermatogenesis and 
patients’ complaints o f infertility and oligozoospermia in which" Sertoli cell asthenia" or 
Sertoli cell insufficiency has been described.
Consequently, this abnormality in Sertoli cell structure and function results in abnormal 
spermatogenesis, while impairment o f intercellular junctions leads to sloughing o f germ 
cells and the formation o f large vacuoles that occupy the basal and adluminal 
compartments. In severe cases, Sertoli cells might be released from epithelium after death,
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Ileaving large basal vacuoles. Widening o f  spaces surrounding the seminiferous tubules in 
histological examinations has been interpreted as a preparation artefact caused by 
shrinkage during tissue fixation and dehydration prior to paraffin embedding. It was not 
believed to be due to Leydig cell atrophy, although the histological examination o f  testis 
by light microscopy hinted at Leydig cell toxicity. However, with the aid o f  EM, Leydig 
cell atrophy was clearly detected. Furthermore, the signs o f  insult to Sertoli cells after AA  
treatment were signs o f  Sertoli cell death. This might be due to a direct influence o f  AA  
on Sertoli cells or may be due to testosterone reduction resulting from Leydig cell 
atrophy, or both. Since not all Sertoli cells died, those that remained, and the remaining 
spermatogonia, were capable o f recovery from toxicity and regeneration o f  normal 
spermatogenesis after a period o f  time.
Regarding the effect o f  AA on the widening o f intercellular spaces, Cheville, (1994) 
reported dissociations o f  desmosome-like structures (present normally between cells), and 
o f hemidismosomes (present between the cells and the basement membrane), with 
subsequent detachment o f  cells from the basement membrane and widening o f  
intercellular spaces, usually signs o f  acute cell injury. This pilot electron microscopy study 
o f the AA treated group (45mg/kg for 5 days) needs to be replicated and validated with 
additional studies using larger numbers o f exposed and control rats.
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3.9.7 Summary
In the first part o f  this study, the AA induced testicular toxicity was initially characterized 
in rats on the basis o f significant body weight reduction, reduction in sperm reserves in 
the cauda epididymis, and induction o f many histopathological signs in rat testes and 
epididymis. A pilot electron microscopy study o f AA-treated rat testes (45mg/kg/day) 
indicated the occurrence o f  many pathological events in Sertoli cells, some o f which 
resulted in Sertoli cell death. Leydig cell atrophy was observed, together with reduction in 
Leydig cell numbers. Based on the results o f  this study, we can postulate that AA toxicity 
in the testis results from it being not only a germ cell toxicant but also a Sertoli cell 
toxicant. Further, most o f  the pathology and the pathogenesis o f  AA intoxication 
observed with AA treatment in male rat could be due to testosterone reduction resulted 
from Leydig cell atrophy. Further biochemical studies are needed to clarify this molecular 
mechanism.
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4 Ability of 5-ASA to Protect Against Acrylamide-Induced 
Testicular Toxicity
4.1 Introduction
The previous chapter characterized mainly the deleterious effects o f acute AA exposure 
on male rat testis. In addition to these acute effects on testicular function, acrylamide 
has also been proposed by other investigators to cause the release o f free radicals, which 
decrease the oxidative defense system in the cell, leading to the development o f  cancer 
(Blasiak et al., 2004). Taken together, it is therefore im portant to identify protective 
applications against the actions o f acrylamide, both to prevent immediate and long-term 
damage from low- level environmental exposures and in victims o f acrylamide poisoning. 
5-ASA has been reported previously to have a potent antioxidant activity and also has an 
anti-inflammatory activity which were proposed to be due to inhibition o f prostaglandin 
synthase an d /o r lipoxygenase activities (Miles and Grisham, 1994). In addition, ASA been 
shown to improve semen characteristics and restore fertility in patients with ulcerative 
colitis who suffered from infertility after long-term treatment with sulfasalazine (SSZ) 
(Cann and Holdsworth, 1984). Also, pretreatm ent o f endosulfan treated rats with 5-ASA, 
significantly reduced sperm shape abnormalities, with histopathological analysis o f 
seminiferous tubules and Leydig cells indicating significant protection from endosulfan 
induced tissue damage Qaiswal et al., 2005). Taken together, these two last pieces o f data 
are strongly supportive that 5-ASA is able to protect the testes from ROS-mediated 
damage, as occurs during acrylamide toxicity. It was therefore hypothesized that 5-ASA 
could have a protective role in acrylamide- induced reproductive toxicity in male rats. To 
examine this, rats were exposed to 45 m g/kg  AA for 5 days, eliciting the acute toxicity 
described in the previous chapter, in combination with two different doses o f 5-ASA (25 
and 50 m g/kg  for 5 days by IP injection).
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4.2 General Observations
Rats in the control group showed no symptoms o f illness or mortality during the 
experimental period. Also no mortality was recorded among AA, 5-ASA and vehicle (gum 
acacia) treated rats during the experimental period. However the aggressiveness among 
rats treated with AA, as described previously in (section 3-2), was significantly reduced by 
co-treatment with both doses o f  5-ASA.
4.3 Effects on Absolute and Relative Testes Weights
Following five days o f AA exposure, rats did not show any significant change in either 
absolute (A) or relative (B) testes weights in comparison to control group, consistent with 
the previous observations (Fig. 25). In addition, 5-ASA treatment had no impact on testes 
weight.
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Fig. 25. Absolute (A) and relative (B) testes weights after AA and ASA treatment
Acrylamide was administered by oral gavage at a dose of 45mg/kg/day for 5 consecutive days to 
adult male rats. As indicated ASA (25 or 50 mg/kg) was administered by IP injection 
concomitantly with AA treatment, with gum acacia as a solvent. (Data were expressed as mean ± 
SD, n = 5). The statistical analysis was performed by One-Way ANOVA.
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4.4 Effects on Absolute and Relative Cauda Weights
Following five days o f AA exposure, rats did not show any significant change in either 
absolute (A) or relative (B) cauda weights in comparison to normal control group. ASA 
treatment also, did not have any effect on both cauda weights in comparison to AA 
control group (Fig. 26).
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Fig. 26. Absolute (A) and relative (B) cauda weights after AA and ASA treatment
Acrylamide was administered by oral gavage at a dose of 45mg/kg/ day for 5 consecutive days to 
adult male rats. As indicated ASA (25 or 50 mg/kg) was administered by IP injection 
concomitantly with AA treatment, with gum acacia as a solvent. (Data were expressed as mean ± 
SD, n = 5).
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4.5 Effects of ASA on AA Induced Changes in Epididymal Sperm Count
Whereas we had previously observed no impact on AA treatment on testis and cauda
weight, we had seen a significant impact on epididymal sperm count (section 3-4); we 
hence, examined the effect o f ASA co-treatm ent on this parameter next. Rats treated 
with AA (45m g/kg/day) showed significant reduction in sperm count in comparison to 
normal control group (p<0.05), as was expected. However, no statistically significant 
change in epididymal sperm count was detected for rats treated with AA and both doses 
o f ASA when compared to AA control group which suggested that both doses o f ASA 
on this 5 days duration exposure could not protect rats from the toxic effects o f  AA on 
total sperm count (Fig. 27).
co 450-1
~ o
§  400- 
o) 350-
Fig. 27. Total sperm count per gram o f cauda after AA and ASA treatment 
Acrylamide was administered by oral gavage at a dose of 45mg/kg/ day for 5 consecutive days 
to adult male rats. As indicated ASA (25 or 50 mg/kg) was administered by IP injection 
concomitantly with oral gavage of AA treatment, with gum acacia as a solvent. (Data were 
expressed as mean ± SD, n — 5). The symbol represents statistical significance (ANOVA) from 
normal control: *, p < 0.05, followed by Tukey-Kramer multiple comparison test. The 
AA+ASA groups were compared to AA control.
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4.6 Histological Changes in the Testis After AA and ASA Treatment
We have previously observed significant histological damage to rat testes following AA
treatment, and now examined if  ASA could protect against this damage. In the control 
group seminiferous tubules and spermatogenesis appeared normal with apparent luminal 
sperm reserve, also, there was a clear cellular differentiation starting with the 
spermatogonia from the basement membrane and ending at the lumen with the 
spermatozoa. In addition rats treated with 5-ASA and gum acacia showed normal testes, 
(Fig. 28 A ,B an d C ).
As seen previously evidence o f  morphological changes in the testicular histology was 
observed in the AA-treated rats, including germ cell degeneration and atrophy to the 
seminiferous epithelium o f rat testis, with disruption in the normal looking appearance o f  
the testis. In addition, a reduction in the luminal sperm reserve was observed, and in 
many tubules vacuolations were observed in-between cells o f seminiferous tubule (Fig. 
29B). These detected observations were consistent with the data presented in the 
previous result chapter. Importantly, that Leydig cells showed severe atrophy and 
degeneration with reduction in size, numbers o f  cells and color intensity (Fig. 30B).
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Fig. 28. Representative light microscopy o f transverse sections o f testes 
Isolated from; (A) control, (B) 50m g/kg ASA and (C) 10 % gumacacia. Rats were 
treated for 5 consecutive days. All show testes with normal histology. Sections stained 
with H & E stain and viewed using light microscopy.
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Co-treatment o f  rats with AA and 25 m g/kg 5-ASA, did not completely remove the 
acrylamide-induced testicular changes, but the observed damage was generally less, with a 
significantly less damage to the germ cell population in most o f  the tubules, although 
there was still areas o f  damage (Fig. 29C). In addition, this dose o f  5-ASA appeared to 
prevent the Leydig cell atrophy detected in AA-treated rats alone, because Leydig cells 
appeared normal in this group (Fig. 30C).
Interestingly, AA-treated rats exposed to a dose o f  50 m g/kg 5-ASA, appeared to be 
almost completely protected from the AA-mediated toxicity, with nearly normal 
histological appearance o f the testis. Normal spermatogenesis was observed, with no 
multinucleated giant cells, no vacuolations, and no tubular atrophy (Fig. 29D). In 
addition, this dose o f  ASA appeared to strongly prevent the Leydig cell atrophy detected 
in AA-treated rats alone, because Leydig cells appeared normal in this group o f  rats (Fig. 
30D).
It should be noted that even in this case, protection was not complete, as some o f  the 
tubules still appeared abnormal compared to control, however the protective effect o f  the 
50mg/kg o f ASA was generally more clear than the dose o f 25m g/kg ASA. However 
recovery at both doses o f  5-ASA was not complete at this five days duration o f  
experiment.
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Fig. 29. Representative light microscopy o f transverse sections for general architecture o f  
testes, indicating the AA toxicity and the protective effect o f  ASA, isolated from control, 
AA and ASA treated rats. (B) Shows testis o f  AA(45mg/kg)treated rat, with disruption in 
normal histological appearance o f  the tubules with germ cell degeneration and reduction 
in sperm reserve in the lumen o f  the tubules, note also the multiple vacuoles o f different 
size in-between the cells o f the tubules (red arrows), (C) Shows the mild protective effect 
o f ASA at a dose o f 25m g/kg on the testicular toxicity caused by AA, note the slight 
restoration o f  normal histological structure o f  the testis with increase sperm reserve in the 
lumen o f  the tubule with some residual damage in the form o f  atrophy and germ cell 
degeneration , (D) Shows the strong protective effect o f  ASA at a dose o f 50mg/kg on 
the testicular toxicity caused by AA, the tubules almost appeared normal with normal 
histology and restoration o f luminal sperm reserve with normal germ cells. Sections 
stained with H&E stain and viewed using light microscopy.
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Fig. 30. Representative light microscopy o f transverse sections for Leydig cells o f the 
testes, indicating the AA toxicity and the protective effect o f  ASA on these cells, isolated 
from Control, AA and ASA treated rats.
(A) Shows leydig cells from control rat testis, with normal histology and color intensity,
(B) Shows leydig cells from AA (45mg/kg) treated rat testis with severe atrophy and 
reduction in color intensity, (C) Shows Leydig cells from rat treated with AA and ASA at 
a dose o f 25m g/kg, indicating the protective action o f ASA on AA induced toxicity on 
leydig cells, note the normal appearance o f cells with increase in cells num ber and color 
intensity, (D) Shows Leydig cells from rat treated with AA and ASA at a dose o f 
50m g/kg, indicating the protective action o f ASA at higher dose level, note the normal 
appearance o f cells with increase in cells number. Sections stained with H & E  stain and 
viewed using light microscopy.
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4.7 Effect of AA and ASA on Seminferous Tubules Diameter
To examine the impact o f  AA and ASA on seminiferous tubules more robustly, a
morphometric study on seminiferous tubules diameter was undertaken, to investigate 
the influence o f  AA and ASA on tubule diameters o f  the rat testis. N o  statistical 
significant difference was detected in AA-treated rats in comparison to normal control 
group. Further, no statistical significant difference was detected with both doses o f  
A A + ASA in comparison to AA control group (Table 7).
Groups Diameter (jam) 
mean ± SD
Control 83.77 ± 10.45
AA +ASA(50 mg/kg) 79.84 ± 9.02
AA + ASA(25 mg/kg) 77.61 ± 8.20
AA (45 mg/kg) 82.71 ± 8.50
Gum acacia (10%) 82.43 ± 9.60
ASA(50 mg/kg) 75.36 ± 6.20
Table 7. Mean seminiferous tubule diameters for AA and ASA treated rats 
Acrylamide was administered by oral gavage at a dose of 45mg/kg/day for 5 consecutive days 
to adult male rats. ASA (25 or 50 mg/kg) was administered by IP injection concomitantly 
with AA treatment, with gum acacia as a solvent. Mean diameter of 100 tubules for each rat 
was calculated. A study conducted by using Image-pro express for windows 2000/XP. (Data 
were expressed as mean ± SD, n = 5).
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4.8 Effect of ASA on Acrylamide-induced Sperm Shape Abnormality
AA is known to cause sperm abnormalities, and this was observed in the current study.
AA treatment (45 mg/kg) produced sperm shape abnormalities in the cauda epididymis, 
mainly in the form o f  detached heads. A significant increase in detached heads was found 
in the group treated with 45 m g/kg AA, when compared to the normal control group. 
However, no statistical significant difference was detected with both groups o f  AA- 
treated ASA rats, when compared to the AA control group (Table 8). Representative 
photos for detached heads abnormality are shown in (Fig. 31).
Groups Detached heads 
(mean ± SD)
Control 2.03 ± 0.71
AA +ASA(50 mg/kg) 4.31 ±0.55
AA + ASA(25 mg/kg) 4.21 ± 0.84
AA (45 mg/kg) 5.04 ± 1.58***
Gum acacia (10%) 2.15 ± 0.84
ASA (50 mg/kg) 1.53 ±0.89
Table 8. Mean o f detached heads abnormality in AA and ASA treated rats, prepared from 
cauda epididymis. Acrylamide was administered by oral gavage at a dose o f 45m g/kg/ 
day for 5 consecutive days to adult male rats. ASA (25 or 50 mg/kg) was administered by 
IP injection concomitantly with AA treatment, with gum acacia as a solvent. The number 
o f detached heads was counted/100 sperm s/field/5 different fields, for each rat in the 
group. Data were expressed as mean ±  SD, n =  5. The statistical analysis was performed 
by One-Way ANOVA. The symbol represents statistical significance (ANOVA) from 
normal control: ***, p < 0.001, followed by Tukey-Kramer multiple comparison test.
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Fig. 31. Light microscopies o f smears from cauda suspension o f normal control and AA- 
treated rat. (A) From normal control rat, with normal head (B) From AA (45mg/kg) treated rat, 
note many detached heads (red heads arrows). Smears were stained by 10% Rose Bengal solution.
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4.9 TU N EL ASSAY on Testicular Tissue
To investigate the effect o f  AA and ASA on germ cell apoptosis, Tunnel assay was 
applied on testis isolated 24h after the last AA and 5-ASA doses.
As shown in (Fig. 32), a positive control that was induced by applying Tacs® nuclease 
with the reaction mixture to induce a positive apoptotic cells, it results in many TUNEL  
positive germ cells. These cells were characterized by brownish coloration, shrinkage and 
nuclear fragmentation & condensation. In comparison, examination o f  germ cells from 
experiment normal control rats showed very low levels o f  TUNEL positive germ cells 
(Fig. 32B) as was expected. In addition, Acrylamide (45mg/kg) treated rats for 5 days did 
not show any significant increase in apoptotic germ cells (Fig. 33), also co-treatment o f  
AA-treated with 25 or 50 m g/kg ASA did not show any positive effect on apoptosis in 
the testes o f  the treated rats when compared to AA control group. Moreover, testes from 
rats treated with 5-ASA (50mg/kg) and gum acacia (10%) alone did not show any Tunnel 
positive cells.
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Fig. 32. T U N E L Assay in induced positive control (A) and normal control rat (B) 
testicular tissue. (A) Shows seminiferous tubule with 4-6 Tunel positive germ cells 
(arrows) mainly spermatogonia, characterized by brownish coloration, shrinkage and 
nuclear fragmentation & condensation, were induced by Tacs® nuclease (B) Shows 
seminiferous tubule with one TU N E L positive cell from normal control rat (arrow), x20. 
The antigen retrieval-TUNEL stained sections were counterstained with methyl green and 
viewed using tight microscopy.
200 microns
Fig. 33. Representative transverse section for T U N E L  assay on testicular tissue o f AA 
(45mg/kg) treated rat for 5 consecutive days. Shows seminiferous tubule that was 
negative for T U N E L positive cells. Apoptotic cells were examined in 100 tubules (20 
tu b u les/h e ld /5 different fields) for each rat in the group. Antigen retrieval TU N E L 
stained sections were counterstained with methyl green and viewed using light 
microscopy.
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4.10 COMET Assay in Peripheral Blood Leukocytes
As previously discussed, AA is a known mutagen, potentially through the production o f  
ROS. To examine this D N A  damage, and determine whether it could be prevented by co­
treatment with ASA, I next used the COMET assay to study D N A  damage. In the 
control group; group treated with 5-ASA; and gum acacia group the measure tail moment 
was (0.00- 0.001) (Fig. 34), which is consistent with a very low level o f  D N A  damage. In 
comparison, the group treated with 45 m g/kg AA demonstrated (8.3%) olive shape 
COMET cells, (tail moment 37.5—44), indicative o f  massive levels o f  D N A  damage 
(Table 9). Co-treatment with 25 m g/kg ASA dramatically reduced the tail moment o f  the 
detected COMET (0.8—1.0), with no further protection observed with the higher ASA 
dose treatment (50mg/kg).
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oFig. 34. Photographic Images o f leukocytes from (A) control, (B) gum acacia (10%) and (C) 
ASA treated rats, subjected to Single Cell Gell Electrophoresis, subsequently analyzed by 
Image Analysis System. Tail M oment = 0.00-0.01.
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Treatment
group
Tail
moment
% of total 
COMETs
COMET cells
AA(45mg/kg)
(olive-shape)
37.5-44 8.3
AA(45mg/kg)
+25mg/kg
ASA.
AA(45mg/kg)
+50mg/kg
ASA.
0.8 - 1 8.2
0.8- 1.1 8.1
Table 9. Photographic Images o f leukocytes from rat gavaged with 45mg/kg AA for 5 
consecutive days with simultaneous injection of different doses of ASA and subjected to Single 
Cell Gell Electrophoresis, subsequently analyzed by Image Analysis System.
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4.11 Effects of ASA on AA Induced Changes in Serum Testosterone level
As testosterone is produced within the Leydig cells o f the testis, we next examined the
impact o f AA-mediated toxicity on circulating testosterone levels, and the ability o f ASA 
to protect against these effects. As expected, a significant reduction in blood testosterone 
level was detected in rats treated with 45m g/kg AA when compared to the normal 
control group, with no statistically significant differences detected between the control 
group and AA+ASA treated group. Further, there was a statistically significant increase in 
the level o f  circulating testosterone hormone among the A A + ASA (25 or 50mg/kg) 
treated rats when compared to AA control group (Fig.35). Once again, ASA co-treatment 
appeared to prevent AA toxicity. This suggests that the suppressive effect o f  AA on 
circulating testosterone levels can be ablated by concomitant ASA treatment.
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Fig. 35. M odulatory effect o f ASA on scrum testosterone concentration in AA-treated 
rats. Acrylamide was administered by oral gavage at a dose of 45mg/kg/day for 5 consecutive 
days to adult male rats. As indicated 5-ASA (25 or 50 mg/kg) was administered by IP injection 
with gum acacia as a solvent, concomitantly with oral AA treatment. (Data were expressed as 
mean ± SD, n = 5). The symbol represents statistical significance (ANOVA) from normal 
control: ***, p < 0.001, followed by Tukey-Kramer multiple comparison test. The letter (a) 
represents statistical significance (ANOVA) from AA control, p < 0.01. And (b) represents 
statistical significance (ANOVA) from AA control, p < 0.001.
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4.12 Effect of AA and ASA on CYP2E1 Expression in Liver and Testis (S9) 
fractions
CYP2E1 has been linked to the mechanism o f AA- mediated toxicity, due to both the 
ability o f this enzyme to readily become uncoupled and produce ROS and the CYP2E1- 
catalysed metabolism o f AA to the reactive molecule glycidamide (Ghanayem et al., 
2005a,b). To investigate the protective mechanism o f 5-ASA on AA-mediated testicular 
toxicity in rat, CYP2E1 concentration was measured using an ELISA. A calibration curve 
was constructed from mean absorbance versus concentration, using the least square 
regression equation with correlation coefficients (r2) routinely ~  greater than 0.999. As 
shown in (Fig. 36A), CYP2E1 is expressed in the S9 fraction from control rats liver at a 
higher concentration (0.44 ng /m g protein) than in the control testis (0.074 ng /m g  
protein) (Fig. 36B), which is perhaps not surprising, given the im portant role o f  the liver 
in xenobiotic metabolism. However, whereas, AA caused a significant reduction (P<0.01) 
in CYP2E1 levels in the liver when compared to the normal control, the impact o f AA- 
treatment was the reverse in the testes when compared to the control, with CYP2E1 
concentrations increased up to two fold when compared to the normal control in the 
testis. It should be noted that the decrease in CYP2E1 levels in the fiver was not due to 
fiver weight changes, because no significant difference was detected in fiver weight 
between all groups, with mean fiver weight o f 9.77gm (Fig. 37).
In the fiver, co-treatment o f AA-treated rats with ASA at a dose o f 25m g/kg/day for 5 
days does not show any significant differense when compared to AA control group (Fig. 
36B). However, at a dose o f 50m g/kg ASA there was a significant increasc(P<0.01) in the 
level o f CYP2E1 when compared to A A control group, which indicates the strong 
reversing action o f this higher dose o f ASA on acrylamide effect on CYP2E1 level in the 
fiver, with increasing rate o f AA metabolism. This is again consistent with the hypothesis
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that ASA(25mg/kg) can protect the rat body from the toxic effects o f AA, and expands 
this to include other organs than the testes, such as the liver.
In the testis, AA exposure causing induction o f CYP2E1(P< 0.01) when compared to 
normal control, as was expected because o f the littile amount o f AA escaping the first 
pass metabolism in the liver and reaching to the testis through the circulation, which is 
not enough to cause depletion o f  the CYP2E1 as happened in the liver. In addition, 
exposing acrylamide treated rats to two different doses o f ASA dose not show any 
significant differense from AA control group in the testis (Fig. 36B).
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Fig. 36. CYP2E1 concentration in liver (A) and testis (B) S9, following AA and ASA 
treatment in rat, as detected by ELISA 3h after the last doses
Acrylamide was administered by oral gavage at a dose of 45mg/kg/ day for 5 consecutive days to 
adult male rats. As indicated ASA (25 or 50 mg/kg) was administered by IP injection with gum 
acacia as a solvent, concomitantly with oral AA treatment. Data are expressed as mean ± SD, n = 
5). The symbol represents statistical significance (ANOVA) from normal control: **, p < 0.01, 
followed by Tukey-Kramer multiple comparison test. The letter (a) represents no statistical 
significance from AA control. And (b) represents statistical significance (ANOVA) from AA 
control, p < 0.01.
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Fig. 37. Mean liver weight o f control, A A and ASA treated rats
Acrylamide was administered by oral gavage at a dose of 45mg/kg/ day for 5 consecutive days to 
adult male rats. As indicated ASA (25 or 50 mg/kg) was administered by IP injection with gum 
acacia as a solvent, concomitantly with oral AA treatment. (Data are expressed as mean ± SD, n = 
5).
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4.13 Acrylamide Concentration in Rat Serum (Reversed HPLC)
To examine the serum concentration o f  AA, reversed HPLC approach was used. Initially,
the resolution and sensitivity o f the assay were determined by standards extracted from 
control rat serum. At a flow rate o f 0.5 ml/min, the retention time o f  AA was 8.5 min ±  
0.1. Chromatographic method performance was estimated based on injection o f  system 
suitability solution (median calibration level extracted from spiked plasma, 40pg/mL). 
The calculated parameters were, retention time (tR), capacity factor (k’), resolution from 
the closest peak (R), peak tailing (/) and number o f  theoretical plates (N). The calculated 
chromatographic parameters were as follows; tR; 8.5 min ±0.1, k’; 3.1 ±0.01 (SD), R; 
2.4±0.02 (SD), t, 1.0, N; 14200±1.2 (SD). The assay was linear between 0.1 and 100 
pg/m l for AA. A calibration curve was constructed from peak area versus concentration, 
using least square regression equation. Correlation coefficients (r2) were ~  greater than 
0.99. Recovery for AA was ~ 99±  0.4 % (6 determinations). Chromatogram o f  AA  
standards (Fig. 38) and because o f  possible interference by plasma components at 205 
nm, a representative chromatogram from control rat serum are presented (Fig. 39, 
chromatogram-A). Also, groups treated with gum acacia and 5-ASA alone, showed no 
peak for AA at 8.5 minutes o f  retention time (Fig. 39, chromatogram B, C).
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Fig. 38. Chromatogram for AA standard (lOjag/ml serum). As analyzed by reversed phase 
HPLC, Retention time (tR) for AA was detected to be 8.5 min ± 0.1.
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Fig. 39. Chromatograms o f serum extracts from; control (A), 10% gum acacia (B), and 
50mg/kg ASA(C) treated rats, as analyzed by reversed phase HPLC. Gum acacia was used as a 
solvent for ASA and was introduced by IP injection to adult male rat.
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Representative chromatograms from rat serum treated with AA and rats treated with 
AA+ASA were also presented at (Fig. 40). N o statistically significant difference was 
detected between the AA-treated rats and rats treated with either doses o f ASA (Fig. 41) 
at this 5 days duration experiment.
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F ig . 40. Chromatograms o f serum extracts from AA 45m g/kg (A), from A A +25m g/kg 
ASA (B), and AA +50m g/kg ASA (C) treated rats, as analyzed by reversed phase 
HPLC. Acrylamide was administered by oral gavage at a dose of 45mg/kg/ day for 5 consecutive 
days to adult male rats. ASA (25 or 50 mg/kg) was administered by IP injection with gum acacia 
as a solvent concomitantly with oral AA treaUnent. Serum samples taken 3h after the last AA 
dose. Calculated tR for AA; was 8.5 min. As analyzed by reversed phase HPLC.
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Fig. 41. Acrylamide concentration in the serum o f AA and ASA treated rats 
Acrylamide was administered by oral gavage at a dose o f 45m g/kg/day for 5 consecutive 
days to adult male rats. As indicated 5-ASA (25 or 50 m g/kg) was administered by IP 
injection with gum acacia as a solvent concomitantly with oral AA treatment. Serum 
samples taken 3h after the last AA dose (Data were expressed as mean ±  SD, n = 5).
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4.14 Discussion
In this study the potential role o f the antioxidant 5-ASA in protection o f AA- induced 
reproductive toxicity following a subacute exposure to AA was evaluated in the rats. . 
Concomitant treatment o f 5-ASA with acrylamide was effective in preventing AA- 
mediated suppression in the blood testosterone level at both examined doses o f  ASA. In 
addition, ASA co-treatment improved the histological appearance o f the testis, reduced 
the tail m om ent in the detected CO M ET cells in the blood, and suppresses CYP2E1 
induction in the liver.
4.14.1 E ffect o f  5-ASA on Testis weight, Cauda W eight
The results o f this study showed that there was no significant difference detected in either 
absolute or relative testis or cauda weight compared to the control. In contrast to other 
study (Jaiswal et al., 2005) in which treatment o f rats with 5-ASA at both doses caused an 
increase in testis weight, indicating the recovery o f spermatogenic activity in the tubules 
after the toxic effect o f  endosulfan, which causes a reduction in num ber o f cells available 
for spermatogenesis due to death o f immature germ cells, and hence a reduction in testis 
weight.
4.14.2 E ffects o f  5-ASA on Acrylamide-Induced D ecrease in Total Sperm Count 
per cauda
The result o f this study indicated that, while a significant reduction was found between 
the 45m g/kg AA group and the normal control with respect to sperm count per cauda, 
there was no significant difference from AA control group at both tested ASA doses. The 
result o f the current study was consistent with the observed effects o f ASA in ulcerative 
colitis patients (Cann and Holdsworth, 1984), in which reported a reduction in total 
sperm count in patients suffering from ulcerative colitis after changing treatment from 
sulphasalazine to 5-ASA, some improvement in spermatozoa function was noted,
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resulting in an im provem ent o f fertility in those patients. Further O'Marain et al., (1982) 
reported that 13 slow acetylator patients had significantly lower sperm counts (6.3xlO 6) 
and motility than 9 fast acetylator patients (41.2XlO6). Importantly, these data also 
support the idea that the protective effect o f ASA against testicular toxins is applicable to 
both humans and the model system used herein, rats.
In contrast, other investigators (Jaiswal et ah, 2005) reported a significant increase in total 
sperm count at (25 and 50mg/kg) o f 5-ASA as com pared with endosulfan (7.5mg/kg) 
alone, which was documented previously to cause a reduction in total sperm count. 
However, in the previous study, 5-ASA at a dose o f 25m g/kg for 10 days was reported to 
improve sperm counts m ore than at a dose o f 50m g/kg without complete recovery. This 
improvement in sperm count after a high dose o f 5-ASA could be due to the established 
antiprostaglandin-like activity o f ASA, as was reported by Moskov et al., and indeed ASA 
has been suggested as a potential treatment in some cases o f unexplained oligospermia, as 
sperm improvement has been observed after antiprostaglandin therapy (Moskov et al., 
1988). In the current study the reason for the lack o f significant effect o f ASA on AA- 
treated rats with respect to sperm count/cauda, could be due to dose, or short duration 
o f exposure to ASA.
4.14.3 Effects of 5-ASA on AA Induced Decrease in Serum Testosterone Level 
A striking feature o f this study was the effect o f 45m g/kg acrylamide on serum
testosterone concentrations when compared to the normal control. In the current study,
blood was taken 24h after the last dose, and the result showed that there was a very
significant reduction in blood testosterone level following treatment with 45m g/kg
acrylamide. The reduction in serum testosterone following A A exposure is consistent
with the reports o f Yang et al., who demonstrated a significant reduction in testosterone
concentration by using radioimmunoassay, in sera o f AA-treated rats at a dose o f 30, 45,
147
and 60 m g/kg/day  for 5 days followed by 3 days o f  observation (Yang et al., 2005b). 
Moreover, testosterone concentration in the culture medium o f Leydig cells after 
incubation for 24b, decreased significantly in all AA-treated groups, indicating that 
testosterone reduction was due to influence o f acrylamide, presumably caused by the 
observed dose-dependent Leydig cell death (Yang et ah, 2005b). As a result o f increased 
Leydig cell death, testosterone level in the testis is likely to be decreased, resulting in a 
reduction in spermatogenesis. The result o f the current study further showed that both 
doses o f ASA can cause significant increase in the level o f circulating testosterone level 
when compared to the AA control, which indicated that 5-ASA was successful at 
antagonizing the toxic effect o f AA in reducing testosterone concentration in serum. In 
contrast, another study reported that 5-ASA could cause a reduction in the level o f 
testosterone, when 7.5m g/kg endosulfan was given to the rats for 10 days, during which 
testosterone was significantly increased, but this was not recovered following an 
additional 10 days treatment with 25m g/kg ASA. It was stated by the authors that the 
mechanism by which 5-ASA causes a reduction in testosterone level is not clear, although 
it is not clear if  this is really a case o f ASA causing a reduction, or failing to prevent the 
endosulfan-mediated reduction (Jaiswal et al., 2005). The powerful antioxidant capacity o f 
5-ASA exerted on the Leydig cells, could be the cause o f its influence on testosterone 
level, as it was reported previously that Leydig cell atrophy and death could be the cause 
o f testosterone reduction in AA-treated rats (Yang et al., 2005b).
Further, (Georgellis and Rydstrom, 1989 ; Georgellis et ak, 1990) it was reported that 7, 
12-dime thylbenz (a) anthracene and many other poly cyclic aromatic hydrocarbons are 
metabolically activated to active metabolites in rat Leydig cells. Also, CYP2L1 is 
documented to have a role in the metabolic activation o f various toxicants and 
carcinogens such as benzene, styrene, Acrylonitrile, vinyl carbamate and many other
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halogenated hydrocarbon compounds (Wrighton et al., 1987). Taken together, these data 
suggest that CYP2E1 expressed in Leydig cells, will potentiate the toxicity o f  these 
compounds with increasing their active toxic metabolites with excessive release o f  free 
radicals, causing increased oxidative stress in the Leydig cells. Hence, the antioxidant 
activity o f ASA might improve the Leydig cell toxicity after AA treatment leading to 
increased testosterone level.
4.14.4 Effects o f  5-ASA on A A  Induced H istopathological Changes
The result o f the current study indicated that AA at a dose level o f  45m g/kg causing
histopathological changes in the testis o f the rats. These include tubule disruption, 
reduction in the luminal sperm reserve, shedding o f normal germinal epithelium in the 
lumen o f the seminiferous tubules, maturation arrest in some tubules and multinucleated 
giant cells with vacuolations in between inner cells o f the tubules. Histopathological 
changes in rat testis after AA treatment were well documented previously by (Yang et ak, 
2005a,b) and the results o f this work support these studies. Acrylamide treated rats co­
exposed to 25m g/kg ASA showed signs o f reparation with significant increase in germ 
cells populations in m ost o f the tubules, compared to AA alone, although the recovery 
was far from complete. This result is in agreement with (Jaiswal et ak, 2005) study, when 
male rats were exposed to endosulfan, together with a dose o f 25m g/kg o f 5-ASA in a 
preventive study, the rats showed signs o f recovery and im provem ent in spermatogenesis. 
In the current study, the dose o f 50m g/kg o f 5-ASA was much better in reducing the 
signs o f acrylamide-induced toxicity than with the dose o f 2 5 m g/kg  o f 5-ASA, although 
at the level o f both doses o f 5-ASA the recovery was not complete. This, protective 
action o f 5-ASA on acrylamide induced-histopathological changes might be due its 
antioxidant power to inhibit oxidative damage which depends on its ability to scavenge
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free radicals and by acting as a chain breaking antioxidant with interference with the
initiation and progression o f lipid peroxidation (Jaiswal et ak, 2005). As well as its
antiprostaglandin property might improve signs o f the accompanied inflammatory
process. As a result, an im provem ent in intratubular testosterone levels could result,
leading to an im provement on spermatogenesis. A nother im portant factor that improves
testosterone levels is the effect o f 5-ASA on Leydig cell atrophy, as AA causes atrophy o f
these cells with reduction in serum testosterone level, 5-ASA prevents Leydig cell atrophy
and hence maintain normal testosterone level which results in normal spermatogenesis.
4.14.5 E ffects o f  5-ASA on A A  Induced Sperm Shape Abnormalities
The results o f the current study indicate that AA treatment at a dose o f 45m g/kg bw, can
produce sperm shape abnormalities mainly in the form o f increasing detached heads
when compared with the control. However, the increasing percentage o f detached heads
observed with the groups treated with AA alone, had been reduced dramatically in the
group treated with AA and 5-ASA with no difference between the two doses o f ASA.
The result is highly consistent with the study conducted by Jaiswal et ak, (2005) on male
rats that were exposed to endosulfan at a dose o f 10m g/kg for 10 days. The num ber o f
abnormal sperms in cauda epididymis was markedly increased after endosulfan treatment
mainly in the form o f head deformity including; amorphous, hook-less, banana-shaped,
double-headed and double-tailed forms. However when 5-ASA was given simultaneously
with the endosulfan, there was a significant reduction in sperm shape abnormalities,
which was more prom inent with the dose o f 25m g/kg ASA, but the recovery at both
doses was far from  complete. Further, another study conducted by Cann and 1 loldsworth
on humans, when 5-ASA was administered to patients o f ulcerative colitis, suffered long
time from infertility after chronic treatment with sulfasaEinc. The patients showed
improvement in spermatozoa functions and restoration o f fertility with successful
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impregnation, although the total sperm count was low (Cann and Holdsworth, 1984). The 
positive effect o f 5-ASA in reversing the genotoxic effect o f AA on producing abnormal 
sperm shapes, needs further investigation to know the exact underlying mechanism. It 
could be due to prevention o f the induction o f CYP2E1 in the liver with formation o f 
less glycidamide and further less toxicity. A nother factor related to the increase in sperm 
deformities, could be the reduction o f testosterone horm one that would be impacted on 
increasing abnormal spermatogenesis and hence abnormal sperms. The antioxidant effect 
o f 5-ASA will reverse this toxicity on Leydig cells and hence improve spermatogenesis.
4.14.6 E ffects o f  5-ASA on Germ Cell A poptosis
The results o f  the current study indicate that no difference between the control and 
treated rats could be detected, and no Tunnel positive cells could be observed in any o f 
the treatment groups. The negative result after AA treatment could be due to delay in 
taking the specimens after the repair was already taking place. Also, this result indicated 
that no effect o f 5-ASA on induction o f germ cell apoptosis.
In rodent testes, germ cell apoptosis has been reported to occur as an element o f normal 
spermatogenesis and can be up-regulated or increased by some testicular toxicants (Kerr, 
1992). However, this does not appear to be the case for AA, as my findings are consistent 
with those o f Lafferty et ak, (2004) who saw no increases in apoptotic indices in testicular 
mésothélium following AA exposure. They used doses o f 2 or 15m g/kg AA for 7, 14, or 
28 days and did find significant increases in D N A  synthesis (Lafferty et ak, 2004), which 
led them to postulate that the lack o f an observed effect on apoptosis by AA may have 
been due to experimental design/sampling issues, and may not have reflected biological 
reality. Indeed, Yang et ak, reported up-regulation o f genes related to apoptosis due to 
AA in cDNA microarrays o f male rats exposed to A A at a dose o f 60 m g/kg  for 5 
consecutive days by oral gavage (Yang et ak, 2005b). It is thus not clear if A A is able to
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produce an increase in testicular apoptosis in rats, as a single high-dose study has reported 
an increase, whereas others studies, including my own, do not show an effect. Taking into 
account the difference in duration o f exposure o f rats to AA, in the Yang et al., (2005b) 
study, rats were treated with 60m g/kg for 5 consecutive days and rats were sacrificed after 
72 h o f recovery. The negative results o f the current study, and others, may be explained 
by the experimental design, with samples having been taken after repair o f apoptosis had 
occurred. As apoptosis is a relatively rapid mechanism o f cell death, often complete 
removal o f cells from the tissue occurs within hours (Jacobson and Weil, 1997).
In summary, whereas the data on induction o f apoptosis by AA is not fully robust, it does 
suggest that any effect on apoptosis in testis is relatively mild an d /o r transient, which is 
consistent with the mixed reports in the literature. One biological interpretation o f this 
data is that AA might act as a Sertoli cell toxicant, with Sertoli cells as the primary target 
cell, producing testicular injury resulting in germ cell apoptosis through paracrine Sertoli- 
germ cell interaction (e.g. Fas system) (Boekelheide et ak, 2000). Taken together, these 
findings suggest that AA at the dosage used here (45mg/kg) acts as a weak Sertoli cell 
toxicant as well as a testicular toxicant. This is in contrast to higher doses, which cause 
more Sertoli cell destruction and hence, more apoptotic cell formation in the 
seminiferous tubules.
4.14.7 Effects o f  5-ASA on B lood CO M ETs Produced by A A
This work showed a tremendous effect o f 5-ASA on COM ETs produced by A A in blood 
lymphocytes. ASA co-treatment results in dramatic reduction in COM ETs tail m om ent, 
which indicates a reduction in genotoxic damage. To prove our hypothesis that AA and 
not Glycidamide is responsible for reprotoxicity and genotoxicity noted, for this reason, 
any com pound that causes increase in A A metabolism will improve the level o f 
genotoxicity produced by AA. In this study 5-ASA has been shown to exert an induction
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effect on CYP2E1 expression, which results in an im provement in the level of 
genotoxicity when compared to the group that received AA alone. Moreover, as free 
radicals produced by AA may impair D N A  repair (Blasiak et ak, 2004), oxidation is an 
im portant mechanism o f cell damage, which initiates a chain - reaction o f lipid 
peroxidation that will spread through the membrane causing cleavage o f unsaturated fatty 
acids and alteration o f integral protein function leading to cell dysfunction and death 
(Pearson et ak, 1996). 5-ASA acts as a free radical scavenger (M acDermott et ak, 1989), 
which characterizes its powerful antioxidant property, and leads to the beneficial effects 
observed when it concomitantly given with AA.
4.14.8 E ffects o f  5-ASA on Acrylamide Induced Changes on CYP2E1 in Liver and 
Testis (S9)
A novel finding o f the current study, was the effect o f  5-ASA on CYP2E1 induction in 
liver and testis. The results showed that CYP2E1 is normally present in the testes (0.074 
ng /m g protein) with lower amount than the liver (0.44 ng /m g  protein); further, this study 
demonstrated for the first time, that 5-ASA at the dose o f 50m g/kg caused a significant 
elevation (induction) o f CYP2E1 in the liver when compared to AA control. Also AA 
caused a significant reduction in enzyme level when compared to the normal control, 
while in the testis AA caused significant increase in CYP2E1 level when compared to the 
normal control. These findings were highly consistent to the report o f (Jiang et ak, 1998) 
who identified the presence o f CYP2E1 mRNA in rat prostate and testis, by reverse 
transcription PCR, southern blotting and D N A  sequencing. From  the im munoblotting 
result, P4502E1 appears to be present in very low amounts in testis. The contents o f 
P450 2E1 in testicular microsomal fractions were determined to be 0.12 pmol /m g  
protein which increases > 2 fold (0.25 pmol / mg protein) after pyridine trea tm en t, which 
was used as an enzyme inducer. It is well docum ented that the expression o f CYP2E1 is
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highest in the liver, mainly found in the endoplasmic reticulum. However it is present in 
small amounts in non—hepatic tissues as kidney, nasal mucosa, lung, ovaries, testis, small 
intestine, colon, umbilical vein endothelial cells, lymphocytes and the brain (Ronis et ak, 
1996). This finding is o f considerable potential importance, because it probably explains 
to a large extent the genotoxic insult produced in rat testis following AA treatment. While 
the physiological significance o f P450 2E1 in testis remains unclear, the induction o f this 
enzyme in testis might have im portant implications in testicular toxicity and function 
(Jiang et ak, 1998). CYP2E1 metabolizes a wide variety o f  chemicals with different 
structures such as small and hydrophobic com pounds, including potential carcinogens 
(Ronis et ak, 1996). For this reason, the presence and inducibility o f CYP2E1 in the testis 
may be o f significance in the bioactivation o f environmental chemicals to genotoxic 
metabolites (Jiang et ak, 1998). Based on the well known and documented role o f 
CYP2E1 in epoxidation o f AA to its active metabolite glycidamide (Ghanayem et ak, 
2005a,b) and as consequence o f the presence o f CYP2E1 in testis, despite o f the 
apparently low level o f expression, enhanced P4502E1 mediated metabolic activation in 
testes by exposure to inducers that are environmental pollutants such as AA, may 
influence adverse effects on spermatogenesis and hence on reproduction (Jiang et ak, 
1998). The result o f the present study hints that glycidamide is not only formed mainly in 
the liver by CYP2E1 and transferred by the blood to testis, but it also formed locally in 
the testis in small amounts.
However, during this study with the concomitant treatment o f AA-treated rats with the 
dose o f 50m g/kg 5-ASA, higher level o f CYP2E1 was detected in liver when compared 
to AA control , which indicated that 5-ASA can induce CYP2E1 in the liver and (might 
be due to protein stabilization) as a consequence, increases rate o f AA metabolism with 
less ROS formation due to antioxidant property o f ASA , the formed glycidamide will
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further metabolized to inactive form and then excreted and hence less genotoxicity and 
less damaging effect and this was clearly observed in this study on COM ETs produced 
by AA in peripheral blood lymphocytes, and histopathology in the testes. In contrast, to 
the group was exposed to AA alone, they showed significant reduction in CYP2E1 level 
in liver. The interpretation is that as the level o f CYP2E1 in the liver is not impressively 
high compared to some other P450 isozymes (Ronis et ah, 1996), this large dose o f AA 
over 5 days o f treatment might cause partial depletion o f this enzyme with significant 
reduction in its level in the liver or another explanation is that AA itself may cause 
inhibition o f the enzyme it induce and this needs further investigations. However in the 
testis, normally the am ount o f the expressed CYP2E1 is less than that in the liver, 
therefore it remains high because the major part o f the given AA was metabolized by 
CYP2E1 in the liver and the small part o f AA transferred to testis acts as an enzyme 
inducer but it does not cause depletion o f the enzyme as in the liver. The mechanism by 
which 5-ASA exerts its effect in inducing induction o f C Y P2Elin the liver is not entirely 
clear at the moment. However it seems likely that the antioxidant property o f 5-ASA is 
the reason behind the improved toxicity seen after ASA treatment. Induction as CYP2E1 
is also very effective in generating reactive oxygen intermediates such as superoxide 
radical and H 20 2 (Gergel et ak, 1997). So, ASA seems to cause induction o f CYP2E1 and 
hence increased AA metabolism with minimum ROS formation that improves the AA 
testicular and genotoxicity.
4.14.9 Effects o f  ASA on serum A A  concentration and the effect on sem inferous 
tubule diameter
In this study no significant difference was detected in serum A A level o f ASA treated rats 
when compared to AA control as was detected by HPLC.
Also, in this study, AA nor 5-ASA at the tested dose level (4 5 m g/kg  for 5 days) have 
been shown not to cause any significant effects on seminiferous tubule diameter in rat
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testes. To my knowledge, this is the first study reporting data about AA effect on tubules 
diameters in rat testis.
4.14.10 Summary
In summary, 5-ASA has been shown to protect partially or completely AA-treated rats 
from the severe testicular toxicity resulted from AA treatment. Both doses o f  5-ASA were 
effective in reducing COMETs in peripheral blood leukocytes. The most striking result o f  
this study was the ability o f  5-ASA to cause induction o f  CYP2E1 in liver also the effect 
o f 5-ASA in reversing atrophy o f  Leydig cells in the testis which will be impacted 
eventually, on the testosterone level. Further studies on acrylamide and 5-ASA are needed 
to explore further molecular mechanisms involved in 5-ASA protection against AA  
testicular toxicity in rats. The result o f  the current study is mainly relevant to human 
health, since the suggested testicular and genotoxic risk o f  dietary acrylamide may be 
reduced by concomitant intake o f 5-ASA. And as the result indicated a fundamental 
interlinking between CYP2E1 induction and 5-ASA, the question remains open, whether 
5-ASA induces CYP2E1 in the liver at both inducible CYP2E1 as well as constitutively 
expressed CYP2E1 or not? This needs further investigations and evaluation.
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5 Reversibility of Acrylamide-induced Testicular Toxicity
5.1 Introduction
Occupational exposure to AA can be through dermal and inhalation routes (Fennell et al., 
2005), in which AA was detected in plasma from workers exposed to AA in workplace. 
Moreover, AA exposure for a general population could be through diet (Parzefall, 2008) 
and through residual acrylamide monomer in polyacrylamide that is widely used in many 
consumer products (Fennell et al., 2005) e.g. in cosmetics and packaging material and in 
drinking water and more seriously in smoking in which one cigarette produces 1-2 pg o f  
AA (Ernst et ak, 2003). For all o f  the above concerns about human exposure and toxic 
effects produced to human health in particular to male fertility as they might be a victim 
for acrylamide poisoning, a special concern about the natural recovery o f acrylamide 
induced reproductive toxicity is raised. While previous sub chronic toxicity study 
conducted by Burek et ak, (1980) in which rats were treated with 20 m g/kg AA for 92 
days the testicular atrophy produced had nearly reversed after 144 days, the aim o f the 
present study was to investigate the natural recovery o f  AA reproductive toxicity and to 
determine the exact period o f  recovery following sub acute exposure (5 days o f  AA  
treatment) in rat with a dose (45mg/kg) that was documented previously in this study to 
give rise to testicular toxicity with minimal neuro-behavioral changes. Six different 
recovery periods were studied after 5 consecutive days o f AA treatment; 3, 5, 10, 15, 25 
and 55 days. Parameters investigated were, changes in sperm morphology, histopathology, 
apoptosis detection in testis and comet assay.
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5.2 General Observations
N o mortality was observed after exposure to the selected dose o f  AA (45mg/kg), but 
some behavioral changes were noted in the form o f  aggressiveness among treated rats; 
this was observed two days after starting AA treatment and it reduced after AA  
withdrawal, also some weight loss was observed during the treatment period.
5.3 Effect on Sperm Morphology in Cauda Epididymis
As shown in (Fig. 42) some sperm abnormalities were detected among sperm from 
animals treated with AA. These include detached heads, which were maximally detected 
among the group that was observed for 10 days (Table 10). Other abnormalities detected 
were tail intersigmentahon (Fig. 43), and it was named (novel nomenclature; tail 
intersigmentation) because o f the intersegmented appearance o f the middle piece o f  the 
sperm tail, and the highest percentage o f this abnormality was also for the group observed 
for 10 days after cessation o f  AA treatment. However after 55 days o f  recovery, 
percentage o f  detached heads was decreased.
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Fig. 42. Light microscopy o f sperm morphology after cessation o f AA treatm ent (45 
m g/kg for 5 days), following different recovery periods. (B) Shows sperms from  the 
group observed for 3 days, (C) Shows sperms from the group observed for 5 days, (D) 
Shows sperms from the group observed for 10 days, (E ) Shows sperms from the group 
observed for 15 days, note tail intersigmentation (black arrows). Rats were gavaged with 
AA (45mg/kg) for 5 days only and then were observed for different recovery periods 
Smears were stained with 10% Rose-bengal solution and viewed using light microscopy.
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Fig. 43. Light microscopy o f sperm morphology after cessation o f AA treatment (45 
m g/kg  for 5 days), following recovery periods. (F) Shows sperms from rat observed for 
25 days (G) Shows sperms from rat observed for 55 days (H ) Shows sperms from rat 
observed for 25 days with tail intersigmentation (I) Shows sperms from rat observed for 
10 days with tail intersigmentation. Rats were gavaged with AA (45mg/kg) for 5 days only 
and then were observed for different recovery periods. Smears were stained with 10% 
Rose-bengal solution and viewed using light microscopy.
1 6 0
Recovery
peroids
Mean±SD 
of detached 
heads
Mean±SD
in
Control
Mean±SD 
of tail 
inters egmentation
Mean±SD in 
Control
3 days 4.01 ± 0.82 4.50 ±0.71 3.23 ± 0.82 2.50 ±0.71
5 days 5.25 ± 0.96 5.31 ±0.96 4.16 ±0.82 3.50 ±0.71
10 days 7.61 ± 0.82 4.50 ±0.71 8.25 ± 0.96 4.41 ± 1.41
15 days 7.14 ±0.82 4.25 ± 1.40 3.50 ± 1.2 2.61 ± 1.41
25 days 5.51 ±0.83 3.50 ±0.71 3.42 ± 0.82 2.50 ±0.71
55 days 4.04 ± 0.84 3.60 ±0.71 3.60 ±0.96 3.50 ±0.71
Table 10. Mean o f Sperm abnormalities detected after cessation o f  A A  treatment, following 
different recovery periods. Acrylamide was administered by oral gavage at a dose o f  
45m g/kg/ day for 5 consecutive days to adult male rats, after different recovery periods the 
abnormal sperms were detected by observing and counting /100  sperm s/field/5 different fields 
under the light microscope. Note the gradual increase in mean of detached heads and tail 
intersigmentation up to 10 days of recovery and after that the gradual decrease in this abnormality 
started to be noted. Data were expressed as mean ±  SD, n =  4.
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5.4 TUNEL ASSAY on Testicular Tissue
As shown in (Fig. 44), a positive control that was induced by applying Tacs® nuclease 
with the reaction mixture to induce a positive apoptotic cells, it results in many TU N E L 
positive germ cells. These cells were characterized by brownish coloration, shrinkage and 
nuclear fragmentation & condensation. In comparison, examination o f germ cells from 
control rats showed very low levels o f T U N E L  positive germ cells. Acrylamide did not 
elicit an increase in apoptotic cells following any o f the recovery periods, although this 
does not exclude an immediate increase in apoptosis following AA treatment.
Fig. 44. TU N EL positive cells, detected in induced positive control and control rat 
testes. (A) Shows seminiferous tubule with many brownish TU N E L positive germ cells 
(arrows) mainly spermatogonia, were induced by Tacs® nuclease (B) Shows seminiferous 
tubule from control rat (arrow). The antigen retrieval-TUNEL stained sections were 
counterstained with methyl green and viewed using tight microscopy.
1 6 2
5.5 Histopathology of Testis and Epididymis
Evidence for testicular histological changes was examined after AA treatment, followed 
by different recovery periods. Representative images are presented in (Fig. 45). N o  
multinucleated giant cells were detected in any o f  the groups, but a number o f  
abnormalities in the tubule were detected compared to the control between 3 and 25 days 
o f recovery include shedding o f germinal epithelium in the lumen o f the tubule, epithelial 
disruption, empty spaces in between cells o f  the tubule caused by sloughing o f germ cells 
with apparent reduction o f  luminal sperms, reduction in germ cells differentiation with 
increased debris. N o  major abnormalities were observed in the testis after 55 days o f  
recovery apart from minor reduction in luminal sperm reserve (Fig. 45). The epididimys 
also showed normal histology during the treatment and during the different recovery 
periods (Fig. 46).
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Fig. 45. Representative light microscopy o f transverse sections for general architecture o f 
testes, after different recovery periods, following cessation o f A A  treatment 
(A) Shows seminiferous tubules from control rat testis with normal histology (B) Shows 
tubules from AA treated rat testis after 3 days o f recovery with disruption & shedding o f 
germ cells in the lumen o f the tubule (arrows head) (C) Shows tubules o f AA treated rat 
testis after 5 days o f recovery with mild epithelial disruption with shedding o f germ cells 
in the lumen (arrow head) (D) Shows tubules from AA treated rat testis after 10 days o f 
recovery, with a reduction in germ cells differentiation with increased debris with 
apparent reduction o f luminal sperms (E) Shows tubules o f AA treated rat testis after 15 
days o f recovery with empty spaces in between cells caused by sloughing o f germ cells 
with apparent reduction o f luminal sperms (F) Shows tubules o f  AA treated rat testis 
after 25 days o f  recovery (G) Shows tubules o f  AA treated rat testis after 55 days o f 
recovery note, normal histological appearance with good sperm reserve in the lumen. 
Acrylamide was given by oral gavage at a dose o f 45m g/kg/day for 5 days. All Sections 
stained with H & E stain and examined with light microscopy.
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Fig. 46. Representative light microscopy o f transverse sections for general architecture 
o f epididymis, after different recovery periods, following cessation o f AA treatment. 
(A)Normal control (B) After 3days of recovery, note the apparent sperm reserve (arrow) (C) 
After 5 days of recovery (D) After 10 days of recovery (E) After 15 days of recovery (F) After 25 
days of recovery (G) after 55 days of recovery. All show normal histology with sperms in the 
lumen. Acrylamide was given by oral gavage at a dose of 45mg/kg/day for 5 days. All Sections 
stained with H&E stain and examined with light microscopy.
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5.6 COMET Assay in Peripheral Blood Leukocytes
The genotoxic potential o f  AA was examined in rat blood leukocytes by the COM ET
assay. Analysis o f COM ET cells produced by 0.025-10 mM glycidamide, a metabolite o f 
AA and a known genotoxin, was used as a positive control, clearly producing both an 
increase in tail m om ent and increase in % o f COM ETs (Fig. 47). Significant DNA- 
damage was also induced by AA in blood leukocytes (Table 11). The results showed that 
the maximum effect o f acrylamide on producing D N A  damage was after 3 days o f 
recovery, in which the tail m om ent was 7-10, compared to control levels o f  0.01-0.05, and 
the percentage o f total COM ETs was 60%. Interestingly, that after this increase in total 
COM ETs, it was followed by a gradual reduction in total COM ETs and tail m om ent until 
the 15 days o f recovery, were levels were concordant with control (Table 11).
M .w  *  W *  %D*W IwyK Am
Fig. 47. Photographic image o f leukocytes from blood exposed in vitro to Im M  
glycidamide as a positive control and subjected to Single Cell Cell Electrophoresis, 
subsequently analyzed by Image Analysis System. Percentage o f total COM ETs were 50% 
and Tail M oment = 10-12.
1 6 8
Rats
groups
Experiment
control
Tail
Moment
0.01-0.05
% of Total 
COMETs
1%
3 days 
recovery
7-10 60%
5 days 
recovery 5-6 40%
10 days 
recovery
1-2 10%
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Table 11. Photographic images of leukocytes from acrylamide treated rats(45mg/kg AA for 5days) 
after cessation of AA treatment and following different recovery periods, subjected to Single Cell 
Gell Electrophoresis, subsequently analyzed by Image Analysis System. Massive DNA destruction 
was detected in blood leukocytes after 3 days of recovery following cessation of AA treatment as 
detected with the large tail moment. After this period there was a sequential reduction in the 
severity of nuclear damage with reduction in tail moment. After 15 days of recovery, the comet cells 
disappeared and there was no difference in tail moment between the control and treated rats 
leukocytes.
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5.7 Discussion
In the third chapter, the acute morphological and ultra structural effects o f AA mediated 
testicular toxicity were characterized. In this chapter, the reversibility o f AA mediated 
testicular toxicity in rats was examined, after a sub acute exposure (5 days) to AA at a 
dose o f 45 m g/kg/day. A range o f parameters were examined to determine the response 
to AA withdrawal during different recovery periods (3, 5, 10, 15, 25, and 55 days), 
included; sperm abnormalities, and histopathological changes, apoptosis detection in the 
testis, COM ETs in blood leukocytes.
5.7.1 Effects o f  A A  on General Rat Behaviour during Treatment and After 
Acrylamide Withdrawal
In chapter three o f this study, AA was shown to produce a num ber o f behavioural 
changes in the form o f increased aggressiveness, irritability, and hyperactivity among the 
treated rats. Although AA is clearly neurotoxic to humans and can produce peripheral 
neuropathy in rats and humans, its ability to affect brain functions is still not entirely clear 
(Garey and Paule, 2007). A nother interpretation for the recorded aggressiveness and 
hyperkinetic behaviour among treated rats might be the fact that AA can inhibit 
dopamine uptake in rat striatal synaptic vesicles, thus leading to disruption o f 
neurotransmitter storage and release (Lopachin et al., 2006). Dopamine belongs to the 
catecholamine group o f neurotransmitters that are released from neurons o f the midbrain 
nucleus, the substantia nigra impacta (SNC) (Vallone et al., 2000). It is an im portant 
neurotransmitter in the brain and aggressiveness could be a side effect o f its insufficient 
release into synaptic junctions in response to AA exposure. Acrylamide has been 
reported to have a partial dopamine agonist activity (Crump, 1999), which would support 
this hypothesis, because dopaminergic neurotransmission is required for locom otor
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activity (Valloue et al., 2000). AA has also been reported to induce changes in thyroid 
gland morphology. A slight dose-dependent increase in plasma thyroxin (T4) level was 
observed previously (Khan et al., 1999) after an acute exposure o f 15 m g/kg  AA 
administered orally by gavage to female rats for 7 days. This elevation in thyroxin 
horm one could, in fact, be a major cause o f the irritability and aggressiveness detected in 
the AA treated rats. Interestingly, following AA withdrawal and during recovery periods, 
rats regained their normal m ood behaviour.
5.7.2 E ffects o f  A A  on Caudal Sperm M orphology
As was observed in the third chapter, 45 m g/kg  AA for 5 days was able to induce sperm 
abnormalities. Upon cessation o f treatment, the level o f these abnormalities continued to 
rise to a maximum at 10 days o f recovery, followed by a gradual reduction in the 
percentage o f these abnormalities, until complete recovery was observed after 55 days. 
These increased levels o f sperm abnormalities after 10 days o f recovery could be one o f 
the contributing factors that trigger an increased release o f TGF-(31 at the same recovery 
period, which ultimately restores normal spermatogenesis and hence normal sperm 
morphology.
5.7.3 H istopathological Examination o f  AA-Treated Testis
In this study, treatment o f male SD rats with 45m g/kg AA for 5 days resulted in mild- 
moderate histological changes in the testes. The changes were mainly in the form of 
excessive shedding or exfoliation o f germinal epithelium in the lumen o f the tubules, with 
epithelial disruptions, reduction in the luminal sperms, and reduction in germ cell 
differentiation. These changes were partially or completely eliminated after 55 days o f 
recovery. N o vacuolations and no multinucleated giant cells could be detected at this dose 
level, and the epididymis appeared not to be affected by this dose. These findings were 
similar to the reports o f other investigators (Yang et al., 2005a,b) when A A was
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administered by oral gavage in a doses o f 5, 15, 30, 45 or 60 m g/kg for 5 days. The major 
pathological changes observed by Yang et al. were degeneration o f seminiferous tubules 
germ cells, vacuolations between the inner cells o f the tubules and numerous 
multinucleated giant cells were reported. Although this appears to be a discrepancy 
between my study and Yang et al., it may be explained by the fact that the multinucleated 
cells were predominantly observed at doses higher than used in the present study, namely 
60 m g/kg. In addition, sloughed epithelium and spermatogenic cells were found in the 
lumen o f the tubules. The lack o f an effect in the epididymis is also consistent with the 
published literature, as reported for both mice (Sakamoto et al., 1988) and rats 
(Hashimoto et ah, 1981). During the current study and after different recovery periods, a 
reduction in the severity o f lesions was noted, with nearly complete recovery after 55 
days. Although recovery studies over these shorter time periods have not been previously 
undertaken in rats, these data are consistent with a study undertaken in mice, where male 
mice were exposed to a single oral dose o f 150 or 100 m g/kg  AA, followed by 10 days o f 
recovery (Sakamoto et al., 1988). Burek et al. exposed male rats to AA at a dose o f 20 
m g/kg  for 93 days, eliciting testicular atrophy, which had nearly completely reversed after 
141 days (Burek et al., 1980).
In summary, in the present study I was able to observe a num ber o f histological 
alterations to the testes following sub acute exposure to AA. These alterations were 
reversible, with nearly complete recovery occurring after 55 days. This ability for testicular 
lesions to repair is perhaps not unexpected, given the rapid turnover o f sperm within the 
testis, provided that the duration o f spermatogenic cycle in a rat is between (48 -53) days 
(Hess, 1990), which is proved during this study in which the recovery from the A A 
toxicity needs about one spermatogenic cycle (in the current study it was 55 days).
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5.7.4 Effects of AA on Leukocyte DNA  (COMET Assay)
As acrylamide, or its metabolite, have been previously reported to cause D N A  damage 
this was next examined, using the Comet assay. I was able to demonstrate that AA 
exposure at a dose level o f 45 m g/kg  for five days induced significant D N A  damage, 
compared to control blood leukocytes. This damage was transient, with a maximal effect 
observed after 3 days o f recovery, and a return to control levels occurring after 15 days o f 
recovery. The induction o f D N A  damage observed here is in agreement with the findings 
o f Maniéré et al., when male rats were administered a single oral dose o f AA (18, 36, or 
54mg/kg) and D N A  damage was measured 5 or 24h later (Maniéré et al., 2005). This 
effect appeared to occur in the human population as well; as Blasiak et al. demonstrated 
that human lymphocytes were also damaged in vitro by 0.5pM  AA (Blasiak et al., 2004). In 
the current study, glycidamide was used as positive control for inducing D N A  damage, 
because AA is known to have clastogenic and mutagenic properties in vivo but it reacts 
very slowly with D N A  (Calleman et al., 1990). Glycidamide, which is the reactive 
metabolite o f AA, is known to be a potent clastogen and mutagen both in vitro and in vivo 
(Paulsson et al., 2003). Indeed, many investigators have suggested that the D N A  
damaging effects o f  AA are actually due to its conversion to glycidamide and are not due 
to AA itself. This hypothesis is supported by Ghanayem et al., who dem onstrated that in 
somatic cells, significant D N A  damage was induced in AA treated wild-type but not in 
the CYP2E1- null mice. The CYP enzyme is responsible for the conversion o f AA to 
glycidamide (Ghanayem et al., 2005a). While this is a plausible explanation, the location o f 
this putative metabolic conversion is not yet clear, as CYP2E1 is present predominantly 
in the liver (Maniéré et al., 2005) and smaller amounts are also found in extrahepatic 
tissues such as kidney (Bonis et al., 1991), nasal mucosa (Ding and Coon, 1990), lung 
(Yang et al., 1991), testis (Jiang et al., 1998) , ovaries (Yang ct al., 1991), small
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intestine(Shimizu et al., 1990), colon (Hakkak et al., 1996), brain(Hansson et al., 1990), 
lymphocytes (Blasiak et al., 2004), umbilical vein endothelial cells (Farin et al., 1994). This 
indicates that genetic damage is dependent on the metabolism o f  the parent compound 
by CYP2E1. As well, D N A  damage to human lymphocytes was explained by Blasiak et 
al., (2004) as arising from the observation that AA, or its metabolite glycidamide, might 
have genotoxic effects in blood lymphocytes, because alkali-labile sites in the D N A  o f  
human lymphocytes were induced. Free radicals may also participate in the D N A  
damaging property o f AA, decreasing the oxidative defence system in the cell. Thus, use 
an antioxidant might decrease the potential o f  AA damage to DNA .
In summary, sub-acute exposure to AA elicits D N A  damage in blood leukocytes, which is 
a reversible process. As the published literature suggests that conversion o f  AA to GLY is 
highest in a low dose, chronic exposure scenario (Barber et al., 2001a), then it can be 
hypothesized that this would elicit the most damage to leukocytes. The repair o f  the 
D N A  lesions produced by glycidamide was associated with a small patch o f  base excision 
repair pathway (Johansson et al., 2005). These findings are o f  considerable potential 
importance, as the D N A  damaging effect o f  AA observed in blood leukocytes reveals a 
potential simple biomarker for AA exposure and recovery in humans.
175
5.7.5 Summary
In summary, the present study has shown that oral administration o f AA to male SD rats 
at a dose level o f  45mg/kg for 5 consecutive days resulted in systemic effects as well as 
reproductive toxicity. In general, these effects were reversible, although the extent o f  the 
recovery during the 55-day period studied varied from complete to partial. In addition, 
the data presented here, in combination with published literature, suggests that D N A  
damage to leukocytes may act as a biomarker for AA exposure. The changes that have 
been shown to occur after different recovery periods following AA treatment can be 
summarized as follows:
•  Maximum level o f  sperm abnormalities is detected after 10 days o f  recovery and 
was recovered after 55 days.
•  Many histopathological changes were detected, which were severe between 3-25 
days o f  recovery, followed by recovery after 55 days.
•  Increase in leukocyte D N A  damage was maximally detected after 3 days o f  
recovery, followed by recovery after 15 days.
176
6 Discussion
6.1 General Introduction
In the current acute study, a high dose o f acrylamide (45mg/kg/day for five days) was 
chosen to induce the reproductive and genotoxic effects o f acrylamide in male rats. The 
reasons for using this high dose, which is much higher than the estimated food intake of 
AA by general population, were because this dose has been tested in this study that it 
produced reproductive and genotoxicity with minimum neurotoxicity could be observed, 
further this high dose was effective in eliciting a strong response over a short period o f  
time (5 days) to be able to study the mechanism o f AA reproductive toxicity and to 
investigate the antagonistic effect o f ASA.
The present work was performed to evaluate the testicular toxicity of AA in adult male 
rat, and the potential for this to extend to humans is the ultimate aim o f the current 
thesis. Correlations have been made with this high dose o f AA used in this experiment 
and victims o f AA poisoning, whether intentional or non- intentional poisoning, using 
oral route as a route o f exposure and not dermal or inhalation route as in occupational 
exposure. In addition, to investigate the modulatory effect o f 5-ASA as an antioxidant in 
reducing the resultant reproductive and genotoxic effects in victims o f AA poisoning and 
to investigate the spontaneous recovery o f reprotoxicity and genotoxicity after sub acute 
AA exposure.
177
6.2 Major Study Findings
This study has addressed for the first time the potential mechanism of action of AA in 
male rat testis. A figure based on the major findings of the two main experiments 
undertaken during this study is presented in (Fig. 48). Acrylamide has been reported 
previously to induce reproductive toxicity in male rats, and our results support these 
studies.
This study has shown that AA reproductive toxicity is associated with testicular toxicity; 
in addition, some systemic toxicity was detected, in the form of some behavioral changes, 
such as aggression, irritability and hind limb weakness, also significant weight loss was 
detected. These toxic effects occurred in a dose dependent manner, being more 
pronounced at higher doses of AA. Acrylamide caused testicular toxicity manifested as 
reduction in caudal sperm count with increased rate of sperm head detachment. This 
effect on caudal sperm count has been previously reported (Yang et al 2005a; Sakamoto 
and Hashimoto, 1986). No significant effect was detected on absolute or relative weights 
for testis, cauda or epididymis. Also no significant effect was detected on seminiferous 
tubules diameter.
O n the structural level of the testis and the epididymis, AA was shown to induce many 
abnormal histological changes in the seminiferous tubules and epididymis, mainly in the 
form of germ cell degeneration, tubular atrophy, and sloughed germ cells in the lumen of 
the tubule, basal and intercellular vacuolations and Leydig cells atrophy. Multinucleated 
giant cells were also seen with nuclear vacuolations of round spermatids. All o f these 
abnormal histological changes were previously reported and are consistent with the 
correct study plan for generation of AA-mediatcd toxicity (Sakamoto et al., 1988 ; Yang 
ct al., 2005a,b). On the pilot electron microscopy study, A A has shown to cause severe 
damage to Sertoli cells with leydig cells atrophy.
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On the biochemical level, it was demonstrated that AA treatment caused a significant 
reduction in the serum testosterone level, probably due to the observed Leydig cell 
atrophy, which is the site o f production o f testosterone in the testis.
In addition, AA was shown to cause a reduction o f liver CYP2E1 enzyme levels, and this 
puzzling phenomenon, as AA supposed to be an inducer of this enzyme, might be due to 
the inhibitory effect o f the AA itself on its metabolizing enzyme, as many inducers are 
also inhibitors o f the enzymes they induce. Also, testicular CYP2E1 enzyme was 
significantly increased compared to the normal control group. However, these alterations 
should be placed into context that levels o f CYP2E1 in the testis of untreated rat was 
reported in previous study (Jiang et al., 1998) as 0.12pmol/mg protein. The levels o f 
CYP2E1 are highest in the liver (Cederbaum, 2006). In the current study CYP2E1 was 
detected to be expressed normally in the liver (0.44 ng/m g protein) at a higher 
concentration than in the testis (0.07 ng/mg proteins), consistent with published literature 
(Ronis et al., 1996). This implies that glycidamide levels in the testis may be derived via 
two routes; first, the major route is via production in the liver; second, a minor route may 
be via local formation in the testes, mainly in Leydig cells (GeorgeUis and Rydstrom, 
1989).
CYP2E1 is an active producer o f  ROS such as O  i  and H 2O 2, which are produced  
during its catalytic cycle even in the absence o f  substrate (Cederbaum, 2006). In this 
study 5ASA at the high dose (50mg/kg) caused induction o f CYP2E1 enzyme in the liver, 
hence increased AA metabolism via this rout, together with the potent antioxidant 
property o f ASA a dramatic improvement in the testis toxicity and genotoxicity was 
observed.
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6.3 Potential M echanistic Pathway for AA-M ediated Reprotoxicity
An important aim of the present study is to define the possible mechanism underlying 
testicular toxicity of AA. As previously reported, acrylamide is metabolized into the 
active metabolite, glycidamide, by CYP2E1 enzyme, both in the liver and testis; CYP2E1 
has previously been reported to be expressed in Leydig cells (Georgellis and Rydstrom, 
1989). Metabolism within the Leydig cells will result in the local formation of glycidamide, 
causing oxidative stress, and ultimately with atrophy and death of Leydig cells.
Consequently, this leads to a reduction in the amount of released testosterone, and this 
reduced testosterone secretion will potentiate the toxic cascade within the seminiferous 
tubules o f rat testis, including Sertoli cell atrophy and death and hypospermatogenesis 
(Fig. 48). Another possible mechanism is the direct toxic effect of AA on the testis, and 
that could be possible in case of inhibition of catalyzing enzyme (CYP2E1) or glutathione 
deficiency, this leads to AA accumulation with more toxicity observed.
In recent years, several studies had reported the toxic reproductive effects of acrylamide 
on the seminiferous tubules and sperms (Wang H. et al., 2007); in particular to direct 
effect of AA on leydig cell damage and the effect of AA on the endocrine function of the 
testis (Song et al., 2008a). Recentely, Alghorashi et al., (2010) reported that AA affects 
the membrane integrity of epididymal spermatozoa in mice, causing abnormal sperm 
parameters such as motility and count. Further, recentely acrylamide has been shown to 
interfere with the remodeling process in spermatogenesis, with spermatogonia and 
primary spermatocytes are the sensitive stages for AA-induced genomic imprinting 
aberration (Wang Z et al., 2010). Several other recent studies reported the toxic effects of 
AA on the reproductive system of the rat and the endocrine function of the testis (Wang 
H. et al., 2007, 2010; Wang R. et al., 2010; and Song et al., 2008 a, b).
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Given the potential for human damage, are there any antagonizing compounds that can 
be used safely by humans and potentially treat or reduce the deleterious reproductive and 
genotoxic effects o f AA poisoning? And if so, how does this protective mechanism work? 
Acrylamide is known to cause oxidative stress by inducing the generation of ROS 
reducing the anti-oxidant defense systems (vitamins and glutathione) and /o r increasing 
susceptibility of cells to oxidative attack by altering the membrane integrity and fatty acids 
composition ( Yousef and El-Demerdash, 2006 ; Song et al., 2008b). Previous study by 
(Sikka et al., 1995) has reported a relationship between ROS and the role of oxidative 
stress in the etiology of defective sperms functions and male infertility.
Also Bagchi and Stohs (1992) reported the effect o f many environmental contaminants 
on the disturbance of pro-oxidant/anti-oxidant systems of the cells, and hence leading to 
generation of oxygen free radicals and Reactive oxygen species. This elevation in the level 
o f ROS leading to oxidation of cellular components in particular to unsaturated fatty 
acids. Hence, mammalian spermatozoa are rich in polyunsaturated fatty acids (PUSFA), 
they are more susceptible to ROS attack, leading to reduction in sperm motility and 
viability and that results in infertility (Aitken and Clarkson, 1987). Taken together, AA has 
a toxic effect on sperm functions, motility and fertility due to its ability to produce ROS.
A novel finding in this study is the antagonizing effect o f 5-ASA on the testicular and 
genotoxic effects of AA. 5-ASA is a known antioxidant, and it is an effective treatment 
for patients suffering from ulcerative colitis, with restoration of sulfasalzine-induced 
impaired fertility (Cann and Holdsworth, 1984). Concomitant treatment of AA- treated 
rats with 5-ASA at the two examined doses (25 or 50mg/kg/day) significantly reduced 
the appearance of toxicity from A A. These effects were observed as; dramatic
improvement in testis histological structure in particular to Leydig cell atrophy; 
restoration of normal serum testosterone; reduction on the COMETs produced in the
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peripheral blood leukocytes with reduced tail moments. Although the recovery at both 
doses was not complete with the higher dose being more effective in reducing sperm 
shape abnormalities and improved histological appearance of the testis.
In attempting to understand the mechanism of action of 5-ASA in antagonizing the toxic 
effects of AA, a novel finding of this study was the effect o f 5-ASA on CYP2E1 
induction in rat liver as determined by ELISA assay. What was shown in this study was 
that 5-ASA exerts its protective role against AA induced genotoxicity and reproductive 
toxicity by increasing induction of CYP2E1 in liver. Further, it was shown that AA 
caused depletion of liver CYP2E1, which was most likely due to excessive use of this 
enzyme in metabolizing AA. This increase in CYP2E1 induction in the liver increases 
metabolism of AA to its active metabolite glycidamide, which is subsequently conjugated 
to glutathione and excreted in the urine as an inactive metabolites, with consequent 
improvement in Leydig cell atrophy and histological structure of testis in general, which 
will be impacted on intra testicular testosterone level and eventually on fertility. No 
significant effect on liver weight was detected in the current study in AA or ASA treated 
rats. Also HPLC study on rat serum for quantitation of AA in treated rat did not show 
any significant difference in this acute study.
Could 5-ASA used safely by humans?
5-ASA (Pentasa® or Asacol®) is a medication used for a long period of time by millions 
of patients around the world for symptomatic treatment of inflammatory bowel disease 
(IBD), with no serious side effects observed (Qureshi and Cohen, 2005; Sonu ct al., 2010) 
because of its efficacy in mild to moderate disease and excellent safety profile for both 
shorte-term and long-term use. However, caution should be taken by individuals who are 
allergic to any derivatives of salicylates, and patients with preexisting renal or liver disease.
1 8 2
5-ASA, when administered orally is rapidly and completely absorbed from the upper 
intestine, but poorly absorbed from the colon (Schroder and Campbell, 1972). After 
nearly complete absorption of free 5-ASA from the proximal intestine, it is subjected to 
extensive metabolism to N-acetyl-5-ASA by the N-acetyl-transferase 1 (NAT) enzyme in 
intestinal epithelial cells and the liver, and finally is excreted in the urine as a mixture of 
free 5ASA and N-acetyl-5ASA, which is inactive as an anti-inflammatory agent. In 
humans the half life o f the 5ASA is 0.6 to 1.4 hr, while the half life for the metabolite 
(Ac-5-ASA) is 6h (Qureshi and Cohen, 2005).
Are the doses of 5-ASA examined in this study, effective and can be extrapolated to be 
used by humans?
Patients for ulcerative colitis are using much higher doses of 5-ASA by different routes, 
oral or rectal, it could reach up to 2-4g/day as a high once daily oral dose in the treatment 
of mild to moderate active ulcerative colitis (De Vos, 2000). Lower doses (800mg three 
times a day) are also used (Parakkal et al., 2010). Following intravenous administration in 
humans, it was rapidly eliminated with a plasma half-life about 40min (Bondesen et al., 
1991).
Certainly, this issue needs further clinical trials on humans, to determine the effective 
dose of 5-ASA that can be used in case of AA poisoning.
Further investigations are needed to prove the effectiveness of 5-ASA in protecting 
victims of AA poisoning with minimal side effects, as for the other compounds that have 
been shown to protect or to accelerate recovery from AA induced neuropathy such as 
vitamin B6 and sodium pyruvate (Friedman, 2003).
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Given that human sub acute acrylamide exposure can theoretically induce reproductive or 
genotoxicity, it is important to clarify if  any damage is reversible or permanent. Finally, if 
damage is reversible, what is the time period required for this recovery?
In accordance with the results o f this study, natural recovery of rats from both 
reproductive and genotoxic effects of AA following a sub acute exposure o f a high AA 
dose was shown for the first time, to take place after 55 days o f recovery. Within ten days 
of recovery certain parameters were shown to be maximally detected stich as sperm shape 
abnormalities and histopathology of the testis, and after 3 days o f recovery genotoxicity in 
the form o f increasing COMETs in the peripheral blood leukocytes shown to be 
maximally detected. This near-complete recovery following 55 days suggests that AA- 
mediated repro-damage is reversible and this should translate to humans as well. Because 
all the mechanisms observed in rat can, theoretically occur in humans, it is hence 
probable that rat reprotoxicity is a viable mechanism in humans.
184
CYP2E1
A c r y l a m i d e  L- Glycidamide
I
Ley dig Cell Atrophy
Decreased Testesterone Secretion
Abnormal Sertoli Cells !
- Spermatogonial degeneration
-Increased cells detachment due to tight junctions 
dissociations.
- Intercellular vacuolations
Abnormal Spermatogenesis
-Increased numbers of deformed sperms. 
-Reduction in total sperm count 
-Hypospermatogenesis
Reduced fertility
Fig. 48. Diagrammatical illustration of possible AA testicular mechanism in rat 
Induced testicular toxicity of AA is mainly due to its active metabolite, glycidamide. AA 
exerts its effects primarily on the Leydig cells, with possibly another minor mechanism 
due to a direct effect of AA itself on Sertoli cells.
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Finally, it is important to emphasize that humans are exposed to AA by different routes; 
oral (food and water); inhalation (smoking); dermal contact in occupational exposed 
workers. Absorption o f AA via the oral route is considered to be rapid and complete, 
potentially resulting in a high systemic exposure for a given dose, and therefore a 
potential risk management strategy might be to reduce the AA content o f food, such as 
selecting from available cultivars (potatoes, cereal grain) those that contains low levels o f 
asparagines (Friedman, 2003), the precursor for AA in most foodstuffs. In addition, food 
should not be fried/ baked for long time and at too high temperature, conditions ideal for 
the formation o f AA. Finally, the general population should be educated about the need 
for healthy eating and a balanced and varied diet containing plenty o f fruits and vegetable, 
a strategy that would both reduce AA exposure and increase the general health o f the 
population.
Exposure via inhalation/dermal routes occurs both within the general population, and 
through occupational exposures. Inhalation exposure in the general population can be 
drastically reduced by the avoidance of active and passive cigarette smoking, reducing 
AA exposure by the inhalation route. Finally, occupational exposure can be significantly 
reduced through the correct use o f personal protective equipment and an increase in 
workplace practice management to reduce the potential for exposure.
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6.4 Future Work
This study investigated using rats; however, it would be more interesting to perform some 
human epidemiological studies on AA, in relation to male fertility and chronic oral AA 
exposure in food or in chronic smokers. O f particular interest is whether low levels of 
AA exposure over a long period in the diet or smoking can cause reproductive adverse 
effects in exposed people. This would be of particular interest in some areas of Saudi 
Arabia known to have higher percentage of men infertility with the possibility to find a 
link between infertility and the type of drinking water, heavy smoking and diet habits by 
using questionnaires applied to different men with different ages and different 
occupations. Some of this work was pilot study, such as electron microscopic study on rat 
testis, so it would be valuable to extend those experiments with a reasonable number of 
animals. In addition the present study showed that AA induced histological changes in rat 
testis with no apoptotic changes could be detected, however liver tissue was not examined 
for the same toxic effects, so it is valuable to examine liver tissue after sub acute AA 
exposure. Also no quantitation of the histopathologic abnormalities was applied during 
this study, so it is much accurate outcome if quantization of the histopathologic 
abnormalities was done.
The current study investigated the in vivo toxic effect o f AA on rat reproductive system; 
however it would be interested to apply some in vitro studies such as culturing of Leydig 
cells and examine the direct effect of AA and 5-ASA directly on the cultured cells.
This study characterizing the dose response effects of AA on the rat reproductive system, 
but dose response effects o f the active metabolite glycidamide was not done, so it should 
also be performed. In the current study, sperms were prepared for examination from 
caudal suspension, but were not prepared directly from rat semen; therefore with the aid 
of artificial inscminator, fresh semen can be taken from a rat after AA treatment, under
187
anesthesia and examined for different chemistry, pH, sperm abnormalities, and number 
o f dead and alive sperms. Finally comet assay in this study was investigated only in 
leukocytes o f peripheral blood, but it would be interested to perform it also on the target 
tissue as liver and testis.
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